CN1246845A - 杀菌的羧酰胺 - Google Patents
杀菌的羧酰胺 Download PDFInfo
- Publication number
- CN1246845A CN1246845A CN98802296A CN98802296A CN1246845A CN 1246845 A CN1246845 A CN 1246845A CN 98802296 A CN98802296 A CN 98802296A CN 98802296 A CN98802296 A CN 98802296A CN 1246845 A CN1246845 A CN 1246845A
- Authority
- CN
- China
- Prior art keywords
- pyrroles
- base
- thienyl
- compound
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
- A01N37/20—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/34—Nitriles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrrole Compounds (AREA)
Abstract
本发明公开了一种用作杀菌剂的通式(Ⅰ)化合物,其中Q是:(Q-1)或(Q-2),Z是(Z-1);(Z-2);(Z-3)或(Z-4);X是-O-,-CH(R11)-或=C(R11)-;R1是H或C1-C2烷基;R2是H;C1-C6烷基;C3-C6环烷基;或被卤素,氰基,C1-C2烷基或C1-C2烷氧基任意取代的苯基;以及R3-R11如公开文本中所定义。还公开了含有通式(Ⅰ)化合物的组合物和一种控制由真菌植物病原体引起的植物病害的方法,其中包括施用有效量的通式(Ⅰ)化合物。
Description
发明背景
本发明涉及特定的N-(芳丙基)、N-(芳氧乙基)和N-(芳烯丙基)-羧酰胺,它们用于农业的合适盐和组合物,以及它们用作杀菌剂的方法。
对于由真菌植物病原体引起的植物病害的控制在获得高收成方面是极其重要的。损害观赏植物、蔬菜、田地、谷类和果类作物的植物病害能够引起产率显著的降低,因此导致消费者的费用增加。可以购买到这些用途的许多产品,但是人们一直期望具有较高活性、较低成本、较小毒性、对环境无害或具有不同作用方式的新化合物。
X是卤素;
n是1或2;
R1是氢、卤素或低级烷基;
R2是低级烷基、卤代低级烷基或氢;以及
R3是氢或低级烷基。
美国专利4946867公开了通式ii化合物和组合物及其作为杀菌剂的使用方法:其中
R是C2-C6烷基、C2-C6链烯基、C2-C6炔基或C3-C6环烷基;以及
X是Cl、Br、CF3或低级氟代烷氧基。
发明概述
X是-O-、-CH(R11)-或=C(R11)-;
R1是H或C1-C2烷基;
R2是H;C1-C6烷基;C3-C6环烷基;或被卤素、氰基、C1-C2烷基或C1-C2烷氧基任意取代的苯基;
R3是H、被卤素或CN任意取代的C1-C3烷基;
R4是H或C1-C2烷基;或
R3和R4一起形成-CH2CH2CH2-或-CH2CH2CH2CH2-;
R5是H、被卤素或CN任意取代的C1-C2烷基;
R6是C2-C8烷基、C2-C8链烯基、C2-C8炔基、C2-C8炔烯基或C3-C8环烷基。每个基团均可被卤素任意取代;
R7是H、CN、卤素、C1-C2卤代烷氧基或C1-C2卤代烷硫基;或C1-C4烷基、C2-C4链烯基或C2-C4炔基,每个基团可被卤素或CN任意取代;
R8、R9和R10各自单独是H、卤素、C1-C3烷基、C1-C3卤代烷基或Si(CH3)3;以及
R11是H、C1-C5烷基、C2-C5链烯基或C2-C5炔基。
发明详述
在上面的叙述中,用于复合词如“卤代烷基”中的术语“烷基”包括直链或支链的烷基,例如甲基、乙基、正丙基或异丙基。单独使用的术语“烷基”包括直链或支链的烷基,例如甲基、乙基、正丙基、异丙基,或不同的丁基、戊基、己基、庚基或辛基异构体。“链烯基”包括直链或支链的烯烃如乙烯基、1-丙烯基、2-丙烯基和不同的丁烯基、戊烯基、己烯基、庚烯基和辛烯基异构体。“链烯基”也包括多烯烃如1,2-丙二烯基和2,4-己二烯基。“炔基”包括直链或支链的炔烃如乙炔基、1-丙炔基、2-丙炔基和不同的丁炔基、戊炔基、己炔基、庚炔基和辛炔基异构体。“炔基”也包括由多个叁键组成的组分如2,5-己二炔基。“环烷基”包括,例如环丙基、环丁基、环戊基和环己基。“炔基链烯基”为一复合词,包括在直链或支链烯烃上取代的直链或支链炔烃。“炔基链烯基”的例子包括H2C=CHC(CH3)(C≡CH)和HC≡CCH=C(CH3)2。
在上面的叙述中,用于复合词如“卤代烷氧基”或“卤代烷硫基”中的术语“烷氧基”包括甲基和乙基。“卤代烷氧基”的例子包括CF3CH2O、CF3O、CHF2CF2O、HF2CO和CCl3CCl2O。“卤代烷硫基”的例子包括CF3S、HF2CS、CCl3S、CHF2CF2S和CF3CH2S。
单独使用、当基团为“被卤素任意取代”或在复合词如“卤代烷基”、“卤代烷氧基”或“卤代烷硫基”中使用的术语“卤素”包括氟、氯、溴或碘。此外,当用于复合词如“卤代烷基”中或当基团为“被卤素任意取代”时,所述的烷基或基团可以被相同或不同的卤素原子部分或全部取代。“卤代烷基”的例子包括F3C、ClCH2、CF3CH2和。CF3CCl2“被卤素任意取代”的烷基的例子包括CH(F)=CHC(CH3)(CH2F)和CH2=CHC(CH3)(CH2F)。
取代基中的碳原子总数表示为前缀“Ci-Cj”,其中i和j为1-6。例如,C1-C3烷基是指甲基-丙基。当基团含有可以是氢的取代基时,例如R1或R3,那么,当该取代基被看作是氢时,可以理解它等同于所述的未取代基团。
本发明中的化合物可以一种或多种立体异构体形式存在。多种立体异构体包括对映体、非对映异构体、阻转异构体和几何异构体。本领域技术人员将领会到,当一种立体异构体相对其它立体异构体富集或当从其它异构体中分离出时,该立体异构体具有更大活性和/或显示出有益效果。此外,熟练技术人员知道如何分离、富集和/或选择性地制备所述立体异构体。相应地,本发明包括选自通式I的化合物。本发明的化合物可以立体异构体的混合物、单个立体异构体或旋光形式存在。
值得注意的一类化合物,其中R7不是氢,特别是当Z是Z-1时。还有值得注意的一类化合物,其中R7是氢和R8不是氢以及当Z是与同R7取代的碳原子相邻的碳原子连接的Z-1时。另外值得注意的一类化合物,其中与R1连接的碳原子具有(R)构型。
还有值得注意的一类化合物,其中R1是H或CH3;R2是H或CH3;R6是C2-C6烷基、C2-C6链烯基、C2-C6炔基或C3-C6环烷基,每个基团均可被卤素任意取代;以及R7是H、CN、卤素、C1-C4卤代烷基、C1-C4烷基、C2-C4链烯基或C2-C4炔基,每个基团均可被卤素或CN任意取代。
其中:
Q是Q-1;
R1是CH3;
R2是H;
R3是CH2CH3;以及
R4是CH3。优选2.优选1的化合物,其中:
Z是Z-1或Z-4;
R7是H、卤素、CN、C1-C4烷基或C2-C4链烯基;
当Z是Z-1时,R8是H或F并且在相对于X的对位;以及
当Z是Z-1时,R9在相对于R7的对位。优选3.优选1的化合物,其中:
Z是Z-2或Z-3;以及
R7是H、卤素、CN、C1-C3烷基或C2-C4链烯基。优选4.上面通式I的化合物及其农用合适盐,
其中:
Q是Q-2;
R1是CH3;
R2是H或被卤素、氰基、C1-C2烷基或C1-C2烷氧基任意取代的苯基;以及
R6是均可被卤素任意取代的C2-C6烷基或C2-C6链烯基。优选5.优选4的化合物,其中:
Z是Z-1或Z-4;
R7是H、卤素、C1-C3烷基、C2-C4链烯基或C2-C4炔基;
当Z是Z-1时,R8是H或F并且在相对于X的对位;以及
当Z是Z-1时,R9在相对于R7的对位。优选6.优选4的化合物,其中:
Z是Z-2或Z-3;以及
R7是H、卤素、C1-C4烷基、C2-C4链烯基或或C2-C4炔基。
本发明还涉及杀菌组合物,其包括有效杀菌量的本发明的化合物和至少一种表面活性剂、固体稀释剂或液体稀释剂。本发明优选的组合物是那些含有上述优选化合物的组合物。
本发明还涉及一种控制由真菌植物病原体引起的植物病害的方法,其中包括将有效杀菌量的本发明化合物(如这里描述的组合物)施用到植物及其局部,或施用到植物的种子或幼苗中。优选的施用方法是包括上述优选化合物的那些方法。
合成详述
通式I化合物可以通过反应路线I中描述的下面一种或多种方法及其变化方法制备。下面通式I-XXXIII化合物中Q、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、X和Z的定义如发明概述中所定义的那样。
当A为OH时,在惰性溶剂中在脱水试剂如N,N’-二环己基碳二亚胺(DCC)或羰基二咪唑(CDI)存在下,将通式II胺与通式III羧酸进行缩合。该方法可以在较宽范围的温度下和各种溶剂中进行。一般来讲,在20℃-反应混合物的沸点,优选约100℃下进行缩合0.1-72h。合适溶剂的例子包括二氯甲烷、甲苯、二乙醚、四氢呋喃、丙酮和乙腈。
当A是氯时,在惰性溶剂中在酸性接受体如三乙胺存在下,将通式II胺与通式III酰氯进行缩合。合适的反应温度、时间、溶剂和压力于当A是OH时缩合所描述的相同。
通式II胺是已知的或可以通过不同方法制备。通式II胺可以由氨基甲酸酯IV来制备,其中R12通常为叔丁基或苄基,或者由V来制备,其中Y通常为苯基(形成苯邻二甲酰亚胺环)或二-叔丁氧基羰基(形成二-叔丁氧基羰基保护基团)。可以通过文献中列出的方法除去IV和V中氨基甲酸酯和苯邻二甲酰亚胺保护基团形成II,这些文献例如引用Greene,T.W.有机合成中的保护基团;John Wiley & Sons,New York,NY,(1991),第7章。
通式IVa和Va化合物(其中X是双键连接的碳原子)是通式IV和V化合物的子集,可以通过使用通式VII的芳族溴化物或碘化物(对于Z是苯基或噻吩的情况)和1-10mole%合适Pd(II)催化剂分别处理通式VIa和VIb保护的胺来制备。合适的催化剂包括与过量2-4倍的膦配体如三苯基膦配合的PdCl2和Pd(OAc)2。在0℃-100℃下与1-3摩尔当量碱如K2CO3或三乙胺进行反应。反应混合物中时常使用10-50mole%铵相转移催化剂。常用的溶剂包括乙腈和二甲基甲酰胺。
通式VI化合物是通过文献中列出的方法由相应的未保护的胺制备而成,这些文献例如引用Greene,T.W.有机合成中的保护基团;JohnWiley & Sons,New York,NY,(1991),第7章。此外还可以通过在碱存在下用通式IXa或IXb的氨基甲酸酯或二亚酰胺取代通式VIII化合物中的离去基团LG,其中碱是例如醇盐如叔丁醇钾,氢化物盐如氢化钠,或胺碱如二异丙基乙胺。通常的离去基团LG包括氯化物、溴化物、碘化物、(甲磺酰基)氧或[(4-甲基苯基)磺酰基]氧。
通式VII、VIII和IX化合物可以购买或通过文献中列出的方法合成。
通式IVa化合物(对于Z是苯基或噻吩的情况)也可以通过在通式XXXVI的芳香醛和酮存在下用膦如三苯基膦处理,从通式XXXV的化合物来制备。反应是在醚性溶剂如甘醇二甲醚或四氢呋喃、烃类溶剂如甲苯或质子溶剂如异丙醇或乙醇中以及在20℃-150℃的温度范围下进行。通式XXXV和XXXVI可以购买到或通过文献中列出的方法很容易合成。
反应路线5
通式IVb和Vb化合物是通式IV和V化合物(其中X是单键连接的碳原子)的子集,可以通过使用合适的过渡金属催化剂如钯、铂或铑分别氢化通式IVa和Va化合物来制备。通常是将催化剂沉积在惰性载体如碳、氧化铝或碳酸钙上。加氢反应是在质子溶剂如乙醇或非质子溶剂如四氢呋喃或乙酸乙酯中进行。要求1-10torr的氢气压力。加氢反应在25℃下进行,但也可以在至多100℃的温度下进行。
另外,通式IIb的化合物(其中Z是苯基或噻吩以及X是单键连接的碳原子)可以在1-10当量氢化物还原剂如钠或四丁基氰硼氢化物或三乙酸基硼氢化钠存在下,通过与过量的卤化铵或乙酸铵进行还原性胺化作用从通式X化合物来制备。反应可以在质子溶剂如甲醇或非质子传递溶剂如四氢呋喃或二氯甲烷中进行。通常分批加入酸性催化剂如HCl或对甲苯磺酸使得保持pH为3-5(通过pH计或显色指示剂如溴甲酚绿或甲基橙测定)。还原性胺化作用的温度范围通常为-5℃~60℃。
通式X化合物可以在用于化合物IVa和Va转化至化合物IVb和Vb所述的条件下通过加氢反应从通式XI化合物(其中Z是苯基或噻吩)来制备。通式XI化合物可以通过通式XII化合物(其中Z是苯基或噻吩)与合适的三苯基膦内翁盐或合适的磷酸盐阴离子进行烯化反应来制备。烯化反应通常在醚性溶剂如四氢呋喃或二甲氧基乙烷或极性非质子传递溶剂如二甲亚砜或二甲基甲酰胺中以及在0-100℃的温度范围内进行。内翁盐和磷酸盐阴离子分别用醇化物或氢化物碱和通过文献中列出的其他方法(参见March J.高等有机化学;John Wiley & Sons:NewYork,(1992);第4版,956-963页)产生。
通式IVb或Vb化合物(其中Z是吡咯基)可以通过在酸性接受体存在下取代通式XIIIa或XIIIb化合物的离去基团LG来制备,其中酸性接受体可以是叔胺如三乙胺,醇盐如叔丁醇钾或碳酸盐如碳酸钾。离去基团LG如通式VIII化合物中描述的那样。取代反应通常在极性非质子传递溶剂如二甲基甲酰胺或二甲亚砜、醚性溶剂如四氢呋喃或二恶烷或质子溶剂如甲醇中进行。反应温度可以是20℃-150℃。
反应路线9
通式XIII化合物可以通过标准方法从通式XIVa或XIVb化合物来制备,其中标准方法用于将醇转化为卤化物(March J.高等有机化学;John Wiley & Sons:New York,(1992);第4版,431-433页)和用于将醇转化为磺酸盐(March J.高等有机化学;John Wiley & Sons:New York,(1992);第4版,498-499页)。化合物XIV可以通过文献中列出的方法依次从氨基醇来制备,这些文献例如引用Greene,T.W.有机合成中的保护基团;John Wiley & Sons,New York,NY,(1991),第7章。
通式IVc和Vc化合物是通式IV化合物(其中X是O)的子集,可以在用于XIII转化为IVb和Vb所述的条件下通过用通式XVI化合物取代离去基团LG,分别从通式XVa和XVb化合物来制备。离去基团LG如通式VIII化合物中描述的那样。通式XVa和XVb化合物可以按照用于通式XIII化合物中描述的那样从相应的醇XVIIa和XVIIb来制备。IVc和Vc可以在1-2当量的三苯基膦和1-2当量的二乙基偶氮二羧酸酯存在下,分别直接从XVIIa和XVIIb制备。反应通常在惰性溶剂如二氯甲烷或四氢呋喃中以及在0℃-100℃的温度范围内进行。通式XVI化合物通常可以购买到或通过文献中列出的方法制备。作为当Z为吡咯基时文献方法的综述,参见Achesson,R.M.高等杂环化学(1990),51,115-119。按照通式XIV化合物的制备中所述的那样从相应的氨基醇来制备通式XVII化合物。
此外,通式IVc化合物(其中Z是苯基或噻吩)可以通过将化合物XVIIa与碱和通式XVIII活性芳基氟反应来制备。合适的碱包括氢化物盐如氢化钠,胺盐如二异丙基胺锂和醇化物盐如叔丁醇钾。反应溶剂可以包括醚性溶剂如四氢呋喃或极性非质子传递溶剂如二甲基甲酰胺。反应温度可以是-20℃~150℃。对于XVIII中R7、R8、R9或R10当中至少一个是吸电子基团如CN或卤素的情况下,反应将很容易。
反应路线12
通式IIIa化合物是通式III化合物的子集(其中A是OH),可以通过用于酯水解的标准方法(参见Greene,T.W.有机合成中的保护基团;John Wiley & Sons,New York,NY,(1991),227-260页),从相应的通式XIX酯(其中R13是C1-C5烷基或任意取代的苄基)来制备。
通式XIXa化合物是通式XIX化合物的子集,可以通过用过量的二氯卡宾处理通式XX化合物来制备。二氯卡宾可以在氯仿溶剂中生成,并与含有5-20当量氢氧化钠或氢氧化钾的两相混合物中的XX反应,其中通过1-20mole%四烷基铵卤化物或冠醚相转移催化剂来促进反应。反应在0℃-60℃的温度范围内进行。XX至XIXa的转化也可以通过在醚性溶剂如二甘醇二甲醚或二恶烷或芳香烃类溶剂如苯或甲苯或者在简洁的条件下,用1-5当量的三氯乙酸的碱金属盐处理而完成。反应温度可以是60℃-150℃。加入1-20mole%相转移催化剂如18-冠-6或氯化四丁基铵,可以促进反应。此外,XX至XIX的转化也可以通过在1-5当量甲醇钠或乙醇钠的存在下,用1-5当量的三氯乙酸甲酯或乙酯处理而完成。合适的溶剂包括烃如戊烷或环己烷,醚如四氢呋喃或二甲氧基乙烷或芳香烃如苯或甲苯。反应温度可以是-20℃~120℃。
通过通式XXI和XXII化合物的缩合制备通式XX化合物。该缩合条件在March J.高等有机化学;John Wiley & Sons:New York,(1992);第4版,944-945页的参考文献中有描述。
反应路线15
此外,通式IIIb化合物,即通式IIIa化合物的子集也可以按照文献中列出的许多用于醇氧化为酸的方法(参见Larock,R.C.Comprehensive Organic Transformations;VCH Publishers:New york,(1989),834-837页),通过氧化通式XXIII化合物来制备。按照XX转化为XIXa中描述的条件通过通式XXIV化合物的反应可以生成二氯环丙烷XXIII。
XXIV至XXIII的转化有时通过使用化学保护基团可以更有效地传递。因此XXIV醇可以转化为醚XXV,其中PG可以是烷基、苄基或甲硅烷基保护基团。随后按照XIX转化为IIIa中描述的条件经过环丙化至XXVI,然后除去保护基团完成转化至XXIII。合适的保护基团及其生成和除去的条件在Greene,T.W.有机合成中的保护基团;JohnWiley & Sons,New York,NY,(1991),10-86页中描述。
反应路线17
通式XXIV化合物可以按照下面方法从通式XXVII化合物来制备,即通过加入2-5当量格氏试剂XXVIII并通过滴加过量的质子溶剂如任意含有溶解的质子给体如氯化铵或氯化氢的水、甲醇或乙酸或者通式XXIX的试剂(其中LG为通式VIII化合物所描述的离去基团)骤冷。反应是在醚性溶剂如二乙醚或四氢呋喃中以及0℃-60℃的温度范围下进行,其中骤冷是在-20℃~30℃的温度范围下进行。
反应路线18
此外,通式XXIV化合物可以按照下面方法从通式XXX化合物来制备,即在1-10%过渡金属催化剂如((C6H5)3P)2NiCl2或((C6H5)3P)4Pd存在下通过用2-5当量格氏试剂或通式XXXI(M是卤化镁或卤化锌)的锌有机金属试剂处理。反应通常在醚性溶剂如乙醚或四氢呋喃或极性非质子传递溶剂如二甲基甲酰胺中以及在-20℃-60℃的温度范围下进行。
通式XXX化合物可以按照所描述的通式XXIV化合物的制备方法来制备,其中不同的是在选择的反应溶剂中通过滴加过量的I2或Br2来骤冷反应混合物。
反应路线20
通式XIXb化合物,作为通式XIX化合物的子集。在文献中是已知的(参见例如,Alexander,E.R.;McCollum,J.D.和Pour,D.E.有机化学(1950),72,4791-4972;Stevens,R.V.;Christenson,C.G.;Edmonson,W.L.;Kaplan,M.;Reid,E.B.;Wentlant,M.P.美国化学会志(1971),93,6624-6637;和作者不详,USA Res.Discl.(1985),55,249),可以通过在通式XXXIII化合物中加入1-2当量通式XXXII(其中R16是被CN任意取代的C1-C4烷基、C2-C4链烯基或C2-C4炔基)的烷基镁、铜、锌或锂试剂。XXXIII中的R14和R15分别为H、C1-C4烷基、C2-C4链烯基、C2-C4炔基或C3-C6环烷基,其中每个基团可被卤素任意取代。反应通常在醚性溶剂如二乙醚或四氢呋喃中以及在-20℃~60℃的温度范围下进行。为了促进反应,可以选择地加入Cu(I)催化剂(1-10mole%)如铜(I)卤化物。此外,在IVa和Va转化为IVb和Vb中所描述的条件下可以将XXXIII加氢生成XIXb。通式XXXIII化合物在文献中是已知的,并可通过氰基乙酸酯与醛或酮进行诺文葛耳反应来制备(参见Jones,G.有机反应John Wiley & Sons:New York,(1967);第15卷,238-244页)。
反应路线21
可以从通式XXXIV化合物来制备通式IIIc化合物,该化合物为通式IIIa化合物的子集,其中Q是Q-2;R14和R15如前面所描述;以及R17、R18、R19单独为卤素、C1-C2烷基、C2链烯基、C2炔基,其中每个基团可被卤素任意取代。通式XXXIV化合物重排为通式IIIc化合物可以通过文献中列出的步骤进行(参见March J.高等有机化学;JohnWiley & Sons:New York,(1992);第4版,1136-1141页)。通常在惰性溶剂如四氢呋喃或甲苯中以及在78℃-150℃的温度范围内用1当量氨基化锂或氨基化钾或醇化物碱如二异丙胺锂或叔丁醇钾处理XXXXIV。此外,中间体甲硅烷基乙烯酮缩二乙醇可包含在转化过程中,即通过在1-10当量六甲基二硅氮烷存在下在溶剂如六甲基二硅氮烷中或在惰性溶剂如苯或甲苯中加热XXXIV至回流的转化过程中。甲硅烷基乙烯酮缩二乙醇引起的重排产物是甲硅烷酯,通过酸或碱水解可转化为酸。
通式XXXIV化合物可以按照酯化反应的标准条件从通式XXXV化合物来制备(参见March J.高等有机化学;John Wiley & Sons NewYork,(1992);第4版,392-401页)。通式XXXV化合物通常可以购买到或很容易通过文献中列出的方法合成出。
可以意识到的是,上述用于制备通式I化合物的一些试剂和反应条件可能不适合中间体中含有的特定官能团。这些情况下,在合成中结合保护/脱保护步骤或官能团的相互转换将有助于获得目标产物。对于化学合成中的技术人员来说,保护基团的使用和选择将是显而易见的(参见,例如Greene,T.W.;Wuts,P.G.M.有机合成中的保护基团,第二版.;Wiley:New York,1991)。本领域技术人员将意识到,在一些情况下,在加入任意单个反应路线中描述的特定试剂后,有必要进行未详细描述的另外合成步骤来完成通式I化合物的合成。本领域技术人员还将意识到,有必要进行上述反应路线中描述的步骤的结合,其顺序不同于制备通式I化合物所隐含的特定次序。
本领域技术人员还将意识到,这里描述的通式I化合物和中间体可以经过多种亲电、亲核、自由基、有机金属、氧化和还原反应来添加取代基或修饰已有的取代基。
无需进一步的创造性劳动,可以相信的是,使用前面描述的本领域技术人员能够最大限度地利用本发明。因此,下面的实施例可理解为仅用于说明,而不是以任何方式限制公开。百分数是指重量,除非对于色谱溶剂混合物或另有说明。除非另有说明,用于色谱溶剂混合物的份数和百分数均指体积。1HNMR谱是用来自四甲基硅烷低磁场ppm来表示;s=单峰,d=双峰,t=三重峰,q=四重峰,m=多重峰,dd=两个双峰,dt=两个三重峰,br s=宽单峰。
实施例1步骤A:(顺)-2-乙基-2-丁烯-1-醇的制备
将800mL3.0M溴化乙基镁的乙醚溶液滴加到冷却至0℃含有40ml(690mmol)炔丙醇和13.1g(69mmol)碘化亚铜的1L乙醚溶液中。将混合物加热至室温并搅拌3天。冷却至0℃后,分批加入295g碘。用浓盐酸酸化混合物并分成为乙醚层和水层。分离出乙醚层并用饱和的NaHSO3水溶液、水和盐水洗涤。干燥(MgSO4)并通过在5torr下蒸馏除去溶剂得到油状物。沸程为74-81℃的馏分为产物(反)-2-(碘代亚甲基)-1-丁醇,49g。将该馏分连同7.8g(12mmol)氯化二-三苯基膦镍(II)一起溶于500mL乙醚中并冷却至0℃。逐滴加入231mL3.0M溴化甲基镁的乙醚溶液。将混合物加热至室温并搅拌过夜。首先用1NHCl骤冷,然后使用浓盐酸并分成为乙醚层和水层。分离出乙醚层并用水、饱和NaHSO3水溶液、水和盐水洗涤。干燥(MgSO4)并通过在0.5torr下蒸馏除去溶剂得到油状物。沸程为83-96℃的馏分为产物(顺)-2-乙基-2-丁烯-1-醇,9.6g。步骤B:(顺)-2,2-二氯-1-乙基-3-甲基环丙烷羧酸的制备
将含有9.6g(96mmol)(顺)-2-乙基-2-丁烯-1-醇和0.44g氯化苄基三乙基铵的200mL氯仿溶液冷却至0℃,并逐滴加入95.5mL 50%氢氧化钠溶液。搅拌2小时后,用水稀释混合物并用乙醚萃取3次。干燥(MgSO4)乙醚并汽提得到19.4g油状物,该油状物无需纯化即可进一步使用。16.7g(91.7mmol)油溶液溶于100mL丙酮中并冷却至0℃。逐滴加入含有18.3g(183mmol)CrO3的125mL 25%的H2SO4溶液。搅拌5分钟后,逐滴加入饱和NaHSO3水溶液。用乙醚萃取该混合物。用水洗涤乙醚并用1N氢氧化钠洗涤3次。将该碱性萃取液酸化并用乙醚萃取3次。干燥(MgSO4)乙醚并汽提得到9.32g产物(顺)-2,2-二氯-1-乙基-3-甲基环丙烷羧酸,该油状物缓慢固化,熔点为68-70℃,1H NMR(CDCl3):δ1.0(t,3H),1.25(d,3H),1.25(m,1H),2.25(m,1H),2.35(q,1H)。步骤C:(顺)-2,2-二氯-1-乙基-3-甲基-N-(3-苯丙基)环丙烷羧酰胺的制备
将含有2.06g(10.5mmol)(顺)-2,2-二氯-1-乙基-3-甲基1-环丙烷羧酸的10mL亚硫酰氯溶液加热回流30分钟。真空除去溶剂。将残余物溶于18mL二氯甲烷中。将部分该溶液(5mL,2.55mmol)加到含有0.4mL(2.8mmol) 3-苯基-1-丙胺和0.33mL(3.05mmol)三乙胺的25mL二氯甲烷溶液中。室温下搅拌过夜后,用乙酸乙酯稀释混合物并用水和盐水洗涤。干燥(MgSO4)并除去溶剂得到油状物,将该油状物加到硅胶柱中进行柱层析(2∶1己烷/乙醚)得到260mg标题化合物,熔点为66-70℃,1H NMR(CDCl3):1.05(t,3H),1.3(d,3H),1.5(m,1H),1.8-2.0(m,4H),2.65(t,2H),3.3-3.5(m,2H),5.6(br s,1H),7.2-7.4(m,5H)。
实施例2步骤A:(反)-2-乙基-2-丁烯-1-醇的制备
将1070mL(2.15mol)2.0M氯化乙基镁的乙醚溶液,在0℃及氩气气氛下滴加到含有50ml(720mmol)2-丁炔-1-醇和14.9g(78mmol)碘化亚铜的1L 4∶1乙醚/四氢呋喃溶液中。将溶液加热回流6天。加入65mL 25%(重量)氯化乙基镁的四氢呋喃溶液。再连续加热回流1天。反应通过滴加饱和NH4Cl水溶液进行骤冷,并且混合物分成为水层和乙醚层。分离出乙醚层并用水洗涤。干燥(MgSO4)并除去溶剂得到53.5g(反)-2-乙基-2-丁烯-1-醇流性油。步骤B:(反)-2,2-二氯-1-乙基-3-甲基环丙烷甲醇的制备
将咪唑(13.6g,200mmol)滴加到含有8.0g(80mmol)(反)-2-乙基-2-丁烯-1-醇和14.5g(96mmol)氯化叔丁基二甲基甲硅烷的20mLDMF溶液中,混合物在室温下搅拌过夜。将溶液倒入水中并用乙酸乙酯萃取。用水和盐水洗涤乙酸乙酯4次。干燥(MgSO4)并除去溶剂得到17g(反)-(1,1-二甲基乙基)[(2-乙基-2-丁烯基)氧]二甲基甲硅烷流性油。将含有10g(46.6mmol)油和0.21g氯化苄基三乙铵的100mLCHCl3溶液冷却至-5℃。逐滴加入45mL(85mmol)50%氢氧化钠溶液,将该混合物加热至室温并搅拌3小时。用二氯甲烷稀释混合物并用水、1NHCl和盐水洗涤3次。干燥(MgSO4)并除去溶剂得到14g(反)-[(2,2-二氯-1-乙基-3-甲基环丙基)甲氧基](1,1-二甲基乙基)二甲基甲硅烷粘性油。将该油溶解在200mL含乙醇的1%HCl中并加热回流2.5小时。除去溶剂,用二氯甲烷稀释残余物并用水和盐水洗涤。干燥(MgSO4)并除去溶剂得到8.95g(反)-2,2-二氯-1-乙基-3-甲基环丙烷甲醇。步骤C:(反)-2,2-二氯-1-乙基-3-甲基环丙烷羧酸的制备
将高碘酸钠(21g,98mmol)分批加到含有8.91g(4.92mmol)(反)-2,2-二氯-1-乙基-3-甲基环丙烷甲醇和0.22g(1mmol)RuCl3·H2O的100mL 1∶1乙腈/四氯化碳和70mL水的溶液中。搅拌3小时后,用二氯甲烷稀释混合物并用水和盐水洗涤,干燥(MgSO4)并汽提。将残余物溶于乙醚中并用1N氢氧化钠和水洗涤2次。酸化混合的水层并用乙醚萃取2次。用水洗涤乙醚并干燥(MgSO4)。除去溶剂得到6.1g(反)-2,2-二氯-1-乙基-3-甲基环丙烷羧酸,该油状物缓慢固化,熔点为61-63℃。步骤D:(R)-2-[1-甲基-2-[(甲磺酰基)氧]乙基]-1H-异吲哚-1,3(2H)-二酮的制备
将甲磺酰氯(9.4ml,68mmol)加到含有12.6g(61.5mmol)(R)-2-(2-羟基-1-甲基乙基)-1H-异吲哚-1,3(2H)-二酮(Becker,Y.有机化学会志(1980),45(11),2145-2151页)和5.23mL(67.6mmol)甲磺酰氯的溶液中,混合物在室温下搅拌过夜。除去溶剂,将残余物溶解在乙酸乙酯中,并用水和盐水洗涤。干燥(MgSO4)并除去溶剂得到17g褐色油状物,该油状物缓慢固化。从正丁基氯中重结晶得到白色固体(R)-2-[1-甲基-2-[(甲磺酰基)氧]乙基]-1H-异吲哚-1,3(2H)-二酮,熔点为75-77℃。步骤E:5-氯-6-甲基-2-吡啶胺1-氧化物盐酸盐的制备
向含有110g(666mmol)5-氯-6-甲基-吡啶胺(Kress,T.J.;Moore,L.L.;Costantino,S.M.有机化学会志(1976)41(1),93-96页)的1L二氯甲烷的溶液中加入164g(666mmol)间氯过苯甲酸。混合物在室温下搅拌过夜,并再加入20g间氯过苯甲酸。混合物搅拌1小时并加入50mL饱和NaHSO3水溶液。除去溶剂并将残余物溶解在1L 1NHCl中。过滤掉不溶的固体,并用3N HCl洗涤。从含水的滤液中除去溶剂得到固体,再从乙醇中重结晶获得白色固体56.9g 5-氯-6-甲基-2-吡啶胺1-氧化物盐酸盐,熔点>250℃。步骤F:4-氯-1-羟基-5-甲基-1H-吡咯-2-腈的制备
将含有55.9g(287mmol)5-氯-6-甲基-2-吡啶胺1-氧化物盐酸盐的1L 10%HCl溶液冷却至0℃。逐滴加入25.5g(365mmol)亚硝酸钠水溶液。搅拌15分钟后,逐滴加入23.7g(365mmol)叠氮化钠水溶液。混合物在室温下搅拌过夜,然后用二氯甲烷萃取3次。干燥(MgSO4)并除去溶剂得到35g橙色固体,将该固体溶解在氯仿中并加热回流4天。除去溶剂得到固体,将该固体通过硅胶色谱柱(CH2Cl2,然后乙醚)进行纯化分离出2种组分:4.8g较高Rf物质,被鉴定为4-氯-5-甲基-1H-吡咯-2-腈,1H NMR(CDCl3)δ2.3(s,3H),6.7(s,1H),8.9(br s,1H)和17.8g 4-氯-1-羟基-5-甲基-1H-吡咯-2-腈,熔点为91-101℃,1H NMR(CDCl3)δ2.25(s,3H),6.5(s,1H)。步骤G:(R)-4-氯-1-[2-(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)丙氧基]-5-甲基-1H-吡咯-2-腈的制备
将含有3.0g(10.6mmol)(R)-2-[1-甲基-2-[(甲磺酰基)氧]乙基]-1H-异吲哚-1,3(2H)-二酮、2.0g(12.7mmol)N-氯-1-羟基-5-甲基-1H-吡咯-2-腈和1.76g(12.7 mmol)K2CO3的60mL乙腈溶液加热回流过夜。除去溶剂,将残余物溶解在乙酸乙酯中,并用水和盐水洗涤。干燥(MgSO4)并除去溶剂得到油状物,将该油状物通过硅胶色谱柱(己烷中含35%乙醚)得到2.55g白色固体(R)-4-氯-1-[2-(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)丙氧基]-5-甲基-1H-吡咯-2-腈,1H NMR(CDCl3):δ1.55(d,3H),2.15(s,3H),4.45(m,1H),4.8(m,2H),6.5(s,1H),7.75(m,2H),7.85(m,2H)。步骤H:(R)-1-(2-氨基丙氧基)-4-氯-5-甲基-1-1H-吡咯-2-腈的制备
将含有0.6g(1.75mmol)(R)-4-氯-1-[2-(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)丙氧基]-5-甲基-1H-吡咯-2-腈和0.42mL(8.7mmol)肼的溶液加热回流50分钟,再冷却到室温。过滤掉沉淀出的固体并用乙醚淋洗。除去滤液中的溶剂并将残余物溶解在乙醚中。过滤不溶固体并用乙醚淋洗。汽提滤液获得0.43g油状物(R)-1-(2-氨基丙氧)-4-氯-5-甲基-1-1H-吡咯-2-腈。步骤I:[1R-[1α(R*),3α]]-2,2-二氯-N-[2-[(3-氯-5-氰基-2-甲基-1H-吡咯-1-基)氧]-1-甲基乙基]-1-乙基-3-甲基环丙烷羧酰胺与[1S-[1α(S*),3β]]-2,2-二氯-N-[2-[(3-氯-5-氰基-2-甲基-1H-吡咯-1-基)氧]-1-甲基乙基]-1-乙基-3-甲基环丙烷羧酰胺1∶1混合物的制备
在一分离烧瓶中,将含有0.34g(1.75mmol)(反)-2,2-二氯-1-乙基-3-甲基环丙烷羧酸的15mL亚硫酰氯溶液加热回流30分钟。汽提出亚硫酰氯并在真空中干燥残余物。将残余物溶解在20mL二氯甲烷中,并滴加含有0.43g(R)-1-(2-氨基丙氧)-4-氯-5-甲基-1-1H-吡咯-2-腈和0.25mL(1.8mmol)三乙胺的溶液。混合物在室温下搅拌过夜。汽提去溶剂,将残余物溶解在乙酸乙酯中,并用水和盐水洗涤。干燥(MgSO4)并除去溶剂得到油状物,将该油状物通过硅胶色谱柱(己烷中含40%乙醚)得到1∶1非对映异构体混合物的油状标题化合物,1H NMR(CDCl3):δ1.0(m,3H),1.2(d,3H),1.4(2d,3H,1∶1ratio),1.5-1.65(m,1H),2.0-2.2(m,1H),2.2(s,3H),2.2-2.3(m,1H),4.2-4.4(m,2H),4.4-4.6(m,1H),6.05和6.15(2d,1H,1∶1ratio),6.55(2s,1H,1∶1ratio).
实施例3步骤A:1,1-二甲基乙基[2-(2-氰基-4-氟苯氧基)-1-甲基乙基]碳酸酯的制备
用己烷淋洗氢化钠(1.26g 60%分散于油中,31.5mmol)3次并在5℃下悬浮于30mL DMF中。加入4.5mL(49.6mmol)2,5-二氟苯甲腈,接着分批加入5.0g(28.6mmol)(2-羟基-1-甲基乙基)-氨基甲酸-1,1-二甲基乙基酯。在用饱和NH4Cl水溶液骤冷之前,将该混合物在室温下搅拌过夜。在分成为乙醚层和水层之后,分离出乙醚层并用水和盐水洗涤2次。干燥(MgSO4)并除去溶剂得到固体,将该固体用己烷研碎得到6.3g白色固体1,1-二甲基乙基[2-(2-氰基-4-氟苯氧基)-1-甲基乙基]氨基甲酸酯,熔点为77-78℃。步骤B:2-(2-氨基丙氧基)-5-氟苯甲腈的制备
将含有1.0mL三氟乙酸和1.2g(4.08mmol)1,1-二甲基乙基[2-(2-氰基-4-氟苯氧基)-1-甲基乙基]氨基甲酸酯的10mL二氯甲烷溶液在室温下搅拌3天。除去溶剂并将残余物溶解在Na2CO3水溶液和乙酸乙酯中。分离出有机层并用水和盐水洗涤。干燥(MgSO4)并除去溶剂得到650mg2-(2-氨基丙氧基)-5-氟苯甲腈油状物。步骤C:(反)-2,2-二氯-N-[2-(2-氰基-4-氟苯氧基-1-甲基乙基]-1-乙基-3-甲基环丙烷羧酰胺的制备
在一分离烧瓶中,将含有750mg(3.8mmol)(反)-2,2-二氯-1-乙基-3-甲基环丙烷羧酸的20mL亚硫酰氯溶液加热回流30分钟。汽提出亚硫酰氯并在真空中干燥残余物。将残余物溶解在20mL二氯甲烷中,并滴加含有0.67g(3.45mmol)2-(2-氨基丙氧基)-5-氟苯甲腈和0.55mL(3.95mmol)三乙胺的溶液。混合物在室温下搅拌过夜。汽提去溶剂,将残余物溶解在乙酸乙酯中,并用水和盐水洗涤。干燥(MgSO4)并除去溶剂得到油状物,将该油状物通过硅胶色谱柱(己烷中含50%乙醚)得到1∶1非对映异构体混合物的标题化合物,熔点为119-123℃。
1H NMR(CDCl3)δ0.9和0.95(2t,3H,1∶1ratio),1.2(d,3H),1.45(m,3H),1.5-1.6(m,1H),2.0-2.1(m,1H),2.2(m,1H),4.0-4.2(m,2H),4.45(m,1H),6.95(m,1H),7.3(m,2H).
实施例4步骤A:2-[1-甲基-2-[(甲磺酰基)氧]丙基]-1H-异吲哚-1,3(2H)-二酮的制备
将甲磺酰氯(9.7mL,56mmol)加到含有10.5g(48mmol)2-(2-羟基-1-甲基丙基)-1H-异吲哚-1,3(2H)-二酮(JP 01242569 A2)和8.1mL(58mmol)三乙胺的溶液中,并将该混合物在室温下搅拌过夜。该混合物用乙醚稀释并用水和盐水洗涤。干燥(MgSO4)并除去溶剂得到油状物,该油状物缓慢固化。用己烷捣碎得到11.8g白色固体2-[1-甲基-2-[(甲磺酰基)氧]丙基]-1H-异吲哚-1,3(2H)-二酮,熔点为67-73℃。步骤B:4-氯-1-[3-(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)丁基]-5-甲基-1H-吡咯-2-腈的制备
将含有4.23g(14.2mmol)2-[1-甲基-2-[(甲磺酰基)氧]丙基]-1H-异吲哚-1,3(2H)-二酮、2.05g(14.2mmol)4-氯-5-甲基-1H-吡咯-2-腈和2.35g(14.2mmol)K2CO3的60mL乙腈溶液在60℃下加热过夜。将该混合物用乙醚稀释并用水洗涤4次。干燥(MgSO4)并除去溶剂得到油状物,将该油状物通过硅胶色谱柱(己烷中含15%乙酸乙酯)得到3.2g固体4-氯-1-[3-(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)丁基]-5-甲基-1H-吡咯-2-腈,1NMR(CDCl3):δ1.5(d,3H),2.2(s,3H,和m,1H),2.7(m,1H),3.9(m,1H),4.05(m,1H),4.4(m,1H),6.6(s,1H),7.85(m,2H),7.9(m,2H)。步骤C:1-(3-氨基丁基)-4-氯-5-甲基-1-1H-吡咯-2-腈的制备
将含有3.2g(9.4mmol)4-氯-1-[3-(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)丁基]-5-甲基-1H-吡咯-2-腈和4.8mL(94mmol)肼的乙醇溶液加热回流60分钟,再冷却到室温。过滤掉沉淀出的固体并用乙酸乙酯淋洗,浓缩滤液获得1-(3-氨基丁基)-4-氯-5-甲基-1-1H-吡咯-2-腈油状物。步骤D:2-氰基-3,4,4-三甲基戊酸的制备
将含有10g(50mmol)2-氰基-3,4,4-戊酸乙酯(Clarke,N.C.;Runciman,P.J.I.;Utley,J.H.P.;Landquist,J.K.化学会志,Perkin Trans.2(1987)(4),435-439页)和2.93g(52mmol)氢氧化钾的50mL乙醇溶液加热回流3小时并在室温下搅拌过夜。该混合物用水稀释并用乙醚萃取两次。将水层用浓HCl酸化并用乙醚萃取两次,接着用盐水洗涤,干燥(MgSO4)并浓缩获得9.6g 2-氰基-3,4,4-三甲基戊酸非对映体混合物,熔点为68-78℃。步骤E:N-[3-(3-氯-5-氰基-2-甲基-1H-吡咯-1-基)-1-甲基丙基]-2-氰基-3,4,4-三甲基戊酰胺的制备
将含有0.54g(3.5mmol)2-氰基-3,4,4-三甲基戊酸的15mL亚硫酰氯溶液加热回流30分钟。汽提去亚硫酰氯并将残余物在真空下干燥。然后将残余物溶解在20mL二氯甲烷中并逐滴加入含有0.66g(3.13mmol)1-(3-氨基丁基)-4-氯-5-甲基-1H-吡咯-2-腈和0.59mL(4.2mmol)三乙胺的溶液。混合物在室温下搅拌过夜。汽提去溶剂,将残余物溶解在乙酸乙酯中,并用水和盐水洗涤。干燥(MgSO4)并除去溶剂得到油状物,将该油状物通过硅胶色谱柱(己烷中含40%乙醚)得到为非对映异构体混合物的标题化合物,熔点为111-118℃。1H NMR(CDCl3):δ1.0(m,3H),1.2-1.3(2m,6H),1.4(d,1H),1.6(m,2H),1.9(m,2H),2.2(m,3H),4.1(2m,2H),5.7(m,1H),6.65(2s,1H)。
实施例5步骤A:双(1,1-二甲基乙基)-1-丙烯基亚氨基二碳酸酯的制备
将含有购买到的二叔丁基亚氨基二羧酸酯(25.0g,0.115mol)的100mL四氢呋喃溶液加到己烷淋洗的氢化钠(5.0g 60%油状悬浮液,0.125mol)中并在20℃下搅拌3小时。逐滴加入含有烯丙基溴(12.0mL,0.139mol)的30mL四氢呋喃溶液并将该混合物搅拌20小时。反应通过滴加10mL水来骤冷,蒸发至糊状,用200mL水处理并用乙酸乙酯萃取两次。合并有机层,用氯化铵饱和溶液洗涤然后浓缩得到油状物。将该油状物通过快速硅胶色谱柱进行纯化,其中使用5%乙酸乙酯/己烷溶液作为洗脱剂,得到26.0g(88%)双(1,1-二甲基乙基)-1-丙烯基亚氨基二碳酸酯无色晶体:熔点为44-46℃;1H NMR(300MHz,CDCl3):δ1.50(s,18H),4.18(m,2H),5.14(m,2H),6.85(m,1H)。步骤B:双(1,1-二甲基乙基)-2-丙烯基-3-(2-氟苯基)亚氨基二羧酸酯的制备
将含有双(1,1-二甲基乙基)-1-丙烯基亚氨基二碳酸酯(7.00g,27mmol)和邻氟碘代苯(8.10g,36.5mmol)的溶液用三苯基膦40mL(2.2g,8.4mmol)、氯化四丁基铵(5.30g,18.3mmol)、碳酸钾(12.4g,89.7mmol)和乙酸钯(0.640g,2.85mmol)处理。反应混合物在65℃加热4小时,然后再用乙酸钯(0.320g,1.43mmol)处理。反应混合物在65℃下再搅拌20小时。蒸发去溶剂,将残余物通过快速色谱柱进行纯化,其中使用5%乙酸乙酯/己烷溶液作为洗脱剂,得到4.0g(42%)双(1,1-二甲基乙基)-2-丙烯基-3-(2-氟苯基)亚氨基二羧酸酯,为浅黄色油状物:1HNMR(CDCl3):δ1.52(s,18H),4.36(d,2H),6.30(dt,1H),6.70(d,1H),7.10(m,2H),7.20(m,1H),7.40(t,1H)。步骤C:(反)-3-(2-氟苯基)-2-丙烯-1-胺盐酸盐的制备
将含有双(1,1-二甲基乙基)-2-丙烯基-3-(2-氟苯基)亚氨基二羧酸酯(4.0g,11mmol)的30mL二氯甲烷和15mL三氟乙酸溶液在20℃下搅拌18小时。蒸发反应混合物,用乙酸乙酯吸收残余物并用1N氢氧化钠溶液洗涤两次。蒸发有机层得到粗胺。用氯化氢(1N于二乙醚中)沉淀出游离胺,并通过玻璃漏斗进行过滤得到2.42g(91%)(反)-3-(2-氟苯基)-2-丙烯-1-胺盐酸盐,为白色粉末:熔点为205-208℃;1H NMR(Me2SO-d6):δ3.66(d,2H),6.40(dt,1H),6.81(d,1H),7.24(m,2H),7.40(m,1H),7.60(m,1H),8.20(brs,3H)。步骤D:(反)-2,2-二氯-1-乙基-N-[3-(2-氟苯基)-2-丙烯基]-3-甲基环丙烷羧酰胺的制备
将含有(反)-2,2-二氯-1-乙基-3-甲基环丙烷羧酸(见上文)(5.1g,25.9mmol)和40mL甲苯的溶液用亚硫酰氯(5.0mL,69mmol)处理并在65℃下加热3小时。蒸发去溶剂,将残余物用5%甲苯/己烷稀释并用活性炭处理。过滤悬浮液并将滤液在真空下浓缩得到5.05g(91%)(反)-2,2-二氯-1-乙基-3-甲基环丙烷碳酰氯澄清油。将含有酰基氯(0.33g,1.53mmol)的10mL二氯甲烷溶液滴加到含有(反)-3-(2-氟苯基)-2-丙烯-1-胺盐酸盐(0.40g,2.1mmol)、三乙胺(1.0mL,7.2mmol)的30mL二氯甲烷溶液中。搅拌反应混合物2小时然后在真空下浓缩。将残余物通过快速色谱柱进行纯化,其中使用10%乙酸乙酯/己烷作为洗脱剂,得到0.480g(95%)白色固体的标题化合物:熔点为103-105℃,1H NMR(CDCl3)δ1.01(t,3H),1.25(m,3H),1.60(m,1H),2.00(m,1H),2.22(m,1H),4.11(m,2H),5.90(br s,1H),6.30(dt,1H),6.75(d,1H),7.07(m,2H),7.20(m,1H),7.40(t,1H).
实施例6步骤A:2-[2-(2-乙基苯氧基)-1-甲基乙基]-1H-异吲哚-1,3(2H)-二酮的制备
将含有5.0g(24.4mmol)2-(2-羟基-1-甲基乙基)-1H-异吲哚-1,3(2H)-二酮(Y.Becker, A.Eisenstadt,J.K.Stille,有机化学会志,1980,45,2145)和三苯基膦(7.00g,27.0mmol)的40mL无水四氢呋喃溶液在20℃下搅拌1小时。向该溶液中加入2-乙基苯酚(3.90g,32.0mmol)和偶氮二羧酸二乙酯(5.0mL,32.0mmol),将该溶液再搅拌40小时。在真空下浓缩反应混合物,将残余物在乙酸乙酯中稀释并用水和盐水洗涤。在真空下浓缩有机层,将粗产物通过快速硅胶色谱柱进行纯化,其中使用5%乙酸乙酯/己烷溶液作为洗脱剂,得到3.0g(40%)2-[2-(2-乙基苯氧基)-1-甲基乙基]-1H-异吲哚-1,3(2H)-二酮无色油状物:1H NMR(CDCl3)δ0.96(t,3H),1.60(d,3H),2.40(m,2H),4.18(dd,1H),4.48(t,1H),4.84(m,1H),6.80(m,1H),6.90(m,1H),7.10(m,2H),7.70(m,2H),7.84(m,2H).步骤B:1-(2-乙基苯氧基)丙胺盐酸盐的制备
将2-[2-(2-乙基苯氧基)-1-甲基乙基]-1H-异吲哚-1,3(2H)-二酮(3.0g,9.7mmol)溶解在300mL无水乙醇中,并在回流下用无水肼(3.0mL,96mmol)处理2小时。冷却反应混合物并通过多孔玻璃漏斗进行过滤,然后浓缩滤液。将残余物在乙酸乙酯中稀释并通过多孔玻璃漏斗过滤混合物。将有机层用1N盐酸溶液萃取2次。水层用1N氢氧化钠溶液处理(直至溶液的pH=8-10),然后用乙酸乙酯萃取。在真空下浓缩最后有机层得到1-甲基-2-(2-氟苯氧基)乙胺油状物。用1N氯化氢(1N于二乙醚中)沉淀出游离的胺,并通过多孔玻璃漏斗过滤得到1.30g(62%)1-(2-乙基苯氧基)丙胺盐酸盐白色粉末:熔点为131-133℃;1H NMR(Me2SO-d6)δ1.18(t,3H),1.40(d,3H),2.75(m,1H),3.62(m,1H),4.10(m,2H),6.95(m,2H),7.20(m,2H),8.25(br s,3H)。步骤C:2-氰基-N-[2-(2-乙基苯氧基)-1-甲基乙基]-3,3-二甲基丁酰胺的制备
将含有2-氰基-3,3-二甲基丁酰氯(E.Schaumann,H.Mrotzek;有机化学会志,1979,35,1965)(0.364g,2.28mmol)的10mL二氯甲烷溶液滴加到含有1-(2-乙基苯氧基)丙胺盐酸盐(0.56g,2.6mmol)、三乙胺(1.0mL,7.2mmol)的30mL二氯甲烷溶液中。反应混合物搅拌2小时,然后在真空下浓缩。将残余物通过快速色谱柱进行纯化,其中使用20%乙酸乙酯/己烷作为洗脱剂,得到0.290g(42%)白色固体的标题化合物:熔点为94-97℃,1H NMR(CDCl3)δ1.20(m,12H),1.40(m,3H),2.65(q,2H),3.16(dd,1H),3.98(m,1H),4.05(m,1H),4.40(m,1H),6.00(d,1H),6.25(dd,1H),6.95(t,1H),7.18(t,2H).
实施例7步骤A:2-氟-3-甲基-2-丁烯基氰基乙酸酯的制备
将含有氰基乙酸(2.25g,26.4mmol)的30mL无水CH2Cl2溶液在冰水中冷却,然后加入2.3mL(26.4mmol)草酰氯和3滴DMF。将混合物加热至室温并搅拌过夜,然后滴加到含有2.5g(24mmol)2-氟-4-甲基-2-丁烯-1-醇(Cane,D.E.;Yang,G.;Xue,Q.;Shin,J.H.生物化学(1995),3418,2471-9)和3.7mL(26.4mmol)三乙胺的冰冷却的溶液中。室温下搅拌3小时后,除去溶剂,残余物分布在水层和乙醚层之间。分离出乙醚层并用盐水洗涤。合并的有机洗液用乙醚萃取,再用盐水洗涤。干燥(MgSO4)合并的乙醚萃取液,并除去溶剂得到3.5g油状的步骤A的标题化合物,1H NMR(CDCl3)δ1.7(m,6H),3.5(s,2H),4.85(d,J=22Hz,2H)。步骤B:2-氰基-4-氟-3,3-二甲基-4-戊烯酸的制备
将含有实施例7步骤A中产物(3.5g,20.5mmol)的25mL六甲基二硅氮烷溶液加热回流2小时。除去溶剂并将残余物溶解在50mL 1NHCl中。将混合物加热回流20分钟。冷却后,混合物用乙醚萃取,用盐水洗涤并干燥(MgSO4)。除去溶剂得到3.2g油状的步骤B的标题化合物,1H NMR(CDCl3)δ1.4(s,3H),1.45(s,3H),3.8(s,1H),4.55(dd,J=50,4Hz,1H),4.75(d d,J=25,1Hz,1H),6.5(br s,1H)。步骤C:(R)-2-[2-(2,5-二氟苯氧基)-1-甲基乙基]-1H-异吲哚-1,3(2H)-二酮的制备
将含有15.8g(77mmol)(R)-2-(2-羟基-1-甲基乙基)-1H-异吲哚-1,3(2H)-二酮、24.2g(92mmol)三苯基膦和10.0g(77mmol)2,5-二氟苯酚的溶液搅拌并滴加18.2mL(116mmol)偶氮二羧酸二乙酯。在室温下搅拌过夜后,除去溶剂并将残余物溶解在乙酸乙酯中。乙酸乙酯用水和盐水洗涤。干燥(MgSO4)并除去溶剂得到油状物,将该油状物通过硅胶色谱柱得到15.6g油状的步骤C的标题化合物,1H NMR(CDCl3)δ1.55(d,3H),4.25(m,1H),4.8(m,1H),6.55(m,1H),6.65(m,1H),6.9(m,1H),7.7(m,2H),7.85(m,2H)。步骤D:1-(2,5-二氟苯氧基)丙胺盐酸盐的制备
将含有15.6g(44.2mmol)(R)-2-[2-(2,5-二氟苯氧基)-1-甲基乙基]-1H-异吲哚-1,3(2H)-二酮和7.7mL无水肼的400mL乙醇溶液加热回流2小时。过滤去固体并用乙酸乙酯淋洗。除去溶剂,残余物分布在乙醚和1N HCl(水溶液)之间。分离出含水层,用50%氢氧化钠碱化并用乙醚萃取。乙醚层用盐水洗涤并干燥(MgSO4)。除去溶剂后,将残余物再溶解在乙醚中,并加入45mL 1NHCl的乙醚形成盐酸盐沉淀。过滤沉淀物并用乙醚淋洗,得到8.5g步骤D的标题化合物,为白色固体,熔点为127-129℃。步骤E:[R-(R*,R*)]-2-氰基-N-[2-(2,5-二氟苯氧基)-1-甲基乙基]-4-氟-3,3-二甲基-4-戊烯酰胺与[R-(R*,S*]-2-氰基-N-[2-(2,5-二氟基氧基)-1-甲基乙基]-4-氟-3,3-二甲基-4-戊烯酰胺1∶1混合物的制备
将含有370mg(2.16mmol)步骤A的酸、0.19mL(2.15mmol)草酰氯和2滴DMF的10mL CH2Cl2溶液在室温下搅拌过夜。将该混合物加入含有400mg(1.8mmol)步骤D的胺盐和0.52mL(3.7mmol)三乙胺的10mL CH2Cl2溶液中。搅拌过夜后,加入0.3g Amberlite IRA-78树脂,将混合物通过硅胶过滤并用乙酸乙酯淋洗。浓缩滤液得到570mg步骤E的标题固体化合物,熔点为106-110℃。
实施例8步骤A:[R-(E)]-苯基甲基[3-(2,5-二氟苯基)-1-甲基-2-丙烯基]氨基甲酸酯的制备
将含有4.0g(21mmol)(R)-苯基甲基2-甲基-1-环乙亚胺羧酸酯(Dellaria,J.F.Jr.;Sallin,K.J.四面体通讯(1990),31,2661)、5.0g(35mmol)2,5-二氟苯甲醛(Aldrich)和6.5g(26mmol)三苯基膦(Aldrich)的100mL异丙醇溶液加热回流4小时。将混合物冷却至22℃并搅拌20小时。浓缩反应混合物至油状物,然后通过快速硅胶色谱柱进行纯化(5%乙酸乙酯/己烷),得到4.0g步骤A的白色固体标题化合物,该化合物为顺和反式异构体(4∶5)的混合物,熔点为82-84℃,1H NMR(CDCl3)反式异构体:δ7.35(m,5H),7.10(m,1H),6.95(m,2H),6.60(d,1H),6.25(dd,1H),5.12(s,2H),4.80(m,1H),4.60(m,1H),1.36(d,3H);顺式异构体δ7.35(m,5H),7.10(m,1H),6.95(m,2H),6.40(d,1H),5.65(dd,1H),5.07(s,2H),4.80(m,1H),4.60(m,1H),1.27(d,3H)。步骤B:[R-(E)]-4-(2,5-二氟苯基)-3-丁烯-2-胺盐酸盐的制备
在一小烧瓶中,用8mL 30%溴化氢的乙酸处理3.1g(9.8mmol)实施例8步骤A中的产物。反应混合物在22℃下搅拌8小时。用200mL乙酸乙酯稀释反应混合物,然后用100mL 1N氢氧化钠洗涤2次,然后用50mL盐水洗涤1次。用100mL 1N HCl萃取乙酸乙酯层2次。酸性水层用250mL 1N氢氧化钠处理。然后用乙酸乙酯萃取该溶液。浓缩最后的有机层得到游离胺油状物。将游离的胺在100mL干燥的乙醚中稀释,然后用20mL 1N HCl的乙醚处理。过滤去白色沉淀并干燥得到1.0g步骤B的标题化合物,该化合物为顺和反式异构体(3∶7)的混合物。胺盐为白色固体,熔点为133-136℃,1H NMR((CH3)2SO-d6)反式异构体:δ8.30(br s,3H),7.50(m,1H),7.30(m,2H),6.80(d,1H),6.50(dd,1H),4.00(m,1H),1.39(d,3H);顺式异构体:δ8.30(br s,3H),7.50(m,1H),7.30(m,2H),6.62(d,1H),5.90(t,1H),4.00(m,1H),1.31(d,3H)。步骤C:[1[R-(E)]-反]-2,2-二氯-N-[3-(2,5-二氟苯基)-1-甲基-2-丙烯基]-1-乙基-3-甲基环丙烷羧酰胺的制备
在一单独烧瓶中,将含有0.50g(2.5mmol)(反)-2,2-二氯-1-乙基-3-甲基环丙烷羧酸的20mL亚硫酰氯溶液加热回流30分钟。浓缩反应混合物并在真空中干燥残余物。将粗酰基氯溶解在20mL二氯甲烷中,并滴加到含有0.42g(1.9mmol)[R-(E)]-4-(2,5-二氟苯基)-3-丁烯-2-胺盐酸盐和1.0mL(7.1mmol)三乙胺的20mL二氯甲烷溶液中。反应混合物在22℃下搅拌2小时,然后用100mL二氯甲烷稀释并用100mLHCl洗涤。浓缩有机层至油状物。将粗酰胺通过快速硅胶色谱柱,使用20%乙酸乙酯的己烷溶液作为洗脱剂得到130mg较低极性油状反式异构体,1H NMR(CDCl3)δ7.10(m,1H),6.95(m,2H),6.65(d,1H),6.30(dd,1H),5.80(br s,1H),4.05(m,1H),2.20(q,1H),2.00(m,1H),1.60(m,1H),1.40(d,3H),1.20(d,3H),1.00(t,3H)和140mg较高极性反式异构体的白色固体,熔点为102-105℃,1H NMR(CDCl3)δ7.10(m,1H),6.95(m,2H),6.70(d,1H),6.28(dd,1H),5.80(br s,1H),4.85(m,1H),2.23(q,1H),2.00(m,1H),1.60(m,1H),1.40(d,3H),1.20(d,3H),1.00(t,3H)。
通过这里描述的步骤并结合现有技术中已知的方法,可以制备下面表1-9的混合物。表中使用的缩写如下:t=叔,n=正,i=异,c=环,F=氟,Br=溴,Cl=氯,I=碘,Me=甲基,Et=乙基,Pr=丙基,i-Pr=异丙基,Bu=丁基,Ph=苯基,CF3=三氟甲基,SCF3=三氟甲硫基,CN=氰基和SiMe3=三甲基甲硅烷基。
表1Z=
| 栏1 | 栏2 | 栏3 | |
| 12345678910111213141516 | C6H52-F-C6H43-F-C6H44-F-C6H42-Cl-C6H43-Cl-C6H44-Cl-C6H42-Br-C6H43-Br-C6H44-Br-C6H42-I-C6H43-I-C6H44-I-C6H42-Me-C6H43-Me-C6H44-Me-C6H4 | 2-n-Pr-6-CN-C6H32-Cl-5-F-C6H32-F-3-Me-C6H32-F-5-Me-C6H33-F-6-Me-C6H32-噻吩基3-F-2-噻吩基4-F-2-噻吩基5-Et-2-噻吩基3-Cl-2-噻吩基4-Cl-2-噻吩基5-Cl-2-噻吩基3-(C≡CH)-2-噻吩基4-Br-2-噻吩基5-Br-2-噻吩基3-(CH=CH2)-2-噻吩基 | 2-CF3-1H-吡咯-1-基2,3-二Cl-1H-吡咯-1-基2,4-二Cl-1H-吡咯-1-基3,4-二Cl-1H-吡咯-1-基2,3-二Br-1H-吡咯-1-基2,4-二Br-1H-吡咯-1-基4-F-5-Br-1H-吡咯-1-基2-Cl-3-Br-1H-吡咯-1-基2-Cl-4-Br-1H-吡咯-1-基3-Cl-4-Br-1H-吡咯-1-基3-Cl-5-Br-1H-吡咯-1-基4-F-5-Me-1H-吡咯-1-基2-Cl-3-Me-1H-吡咯-1-基2-Cl-4-Me-1H-吡咯-1-基2-Cl-5-Me-1H-吡咯-1-基3-Cl-4-Me-1H-吡咯-1-基 |
| 栏1 | 栏2 | 栏3 | |
| 171819202122232425262728293031323334353637383940414243444546474849505152 | 2-Et-C6H42-CN-C6H42-CF3-C6H42-n-Pr-C6H42-i-Pr-C6H42-n-Bu-C6H42-SiMe3-C6H42-CH2F-C6H43-CH2F-C6H42-CH2CN-C6H42-CH2CH2F-C6H42-(CH=CH2)-C6H42-(CH2CH=CH2)-C6H42-(CH=CHCN)-C6H42-(C≡CH)-C6H42-(CH2C≡CH)-C6H42-(C≡CMe)-C6H42-(i-Bu)-C6H42-(CH(F)Me]-C6H42,3-二F-C6H32,4-二F-C6H32,5-二F-C6H32,6-二F-C6H33,4-二F-C6H33,5-二F-C6H32,3-二Cl-C6H32,4-二Cl-C6H32,5-二Cl-C6H32,6-二Cl-C6H33,4-二Cl-C6H33,5-二Cl-C6H32,5-二Br-C6H32-Br-5-Cl-C6H33-Br-6-Cl-C6H32-Br-5-Me-C6H33-Br-6-Me-C6H3 | 3,4-二F-2-噻吩基3-F-5-Br-2-噻吩基4-F-5-Br-2-噻吩基3-Br-4-F-2-噻吩基3-Br-5-F-2-噻吩基4-Br-5-F-2-噻吩基3-F-4-Me-2-噻吩基3-F-5-Me-2-噻吩基4-F-5-Me-2-噻吩基3-Me-4-F-2-噻吩基3-Me-5-F-2-噻吩基4-Me-5-F-2-噻吩基3-Me-5-Cl-2-噻吩基3-Br-5-Me-2-噻吩基3-Me-5-Br-2-噻吩基4-Me-5-Br-2-噻吩基3-n-Pr-4-F-2-噻吩基3-n-Pr-5-F-2-噻吩基3-CN-5-Br-2-噻吩基3-噻吩基2-F-3-噻吩基4-F-3-噻吩基5-F-3-噻吩基2-Cl-3-噻吩基4-Cl-3-噻吩基5-Cl-3噻吩基2-CN-3-噻吩基5-CN-3噻吩基2-Br-3-噻吩基5-Br-3-噻吩基2-n-Pr-3-噻吩基2-(CH2CN)-3-噻吩基2,5-二Cl-3-噻吩基2,5-二Br-3-噻吩基2-F-5-Cl-3-噻吩基2-Cl-5-F-3-噻吩基 | 3-Cl-5-Me-1H-吡咯-1-基4-Cl-5-Me-1H-吡咯-1-基2-Br-3-Me-1H-吡咯-1-基2-Br-4-Me-1H-吡咯-1-基2-Br-5-Me-1H-吡咯-1-基3-Br-4-Me-1H-吡咯-1-基3-Br-5-Me-1H-吡咯-1-基4-Br-5-Me-1H-吡咯-1-基2-n-Pr-3-F-1H-吡咯-1-基2-n-Pr-4-F-1H-吡咯-1-基2-n-Pr-5-F-1H-吡咯-1-基2-n-Pr-3-Cl-1H-吡咯-1-基2-n-Pr-4-Cl-1H-吡咯-1-基2-n-Pr-5-Cl-1H-吡咯-1-基2-n-Pr-3-Br-1H-吡咯-1-基2-n-Pr-4-Br-1H-吡咯-1-基2-n-Pr-5-Br-1H-吡咯-1-基2-n-Pr-3-Me-1H-吡咯-1-基2-n-Pr-4-Me-1H-吡咯-1-基2-n-Pr-5-Me-1H-吡咯-1-基2-CN-3-F-1H-吡咯-1-基2-CN-4-F-1H-吡咯-1-基2-CN-5-F-1H-吡咯-1-基2-CN-3-Cl-1H-吡咯-1-基2-CN-4-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-3-Br-1H-吡咯-1-基2-CN-4-Br-1H-吡咯-1-基2-CN-5-Br-1H-吡咯-1-基2-CN-3-Me-1H-吡咯-1-基2-CN-4-Me-1H-吡咯-1-基2-CN-5-Me-1H-吡咯-1-基2-CN-5-n-Pr-1H-吡咯-1-基2,3,4-三Cl-1H-吡咯-1-基2,3,5-三Cl-1H-吡咯-1-基2,3-二Cl-4-Me-1H-吡咯-1-基 |
| 栏1 | 栏2 | 栏3 | |
| 535455565758596061626364656667686970717273747576 | 2-CN-3-F-C6H32-CN-5-F-C6H32-CN-6-F-C6H32-CN-3-Cl-C6H32-CN-5-Cl-C6H32-CN-6-Cl-C6H32-CN-5-Br-C6H32-CN-3-CF3-C6H32-CN-3-Me-C6H32-CN-5-Me-C6H32-CN-6-Me-C6H32-Br-4-F-C6H32-Br-5-F-C6H32-Cl-3-Me-C6H32-Cl-5-Me-C6H32-Cl-6-Me-C6H33-Cl-5-Me-C6H32-n-Pr-3-F-C6H32-n-Pr-4-F-C6H32-n-Pr-5-F-C6H32-n-Pr-3-Cl-C6H32-n-Pr-5-Cl-C6H32-n-Pr-5-Br-C6H32-n-Pr-5-Me-C6H3 | 2-F-5-Br-3-噻吩基2-Br-5-F-3-噻吩基2-Cl-5-Br-3-噻吩基2-Br-5-Cl-3-噻吩基2-n-Pr-5-F-3-噻吩基2-CN-5-F-3-噻吩基2-CN-5-Cl-3-噻吩基2-CN-5-Br-3-噻吩基2-CN-5-Me-3-噻吩基1H-吡咯-1-基2-F-1H-吡咯-1-基3-F-1H-吡咯-1-基2-I-1H-吡咯-1-基2-Cl-1H-吡咯-1-基3-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基2-Br-1H-吡咯-1-基2-n-Pr-1H-吡咯-1-基2-i-Pr-1H-吡咯-1-基2-n-Bu-1H-吡咯-1-基2-CH2CN-1H-吡咯-1-基2-t-Bu-1H-吡咯-1-基5-Et-1H-吡咯-1-基2-(C≡CH)-1H-吡咯-1-基 | 2,3-二Cl-5-Me-1H-吡咯-1-基2,4-二Cl-3-Me-1H-吡咯-1-基2,4-二Cl-5-Me-1H-吡咯-1-基2,5-二Cl-3-Me-1H-吡咯-1-基2-CN-3,5-二Me-1H-吡咯-1-基2-CN-4,5-二Me-1H-吡咯-1-基2-CN-3,4-二Cl-1H-吡咯-1-基2-CN-3,5-二Cl-1H-吡咯-1-基2-CN-4,5-二Cl-1H-吡咯-1-基2-CN-3-Cl-4-Me-1H-吡咯-1-基2-CN-3-Cl-5-Me-1H-吡咯-1-基2-CN-3-Me-4-Cl-1H-吡咯-1-基2-CN-3-Me-5-Cl-1H-吡咯-1-基2-CN-4-Me-5-Cl-1H-吡咯-1-基2-CN-4-Cl-5-Me-1H-吡咯-1-基2-CN-4-Br-5-Me-1H-吡咯-1-基2,3,4,5-四Cl-1H-吡咯-1-基2,3,5-三Cl-4-Me-1H-吡咯-1-基2,5-二Cl-3,4-二Me-1H-吡咯-1-基2,3,4-三Cl-5-CN-1H-吡咯-1-基2,3,4-三Me-5-CN-1H-吡咯-1-基2,3-Cl-4-Me-5-CN-1H-吡咯-1-基2,4-Cl-3-Me-5-CN-1H-吡咯-1-基3,4-Cl-2-Me-5-CN-1H-吡咯-1-基 |
表2Z=
| 栏1 | 栏2 | 栏3 | |
| 123 | C6H52-F-C6H43-F-C6H4 | 2-CN-5-I-C6H32-CN-6-Me-C6H32-Br-4-F-C6H3 | 3-CH2Cl-2-噻吩基3-CH2Br-2-噻吩基3-(CH2CN)-2-噻吩基 |
| 栏1 | 栏2 | 栏3 | |
| 456789101112131415161718192021222324252627282930313233343536373839 | 4-F-C6H42-Cl-C6H43-Cl-C6H44-Cl-C6H42-Br-C6H43-Br-C6H44-Br-C6H42-I-C6H43-I-C6H44-I-C6H42-Me-C6H43-Me-C6H44-Me-C6H42-Et-C6H43-Et-C6H42-CN-C6H42-CF3-C6H42-n-Pr-C6H43-n-Pr-C6H42-i-Pr-C6H43-i-Pr-C6H43-SCF3-C6H42-n-Bu-C6H43-SiMe3-C6H43-SCF2H-C6H42-CH2F-C6H43-CH2F-C6H42-CH2Cl-C6H42-CH2Br-C6H42-CH2CN-C6H42-CH2CH2F-C6H42-CH2CH2Cl-C6H42-CH2CH2CN-C6H42-(CH=CH2)-C6H42-(CH=CHMe)-C6H42-(CH2CH=CH2)-C6H4 | 2-Br-5-F-C6H33-Br-6-F-C6H32-Cl-3-Me-C6H32-Cl-5-Me-C6H32-Cl-6-Me-C6H33-Cl-5-Me-C6H33-Cl-6-Me-C6H32-n-Pr-3-F-C6H32-n-Pr-5-F-C6H32-n-Pr-6-F-C6H32-n-Pr-3-Cl-C6H32-n-Pr-5-Cl-C6H32-n-Pr-5-Br-C6H32-n-Pr-5-Me-C6H32-n-Pr-6-CN-C6H32-Cl-3-F-C6H32-Cl-5-F-C6H32-Cl-6-F-C6H33-Cl-2-F-C6H33-Cl-6-F-C6H34-Cl-2-F-C6H32-F-3-Me-C6H32-F-5-Me-C6H32-F-6-Me-C6H33-F-6-Me-C6H32,3,4-三F-C6H22,3,5-三F-C6H22,3,6-三F-C6H22,4,5-三F-C6H22,3,5-三Cl-C6H22,3,6-三Cl-C6H22,4,6-三Cl-C6H22,5-二F-3-Cl-C6H22,5-二F-6-Cl-C6H22,3-二Cl-5-F-C6H22,3-二Cl-6-F-C6H2 | 5-SiMe3-2-噻吩基3-(CH=CH2)-2-噻吩基3-(CH=CHMe)-2-噻吩基3-(CH2CH=CH2)-2-噻吩基3-(CH2C≡CH)-2-噻吩基3-(C≡CMe)-2-噻吩基3-(CH=CHCN)-2-噻吩基3,5-二F-2-噻吩基3,5-二Cl-2-噻吩基3-F-5-Cl-2-噻吩基3-Cl-5-F-2-噻吩基3-F-5-Br-2-噻吩基3-Br-4-F-2-噻吩基3-Br-5-F-2-噻吩基3-F-5-Me-2-噻吩基3-Me-5-F-2-噻吩基3-Br-5-Cl-2-噻吩基3-Cl-5-Me-2-噻吩基3-Me-5-Cl-2-噻吩基3-Br-5-Me-2-噻吩基3-Me-5-Br-2-噻吩基3-n-Pr-5-Cl-2-噻吩基3-CN-5-F-2-噻吩基3-CN-5-Cl-2-噻吩基3-CN-5-Br-2-噻吩基3-CN-5-Me-2-噻吩基3-噻吩基2-F-3-噻吩基4-F-3-噻吩基5-F-3-噻吩基2-I-3-噻吩基5-I-3-噻吩基2-Me-3-噻吩基5-Me-3-噻吩基2-Et-3-噻吩基2-Cl-3-噻吩基 |
| 栏1 | 栏2 | 栏3 | |
| 4041424344454647484950515253545556575859606162636465666768697071727374 | 2-(CH=CHCN)-C6H42-(C≡CH)-C6H42-(CH2C≡CH)-C6H42-(C≡CMe)-C6H42-(t-Bu)-C6H42-(CH2C≡CMe)-C6H42-[CH(F)Me)-C6H42-[CH(Cl)Me]-C6H42-[CH(Br)Me]-C6H42-[CH(CN)Me]-C6H42-[CH(CN)CH2Me]-C6H42-(CH2CH2C≡CH)-C6H42,3-二F-C6H32,4-二F-C6H32,5-二F-C6H32,6-二F-C6H33,4-二F-C6H33,5-二F-C6H32,5-二Cl-C6H32,6-二Cl-C6H33,5-二Cl-C6H32,5-二Br-C6H32-Br-5-Cl-C6H32-Br-5-Me-C6H32-CN-3-F-C6H32-CN-4-F-C6H32-CN-5-F-C6H32-CN-6-F-C6H32-CN-3-Cl-C6H32-CN-5-Cl-C6H32-CN-6-Cl-C6H32-CN-5-Br-C6H32-CN-3-I-C6H32-CN-3-Me-C6H32-CN-5-Me-C6H3 | 2,5-二Cl-3-F-C6H22,5-二Cl-6-F-C6H22,6-二Cl-3-F-C6H22,3-二F-5-Me-C6H22,5-二F-3-Me-C6H22,5-二F-6-Me-C6H22-CN-3,5-二F-C6H22-CN-3,6-二F-C6H22-CN-5,6-二F-C6H22-CN-3-F-5-Cl-C6H22-CN-3-Me-5-Cl-C6H22-CN-3-Me-5-F-C6H22-CN-5-F-6-Cl-C6H22-Cl-3-F-5-Me-C6H22-F-3-Cl-5-Me-C6H22,3,4,5-四F-C6H2,3,4,6-四F-C6H2,3,5,6-四F-C6H2-噻吩基3-F-2-噻吩基4-F-2-噻吩基5-F-2-噻吩基5-I-2-噻吩基3-Me-2-噻吩基5-Me-2-噻吩基3-Cl-2-噻吩基4-Cl-2-噻吩基5-Cl-2-噻吩基3-CN-2-噻吩基5-(C≡CH)-2-噻吩基3-Br-2-噻吩基5-Br-2-噻吩基3-n-Pr-2-噻吩基5-n-Pr-2-噻吩基5-i-Pr-2-噻吩基 | 4-Cl-3-噻吩基5-Cl-3-噻吩基2-CN-3-噻吩基2-(C≡CH)-3-噻吩基2-Br-3-噻吩基5-Br-3-噻吩基2-n-Pr-3-噻吩基2-i-Pr-3-噻吩基2-n-Bu-3-噻吩基2-CH2F-3-噻吩基2-(CH2CN)-3-噻吩基2-t-Bu-3-噻吩基2-(CH2CH2CN)-3-噻吩基2-(CH=CH2)-3-噻吩基2-(CH=CHMe)-3-噻吩基2-(CH2CH=CH2)-3-噻吩基2-(CH2C≡CH)-3-噻吩基2-(C≡CMe)-3-噻吩基2-(CH=CHCN)-3-噻吩基2,4-二F-3-噻吩基2,5-二F-3-噻吩基4,5-二F-3-噻吩基2,5-二Cl-3-噻吩基2,5-二Br-3-噻吩基2-Cl-5-Br-3-噻吩基2-Br-5-Cl-3-噻吩基2-Br-5-Me-3-噻吩基2-Me-5-Br-3-噻吩基2-n-Pr-5-Cl-3-噻吩基2-n-Pr-5-Br-3-噻吩基2-CN-5-Cl-3-噻吩基2-CN-5-Br-3-噻吩基2-CN-5-Me-3-噻吩基2-CN-5-t-Bu-C6H3 |
表3Z=
| 栏1 | 栏2 | 栏3 | |
| 1234567891011121314151617181920212223242526272829 | C6H52-F-C6H43-F-C6H44-F-C6H42-Cl-C6H43-Cl-C6H44-Cl-C6H42-Br-C6H43-Br-C6H44-Br-C6H42-I-C6H43-I-C6H44-I-C6H42-Me-C6H43-Me-C6H44-Me-C6H42-Et-C6H43-Et-C6H42-CN-C6H42-CF3-C6H42-n-Pr-C6H43-n-Pr-C6H42-i-Pr-C6H43-i-Pr-C6H42-n-Bu-C6H43-SiMe3-C6H42-CH2F-C6H43-CH2F-C6H42-CH2Cl-C6H4 | 2-CN-3-Cl-C6H32-CN-4-Cl-C6H32-CN-5-Cl-C6H32-CN-6-Cl-C6H32-CN-5-Br-C6H32-CN-3-I-C6H32-CN-3-CF3-C6H32-CN-6-CF3-C6H32-CN-3-Me-C6H32-CN-5-Me-C6H32-Br-4-F-C6H32-Br-5-F-C6H33-Br-6-F-C6H32-Cl-3-Me-C6H32-Cl-5-Me-C6H33-Cl-5-Me-C6H32-n-Pr-3-F-C6H32-n-Pr-4-F-C6H32-n-Pr-5-F-C6H32-n-Pr-6-F-C6H32-n-Pr-3-Cl-C6H32-n-Pr-5-Cl-C6H32-n-Pr-5-E-C6H32-n-Pr-5-Me-C6H32-Cl-3-F-C6H32-Cl-4-F-C6H32-Cl-5-F-C6H32-Cl-F-C6H33-Cl-2-F-C6H3 | 2,3,5,6-四Cl-C6H2,3,5-三Cl-6-CN-C6H2,3,4-三F-6-CN-C6H2,5-二Cl-3,6-二F-C6H2,5-二F-3-Cl-6-CN-C6H1H-吡咯-1-基2-F-1H-吡咯-1-基3-F-1H-吡咯-1-基2-I-1H-吡咯-1-基2-Cl-1H-吡咯-1-基3-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基2-Br-1H-吡咯-1-基2-n-Pr-1H-吡咯-1-基2-n-Bu-1H-吡咯-1-基2-t-Bu-1H-吡咯-1-基2,3-二Cl-1H-吡咯-1-基2,4-二Cl-1H-吡咯-1-基2,5-二Cl-1H-吡咯-1-基2,3-二Br-1H-吡咯-1-基2,4-二Br-1H-吡咯-1-基2,5-二Br-1H-吡咯-1-基2-Cl-3-Br-1H-吡咯-1-基2-Cl-4-Br-1H-吡咯-1-基2-Cl-5-Br-1H-吡咯-1-基3-Cl-5-Br-1H-吡咯-1-基4-Cl-5-Br-1H-吡咯-1-基2-Cl-3-Me-1H-吡咯-1基2-Cl-4-Me-1H-吡咯-1-基 |
| 栏1 | 栏2 | 栏3 | |
| 303132333435363738394041424344454647484950515253545556575859606162636465 | 2-CH2Br-C6H42-CH2CN-C6H42-CH2CH2F-C6H42-CH2CH2Cl-C6H42-CH2CH2CN-C6H42-(CH=CH2)-C6H42-(CH=CHMe)-C6H42-(CH2CH=CH2)-C6H42-(C≡CH)-C6H42-(CH2C=CH)-C6H42-(C≡CMe)-C6H42-(C≡CCH2Me)-C6H42-(t-Bu)-C6H42-[CH(F)Me]-C6H42-[CH(Cl)Me]-C6H42-[CH(Br)Me]-C6H42-[CH(CN)Me]-C6H42-[CH=C(Me)2]-C6H42-[CH(Me)CH=CH2]-C6H42-(CH2C(Me)=CH2)-C6H42-(CH2CH2C≡CH)-C6H42,3-二F-C6H32,4-二F-C6H32,5-二F-C6H32,6-二F-C6H33,4-二F-C6H33,5-二F-C6H32,3-二Cl-C6H32,4-二Cl-C6H32,5-二Cl-C6H32,6-二Cl-C6H33,4-二Cl-C6H33,5-二Cl-C6H32,5-二Br-C6H32-Br-5-Cl-C6H33-Br-6-Cl-C6H3 | 3-Cl-6-F-C6H32-F-3-Me-C6H32-F-5-Me-C6H32-F-6-Me-C6H33-F-6-Me-C6H32,3,4-三F-C6H22,3,5-三F-C6H22,3,6-三F-C6H22,4,5-三F-C6H22,4,6-三F-C6H22,3,5-三Cl-C6H22,3,6-三Cl-C6H22,3-二F-5-Cl-C6H22,3-二F-6-Cl-C6H22,5-二F-3-Cl-C6H22,5-二F-6-Cl-C6H22,6-二F-3-Cl-C6H22,3-二Cl-5-F-C6H22,5-二Cl-3-F-C6H22,5-二Cl-6-F-C6H22,3-二F-5-Me-C6H22,5-二F-3-Me-C6H22,5-二F-6-Me-C6H22,5-二Cl-3-Me-C6H22,5-二Cl-6-Me-C6H22-CN-3,5-diMe-C6H22-CN-3,5-diCl-C6H22-CN-3,5-diF-C6H22-CN-5,6-diF-C6H22-CN-3-F-5-Cl-C6H22-CN-3-Me-5-Cl-C6H22-CN-3-Me-5-F-C6H22-CN-5-F-6-Cl-C6H22-Cl-3-F-5-Me-C6H22-Cl-3-F-6-Me-C6H22-F-3-Cl-5-Me-C6H2 | 2-Cl-5-Me-1H-吡咯-1-基2-Br-3-Me-1H-吡咯-1-基2-Br-4-Me-1H-吡咯-1-基2-Br-5-Me-1H-吡咯-1-基3-Br-4-Me-1H-吡咯-1-基2-CN-3-Cl-1H-吡咯-1-基2-CN-4-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-3-Br-1H-吡咯-1-基2-CN-4-Br-1H-吡咯-1-基2-CN-5-Br-1H-吡咯-1-基2-CN-3-Me-1H-吡咯-1-基2-CN-4-Me-1H-吡咯-1-基2-CN-5-Me-1H-吡咯-1-基2-CN-5-n-Pr-1H-吡咯-1-基2,3,4-三Cl-1H-吡咯-1-基2,3,5-三Cl-1H-吡咯-1-基2,3-二Cl-4-Me-1H-吡咯-1-基2,3-二Cl-5-Me-1H-吡咯-1-基2,4-二Cl-3-Me-1H-吡咯-1-基2,4-二Cl-5-Me-1H-吡咯-1-基2,5-二Cl-3-Me-1H-吡咯-1-基2-CN-3,5-二Me-1H-吡咯-1-基2-CN-4,5-二Me-1H-吡咯-1-基2-CN-3,5-二Cl-1H-吡咯-1-基2-CN-4,5-二Cl-1H-吡咯-1-基2-CN-3-Cl-4-Me-1H-吡咯-1-基2-CN-3-Cl-5-Me-1H-吡咯-1-基2-CN-3-Me-4-Cl-1H-吡咯-1-基2-CN-3-Me-5-Cl-1H-吡咯-1-基2-CN-4-Me-5-Cl-1H-吡咯-1-基2-CN-4-Cl-5-Me-1H-吡咯-1-基2-CN-4-Br-5-Me-1H2,3,4,5-四Cl-1H-吡咯-1-基2,3,5-三Cl-4-Me-1H-吡咯-1-基2,5-二Cl-3,4-二Me-1H-吡咯-1-基 |
| 栏1 | 栏2 | 栏3 | |
| 666768697071 | 2-Br-5-Me-C6H33-Br-6-Me-C6H32-CN-3-F-C6H32-CN-4-F-C6H32-CN-5-F-C6H32-CN-6-F-C6H3 | 2,3,4,5-四F-C6H2,3,4,6-四F-C6H2,3,5,6-四F-C6H2,3,4,5-四Cl-C6H2,3,4,6-四Cl-C6H | 2,3,4-三Cl-5-CN-1H-吡咯-1-基2,3,4-三Me-5-CN-1H-吡咯-1-基2,3-Cl-4-Me-5-CN-1H-吡咯-1-基2,4-Cl-3-Me-5-CN-1H-吡咯-1-基3,4-Cl-2-Me-5-CN-1H-吡咯-1-基 |
表4
| R1R2 R6 X | 栏1 | 栏2 |
| H H t-Bu O Z=H H t-Bu O Z=H H t-Bu O Z=H H t-Bu O Z=H H t-Bu O Z=H H t-Bu O Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-u CH2 Z=H H t-Bu CH2 Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=Me Me t-Bu O Z=Me Me t-Bu O Z=Me Me t-Bu O Z=Me Me t-Bu O Z=Me Me t-Bu O Z= | C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H4 | 2,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H3 |
| R1 R2 R6 X | 栏1 | 栏2 |
| Me Me t-Bu O Z=Me Et t-Bu O Z=Me Et t-Bu O Z=Me Et t-Bu O Z=Me Et t-Bu O Z=Me Et t-Bu O Z=Me Et t-Bu O Z=Me H t-Bu CH(Me) Z=Me H t-Bu CH(Me) Z=Me H t-Bu CH(Me) Z=Me H t-Bu CH(Me) Z=Me H t-Bu CH(Me) Z=Me H t-Bu CH(Me) Z=Me H t-Bu CH(Et) Z=Me H t-Bu CH(Et) Z=Me H t-Bu CH(Et) Z=Me H t-Bu CH(Et) Z=Me H t-Bu CH(Et) Z=Me H t-Bu CH(Et) Z=Me H t-Bu CH(n-Pr)Z=Me H t-Bu CH(n-Pr)Z=Me H t-Bu CH(n-Pr)Z=Me H t-Bu CH(n-Pr)Z=Me H t-Bu CH(n-Pr)Z=Me H t-Bu CH(n-Pr)Z=Me H t-Bu =C(Me) Z=Me H t-Bu =C(Me) Z=Me H t-Bu =C(Me) Z=Me H t-Bu =C(Me) Z=Me H t-Bu =C(Me) Z=Me H t-Bu =C(Me) Z=Me H t-Bu =C(Et) Z=Me H t-Bu =C(Et) Z=Me H t-Bu =C(Et) Z=Me H t-Bu =C(Et) Z=Me H t-Bu =C(Et) Z= | 3-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H4 | 2-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H3 |
| R1 R2 R6 X | 栏1 | 栏2 |
| Me H t-Bu =C(Et) Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu CH2 Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z=H H t-Bu =CH Z= | 3-F-C6H42-噻吩基3-F-2-噻吩基3-Cl-2-噻吩基3-CN-2-噻吩基5-F-2-噻吩基5-Cl-2-噻吩基2-噻吩基3-F-2-噻吩基3-Cl-2-噻吩基3-CN-2-噻吩基5-F-2-噻吩基5-Cl-2-噻吩基3-噻吩基2-F-3-噻吩基2-Cl-3-噻吩基2-CN-3-噻吩基5-F-3-噻吩基5-Cl-3-噻吩基3-噻吩基2-F-3-噻吩基2-Cl-3-噻吩基2-CN-3-噻吩基5-F-3-噻吩基5-Cl-3-噻吩基1H-吡咯-1-基2-F-1H-吡咯-1-基2-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基5-F-1H-吡咯-1-基5-Cl-1H-吡咯-1-基1H-吡咯-1-基2-F-1H-吡咯-1-基2-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基5-F-1H-吡咯-1-基 | 2-CN-5-Cl-C6H33,5-二F-2-噻吩基3,5-二Cl-2-噻吩基3-Cl-5-F-2-噻吩基3-F-5-Cl-2-噻吩基3-CN-5-F-2-噻吩基3-CN-5-Cl-2-噻吩基3,5-二F-2-噻吩基3,5-二Cl-2-噻吩基3-Cl-5-F-2-噻吩基3-F-5-Cl-2-噻吩基3-CN-5-F-2-噻吩基3-CN-5-Cl-2-噻吩基2,5-二F-3-噻吩基2,5-二Cl-3-噻吩基2-Cl-5-F-3-噻吩基2-F-5-Cl-3-噻吩基2-CN-5-F-3-噻吩基2-CN-5-Cl-3-噻吩基2,5-二F-3-噻吩基2,5-二Cl-3-噻吩基2-Cl-5-F-3-噻吩基2-F-5-Cl-3-噻吩基2-CN-5-F-3-噻吩基2-CN-5-Cl-3-噻吩基2,5-二F-1H-吡咯-1-基2,5-二Cl-1H-吡咯-1-基2-Cl-5-F-1H-吡咯-1-基2-F-5-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-5-F-1H-吡咯-1-基2,5-二F-1H-吡咯-1-基2,5-二Cl-1H-吡咯-1-基2-2l-5-F-1H-吡咯-1-基2-F-5-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基 |
| R1R2 R6 X | 栏1 | 栏2 |
| H H t-Bu =CH Z=H H t-Bu O Z=H H t-Bu O Z=H H t-u O Z=H H t-Bu O Z=H H t-Bu O Z=H H t-Bu O Z=Me H CH(Me)C(Me)3 O Z=Me H CH(Me)C(Me)3 O Z=Me H CH(Me)C(Me)3 O Z=Me H CH(Me)C(Me)3 O Z=Me H CH(Me)C(Me)3 O Z=Me H CH(Me)C(Me)3 O Z=Me H CH(Me)C(Me)3 =CH Z=Me H CH(Me)C(Me)3 =CH Z=Me H CH(Me)C(Me)3 =CH Z=Me H CH(Me)C(Me)3 =CH Z=Me H CH(Me)C(Me)3 =CH Z=Me H CH(Me)C(Me)3 =CH Z=Me H CH(Me)C(Me)3 CH2 Z=Me H CH(Me)C(Me)3 CH2 Z=Me H CH(Me)C(Me)3 CH2 Z=Me H CH(Me)C(Me)3 CH2 Z=Me H CH(Me)C(Me)3 CH2 Z=Me H CH(Me)C(Me)3 CH2 Z=H H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 =CH Z=H H CH(Me)C(Me)3 =CH Z=H H CH(Me)C(Me)3 =CH Z=H H CH(Me)C(Me)3 =CH Z=H H CH(Me)C(Me)3 =CH Z= | 5-Cl-1H-吡咯-1-基1H-吡咯-1-基2-F-1H-吡咯-1-基2-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基5-F-1H-吡咯-1-基5-Cl-1H-吡咯-1-基C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H4 | 2-CN-5-F-1H-吡咯-1-基2,5-二F-1H-吡咯-1-基2,5-二Cl-1H-吡咯-1-基2-Cl-5-F-1H-吡咯-1-基2-F-5-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-5-F-1H-吡咯-1-基2,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H3 |
| R1R2 R6 X | 栏1 | 栏2 |
| H H CH(Me)C(Me)3 =CH Z =H H CH(Me)C(Me)3 CH2 Z=H H CH(Me)C(Me)3 CH2 Z=H H CH(Me)C(Me)3 CH2 Z=H H CH(Me)C(Me)3 CH2 Z=H H CH(Me)C(Me)3 CH2 Z=H H CH(Me)C(Me)3 CH2 Z=Me H CH(Me)C(Me)3 CH2 Z=Me H CH(Me)C(Me)3 CH2 Z=Me H CH(Me)C(Me)3 CH2 Z=Me H CH(Me)C(Me)3 CH2 Z=Me H CH(Me)C(Me)3 CH2 Z=Me H CH(Me)C(Me)3 CH2 Z=Me Ph CH2CH3 O Z=Me Ph CH2CH3 O Z=Me Ph CH(Me)2 O Z=Me Ph C(Me)3 O Z=Me Ph CH2CH=CH2 O Z=Me Ph CH2CH=CH2 O Z=Me H CH(Me)C(Me)3 O Z=Me H CH(Me)C(Me)3 O Z=Me H CH(Me)C(Me)3 O Z=Me H CH(Me)C(Me)3 O Z=Me H CH(Me)C(Me)3 O Z=Me H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 CH2 Z=H H CH(Me)C(Me)3 CH2 Z=H H CH(Me)C(Me)3 CH2 Z=H H CH(Me)C(Me)3 CH2 Z=H H CH(Me)C(Me)3 CH2 Z=H H CH(Me)C(Me)3 CH2 Z=Me Ph CH2CH3 O Z=Me Ph CH2CH3 O Z=Me Ph CH2CH2F O Z=Me Ph CH2CH2Cl O Z=Me Ph CH2C≡CH O Z= | 3-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H41H-吡咯-1-基2-F-1H-吡咯-1-基2-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基5-F-1H-吡咯-1-基5-Cl-1H-吡咯-1-基2-CN-C6H42,5-二F-C6H32-CN-C6H42-CN-C6H42-CN-C6H42,5-二F-C6H31H-吡咯-1-基2-F-1H-吡咯-1-基2-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基5-F-1H-吡咯-1-基5-Cl-1H-吡咯-1-基1H-吡咯-1-基2-F-1H-吡咯-1-基2-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基5-F-1H-吡咯-1-基5-Cl-1H-吡咯-1-基2-F-5-Cl-C6H32-F-5-Me-C6H32,5-二F-C6H32,5-二F-C6H32,5-二F-C6H3 | 2-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-F-5-Cl-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-1H-吡咯-1-基2,5-二Cl-1H-吡咯-1-基2-Cl-5-F-1H-吡咯-1-基2-F-5-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-5-F-1H-吡咯-1-基2-CN-5-F-C6H32-Cl-5-F-C6H32-CN-5-F-C6H32-CN-5-F-C6H32-CN-5-Cl-1H-吡咯-1-基2-CN-5-F-1H--吡咯-1-基2-Cl-5-F-C6H32,5-二Cl-1H-吡咯-1-基2-Cl-5-F-1H-吡咯-1-基2-F-5-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-5-F-1H-吡咯-1-基2,5-二F-1H-吡咯-1-基2,5-二Cl-1H-吡咯-1-基2-Cl-5-F-1H-吡咯-1-基2-F-5-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-5-F-1H-吡咯-1-基2-CN-5-Cl-C6H32-CN-5-Me-C6H32-CN-5-F-C6H32-CN-5-F-C6H32-CN-5-F-C6H3 |
| R1 R2 R6 X | 栏1 | 栏2 |
| Me Ph CH2C(F)=CH2 O Z=H H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 O Z=H H CH(Me)C(Me)3 O Z=Me H i-Pr O Z=Me H i-Pr O Z=Me H i-Pr O Z=Me H C(Me)2CH=CH2 O Z=Me H C(Me)2CH=CH2 O Z=Me H C(Me)2CH=CH2 O Z=Me H C(Me)2CH=CH2 O Z=Me H C(Me)2CH=CH2 O Z=Me H C(Me)2CH=CH2 O Z=Me H CH(Me)CH(Me)2 O Z=Me H CH(Me)CH(Me)2 O Z=Me H CH(Me)CH(Me)2 O Z=Me H c-Pr O Z=Me H c-Pr O Z=Me H c-Pr O Z=Me H CH(Me)-c-Pr O Z=Me H CH(Me)-c-Pr O Z=Me H CH(Me)-c-Pr O Z=Me H C(Me)2CF=CH2 O Z=Me H C(Me)2CF=CH2 O Z=Me H C(Me)2CF=CH2 O Z=Me H C(Me)2CF=CH2 O Z=Me H C(Me)2CF=CH2 O Z=Me H C(Me)2CF=CH2 O Z=Me H C(Me)2CH=CHF O Z=Me H C(Me)2CH=CHF O Z=Me H C(Me)2CH=CHF O Z=Me H C(Me)2CH=CHF O Z=Me H C(Me)2CH=CHF O Z= | 2,5-二F-C6H31H-吡咯-1-基2-F-1H-吡咯-1-基2-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基5-F-1H-吡咯-1-基5-Cl-1H-吡咯-1-基2,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42-OCH2F-5-F-C6H32-Cl-5-F-C6H32-Br-5-F-C6H32,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42-OCH2F-5-F-C6H32-Cl-5-F-C6H32-Br-5-F-C6H32,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42-OCH2F-5-F-C6H32-Cl-5-F-C6H32-Br-5-F-C6H32,5-二F-C6H32-Cl-5-Me-C6H3 | 2-CN-5-F-C6H32,5-二F-1H-吡咯-1-基2,5-二Cl-1H-吡咯-1-基2-Cl-5-F-1H-吡咯-1-基2-F-5-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-5-F-1H-吡咯-1-基2-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-F-5-Cl-C6H32-F-5-Br-C6H32-F-5-Me-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-F-5-Cl-C6H32-F-5-Br-C6H32-F-5-Me-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-F-5-Cl-C6H32-F-5-Br-C6H32-F-5-Me-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H3 |
| R1 R2 R6 X | 栏1 | 栏2 |
| Me H C(Me)2CH=CHF O Z=Me H C(Me)(CH2F)CH=CH2 O Z=Me H C(Me)(H2F)CH=CH2 O Z=Me H C(Me)(CH2F)CH=CH2 O Z=Me H C(Me)(CH2F)CH=CH2 O Z=Me H C(Me)(CH2F)CH=CH2 O Z=Me H C(Me)(CH2F)CH=CH2 O Z=Me H C(Me)(CH2F)CF=CH2 O Z=Me H C(Me)(CH2F)CF=CH2 O Z=Me H C(Me)(CH2F)CF=CH2 O Z=Me H C(Me)(CH2F)CF=CH2 O Z=Me H C(Me)(CH2F)CF=CH2 O Z=Me H C(Me)(CH2F)CF=CH2 O Z=Me H C(CH2F)2CH=CH2 O Z=Me H C(CH2F)2CH=CH2 O Z=Me H C(CH2F)2CH=CH2 O Z=Me H C(CH2F)2CH=CH2 O Z=Me H C(CH2F)2CH=CH2 O Z=Me H C(CH2F)2CH=CH2 O Z=Me H C(Me)2CCl=CH2 O Z=Me H C(Me)2CCl=CH2 O Z=Me H C(Me)2CCl=CH2 O Z=Me H C(Me)2CCl=CH2 O Z=Me H C(Me)2CCl=CH2 O Z=Me H C(Me)2CCl=CH2 O Z=Me H C(CH2Cl)2CH=CH2 O Z=Me H C(CH2Cl)2CH=CH2 O Z=Me H C(CH2Cl)2CH=CH2 O Z=Me H C(CH2Cl)2CH=CH2 O Z=Me H C(CH2Cl)2CH=CH2 O Z=Me H C(CH2Cl)2CH=CH2 O Z=Me H C(Me)2-c-Pr O Z=Me H C(Me)2-c-Pr O Z=Me H C(Me)2-c-Pr O Z=Me H C(Me)2-c-Pr O Z=Me H C(Me)2-c-Pr O Z= | 3-F-C6H42-OCH2F-5-F-C6H32-Cl-5-F-C6H32-Br-5-F-C6H32,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42-OCH2F-5-F-C6H32-Cl-5-F-C6H32-Br-5-F-C6H32,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42-OCH2F-5-F-C6H32-Cl-5-F-C6H32-Br-5-F-C6H32,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42-OCH2F-5-F-C6H32-Cl-5-F-C6H32-Br-5-F-C6H32,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42-OCH2F-5-F-C6H32-Cl-5-F-C6H32-Br-5-F-C6H32,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42-OCH2F-5-F-C6H32-Cl-5-F-C6H32-Br-5-F-C6H32,5-二F-C6H32-Cl-5-Me-C6H3 | 2-CN-5-Cl-C6H32-F-5-Cl-C6H32-F-5-Br-C6H32-F-5-Me-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-F-5-Cl-C6H32-F-5-Br-C6H32-F-5-Me-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-F-5-Cl-C6H32-F-5-Br-C6H32-F-5-Me-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-F-5-Cl-C6H32-F-5-Br-C6H32-F-5-Me-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-F-5-Cl-C6H32-F-5-Br-C6H32-F-5-Me-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-F-5-Cl-C6H32-F-5-Br-C6H32-F-5-Me-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H3 |
| R1 R2 R6 X | 栏1 | 栏2 |
| Me H C(Me)2-c-Pr O Z=Me H C(Me)2CF=CF2 O Z=Me H C(Me)2CF=CF2 O Z=Me H C(Me)2CF=CF2 O Z=Me H C(Me)2CF=CF2 O Z=Me H C(Me)2CF=CF2 O Z=Me H C(Me)2CF=CF2 O Z=Me H C(CH3)(C≡CH)CH=CH2 O Z=Me H C(CH3)(C≡CH)CH=CH2 O Z=Me H C(CH3)(C≡CH)CH=CH2 O Z=Me H C(CH=CH2)2CH3 O Z=Me H C(CH=CH2)2CH3 O Z=Me H C(CH=CH2)2CH3 O Z=Me H C(CH3)2CH=CHC≡CH O Z=Me H C(CH3)2CH=CHC≡CH O Z=Me H C(CH3)2CH=CHC≡CH O Z= | 3-F-C6H42-OCH2F-5-F-C6H32-Cl-5-F-C6H32-Br-5-F-C6H32,5-二F-C6H32-Cl-5-Me-C6H33-F-C6H42,5-二F-C6H32-Cl-5-F-C6H32,5-二Cl-C6H32,5-二F-C6H32-Cl-5-F-C6H32,5-二Cl-C6H32,5-二F-C6H32-Cl-5-F-C6H32,5-二Cl-C6H3 | 2-CN-5-Cl-C6H32-F-5-Cl-C6H32-F-5-Br-C6H32-F-5-Me-C6H32-Me-5-Cl-C6H32,5-二Cl-C6H32-CN-5-Cl-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H3 |
表5Z=
| 栏1 | 栏2 | 栏3 | |
| 1234567891011 | C6H52-F-C6H43-F-C6H44-F-C6H42-Cl-C6H43-Cl-C6H44-Cl-C6H42-Br-C6H43-Br-C6H44-Br-C6H42-I-C6H4 | 2-F-5-Me-C6H32-F-6-Me-C6H33-F-6-Me-C6H32,3,4-三F-C6H22,3,5-三F-C6H22,3,6-三F-C6H22,3-二F-5-Cl-C6H22,6-二F-3-Cl-C6H22,5-二Cl-3-F-C6H22,5-二Cl-6-F-C6H22,3-二F-5-Me-C6H2 | 2-I-1H-吡咯-1-基2-Cl-1H-吡咯-1-基3-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基2-Br-1H-吡咯-1-基2-n-Pr-1H-吡咯-1-基2-i-Pr-1H-吡咯-1-基2-n-Bu-1H-吡咯-1-基2-CH2CN-1H-吡咯-1-基2-i-Bu-1H-吡咯-1-基2-CN-5-F-3-噻吩基 |
| 栏1 | 栏2 | 栏3 | |
| 1213141516171819202122232425262728293031323334353637383940414243444546 | 3-I-C6H44-I-C6H42-Me-C6H43-Me-C6H44-Me-C6H42-Et-C6H42-CN-C6H42-CF3-C6H42-n-Pr-C6H43-n-Pr-C6H42-i-Pr-C6H43-i-Pr-C6H42-n-Bu-C6H42-CH2F-C6H43-CH2F-C6H42-CH2CN-C6H42-CH2CH2F-C6H42-CH2CH2Cl-C6H42-CH2CH2CN-C6H42-(CH=CH2)-C6H42-(C≡CH)-C6H42-(C≡CMe)-C6H42-(t-Bu)-C6H42-[CH(F)Me]-C6H42-[CH(Cl)Me]-C6H42-[CH(Br)Me]-C6H42-[CH(CN)Me]-C6H42-[CH(CN)CH2Me]-C6H42,3-二F-C6H32,4-二F-C6H32,5-二F-C6H32,6-二F-C6H33,4-二F-C6H33,5-二F-C6H32,3-二Cl-C6H3 | 2,5-二F-3-Me-C6H22,5-二F-6-Me-C6H22-CN-3,5-二Me-C6H22-CN-3,5-二Cl-C6H22-CN-3,5-二F-C6H22-CN-3,6-二F-C6H22-CN-5,6-二F-C6H22-CN-3-F-5-Cl-C6H22-CN-3-Me-5-Cl-C6H22-CN-3-Me-5-F-C6H22-Cl-3-F-5-Me-C6H22-F-3-Cl-5-Me-C6H22,3,4,5-四F-C6H2,3,4,6-四F-C6H2,3,5,6-四F-C6H2-噻吩基3-F-2-噻吩基4-F-2-噻吩基5-Et-2-噻吩基3-Cl-2-噻吩基4-Cl-2-噻吩基5-Cl-2-噻吩基3-(C≡CH)-2-噻吩基4-Br-2-噻吩基5-Br-2-噻吩基3-[CH2CH(CN)Me]-2-噻吩基3-(CH=CH2)-2-噻吩基3,4-二F-2-噻吩基3,4-二F-2-噻吩基3-F-4-Br-2-噻吩基3-F-5-Br-2-噻吩基3-Br-5-F-2-噻吩基4-Br-5-F-2-噻吩基3-F-4-Me-2-噻吩基3-F-5-Me-2-噻吩基 | 2-Me-4-CN-3-噻吩基1H-吡咯-1-基2-F-1H-吡咯-1-基5-F-1H-吡咯-1-基5-Et-1H-吡咯-1-基5-Cl-1H-吡咯-1-基2-(C≡CH)-1H-吡咯-1-基5-Br-1H-吡咯-1-基2-n-Pr-1H-吡咯-1-基2-i-Pr-1H-吡咯-1-基2-CF3-1H-吡咯-1-基2,3-二Cl-1H-吡咯-1-基2,4-二Cl-1H-吡咯-1-基3,4-二Cl-1H-吡咯-1-基2,3-二Br-1H-吡咯-1-基2,4-二Br-1H-吡咯-1-基4-F-5-Br-1H-吡咯-1-基2-Cl-3-Br-1H-吡咯-1-基2-Cl-4-Br-1H-吡咯-1-基3-Cl-4-Br-1H-吡咯-1-基3-Cl-5-Br-1H-吡咯-1-基4-F-5-Me-1H-吡咯-1-基2-Cl-3-Me-1H-吡咯-1-基2-Cl-4-Me-1H-吡咯-1-基2-Cl-5-Me-1H-吡咯-1-基3-Cl-4-Me-1H-吡咯-1-基3-Cl-5-Me-1H-吡咯-1-基4-Cl-5-Me-1H-吡咯-1-基2-Br-3-Me-1H-吡咯-1-基2-Br-4-Me-1H-吡咯-1-基2-Br-5-Me-1H-吡咯-1-基3-Br-4-Me-1H-吡咯-1-基3-Br-5-Me-1H-吡咯-1-基4-Br-5-Me-1H-吡咯-1-基2-n-Pr-3-F-1H-吡咯-1-基 |
| 栏1 | 栏2 | 栏3 | |
| 474849505152535455565758596061626364656667686970717273747576777879808182 | 2,4-二Cl-C6H32,5-二Cl-C6H32,6-二Cl-C6H33,4-二Cl-C6H33,5-二Cl-C6H32,5-二Br-C6H32-Br-5-Cl-C6H32-Br-5-Me-C6H33-Br-6-Me-C6H32-CN-3-F-C6H32-CN-4-F-C6H32-CN-5-F-C6H32-CN-6-F-C6H32-CN-3-Cl-C6H32-CN-5-Cl-C6H32-CN-5-Br-C6H32-CN-3-I-C6H32-CN-3-CF3-C6H32-CN-6-CF3-C6H32-CN-3-Me-C6H32-CN-4-Me-C6H32-CN-5-Me-C6H32-CN-6-Me-C6H32-Br-4-F-C6H32-Br-5-F-C6H33-Br-6-F-C6H32-Cl-5-Me-C6H33-Cl-5-Me-C6H33-Cl-6-Me-C6H32-n-Pr-3-F-C6H32-n-Pr-5-F-C6H32-n-Pr-5-Cl-C6H32-n-Pr-5-Br-C6H32-n-Pr-5-Me-C6H32-Cl-3-F-C6H32-Cl-4-F-C6H3 | 4-F-5-Me-2-噻吩基3-Cl-5-Br-2-噻吩基3-Me-4-F-2-噻吩基3-Me-5-F-2-噻吩基3-Br-5-Cl-2-噻吩基4-Br-5-Cl-2-噻吩基3-Cl-5-Me-2-噻吩基3-Me-5-Cl-2-噻吩基3-Br-5-Me-2-噻吩基3-Me-5-Br-2-噻吩基4-Me-5-Br-2-噻吩基3-n-Pr-4-F-2-噻吩基3-n-Pr-5-F-2-噻吩基3-CN-5-Cl-2-噻吩基3-CN-5-Br-2-噻吩基3-噻吩基2-F-3-噻吩基4-F-3-噻吩基5-F-3-噻吩基2-Cl-3-噻吩基4-Cl-3-噻吩基5-Cl-3-噻吩基2-CN-3-噻吩基2-Br-3-噻吩基5-Br-3-噻吩基2-n-Pr-3-噻吩基2-(CH2CN)-3-噻吩基2,5-二Cl-3-噻吩基2,5-二Br-3-噻吩基2-F-5-Cl-3-噻吩基2-Cl-5-F-3-噻吩基2-F-5-Br-3-噻吩基2-Br-5-F-3-噻吩基2-Cl-5-Br-3-噻吩基2-Br-5-Cl-3-噻吩基2-n-Pr-5-F-3-噻吩基 | 2-n-Pr-4-F-1H-吡咯-1-基2-n-Pr-5-F-1H-吡咯-1-基2-n-Pr-3-Cl-1H-吡咯-1-基2-n-Pr-4-Cl-1H-吡咯-1-基2-n-Pr-5-Cl-1H-吡咯-1-基2-n-Pr-3-Br-1H-吡咯-1-基2-n-Pr-4-Br-1H-吡咯-1-基2-n-Pr-5-Br-1H-吡咯-1-基2-CN-3-F-1H-吡咯-1-基2-CN-4-F-1H-吡咯-1-基2-CN-5-F-1H-吡咯-1-基2-CN-3-Cl-1H-吡咯-1-基2-CN-4-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-3-Br-1H-吡咯-1-基2-CN-4-Br-1H-吡咯-1-基2-CN-5-Br-1H-吡咯-1-基2-CN-3-Me-1H-吡咯-1-基2-CN-4-Me-1H-吡咯-1-基2-CN-5-Me-1H-吡咯-1-基2-CN-5-n-Pr-1H-吡咯-1-基2,3,4-三Cl-1H-吡咯-1-基2,3,5-三Cl-1H-吡咯-1-基2,3-二Cl-4-Me-1H-吡咯-1-基2,3-二Cl-5-Me-1H-吡咯-1-基2,4-二Cl-3-Me-1H-吡咯-1-基2,4-二Cl-5-Me-1H-吡咯-1-基2,5-二Cl-3-Me-1H-吡咯-1-基2-CN-3,4-二Cl-1H-吡咯-1-基2-CN-3,5-二Cl-1H-吡咯-1-基2-CN-4,5-二Cl-1H-吡咯-1-基2-CN-3-Cl-4-Me-1H-吡咯-1-基2-CN-3-Cl-5-Me-1H-吡咯-1-基2-CN-3-Me-4-Cl-1H-吡咯-1-基2-CN-3-Me-5-Cl-1H-吡咯-1-基2-CN-4-Me-5-Cl-1H-吡咯-1-基 |
| 栏1 | 栏2 | 栏3 | |
| 83848586878889 | 2-Cl-5-F-C6H32-Cl-6-F-C6H33-Cl-2-F-C6H33-Cl-6-F-C6H34-Cl-2-F-C6H32-F-3-Me-C6H32-F-4-Me-C6H3 | 2-CN-5-F-3-噻吩基2-CN-5-Cl-3-噻吩基2-CN-5-Br-3-噻吩基2-CN-5-Me-3-噻吩基1H-吡咯-1-基2-F-1H-吡咯-1-基3-F-1H-吡咯-1-基 | 2-CN-4-Cl-5-Me-1H-吡咯-1-基2-CN-4Br-5-Me-1H-吡咯-1-基2,3,4-triCl-5-CN-1H-吡咯-1-基2,3-Cl-4-Me-5-CN-1H-吡咯-1-基2,4-Cl-3-Me-5-CN-1H-吡咯-1-基3,4-Cl-2-Me-5-CN-1H-吡咯-1-基 |
表6Z=
| 栏1 | 栏2 | 栏3 | |
| 12345678910111213141516171819 | 1H-吡咯-1-基2-Cl-1H-吡咯-1-基3-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基2-Br-1H-吡咯-1-基3-Br-1H-吡咯-1-基2-CH2CN-1H-吡咯-1-基2,3-二Cl-1H-吡咯-1-基2,4-二Cl-1H-吡咯-1-基2,5-二Cl-1H-吡咯-1-基3,4-二Cl-1H-吡咯-1-基2,3-二Br-1H-吡咯-1-基2,4-二Br-1H-吡咯-1-基2,5-二Br-1H-吡咯-1-基3,4-二Br-1H-吡咯-1-基2-Cl-3-Br-1H-吡咯-1-基2-Cl-4-Br-1H-吡咯-1-基2-Cl-5-Br-1H-吡咯-1-基3-Cl-4-Br-1H-吡咯-1-基 | 2-Cl-4-Me-1H-吡咯-1-基2-Cl-5-Me-1H-吡咯-1-基2-Br-3-Me-1H-吡咯-1-基2-Br-4-Me-1H-吡咯-1-基2-Br-5-Me-1H-吡咯-1-基2-n-Pr-5-Br-1H-吡咯-1-基2-CN-3-Cl-1H-吡咯-1-基2-CN-4-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-3-Br-1H-吡咯-1-基2-CN-4-Br-1H-吡咯-1-基2-CN-5-Br-1H-吡咯-1-基2-CN-4-Me-1H-吡咯-1-基2,3-二Cl-4-Me-1H-吡咯-1-基2,3-二Cl-5-Me-1H-吡咯-1-基2,4-二Cl-3-Me-1H-吡咯-1-基2,4-二Cl-5-Me-1H-吡咯-1-基2,5-二Cl-3-Me-1H-吡咯-1-基3,4-二Cl-5-Me-1H-吡咯-1-基 | 2-CN-5-Me-1H-吡咯-1-基2-CN-5-n-Pr-1H-吡咯-1-基2,3,4-三Cl-1H-吡咯-1-基2,3,5-三Cl-1H-吡咯-1-基2-CN-3,4-二Cl-1H-吡咯-1-基2-CN-3,5-二Cl-1H-吡咯-1-基2-CN-4,5-二Cl-1H-吡咯-1-基2-CN-3-Cl-4-Me-1H-吡咯-1-基2-CN-3-Cl-5-Me-1H-吡咯-1-基2-CN-3-Me-4-Cl-1H-吡咯-1-基2-CN-3-Me-5-Cl-1H-吡咯-1-基2-CN-4-Me-5-Cl-1H-吡咯-1-基2-CN-4-Cl-5-Me-1H-吡咯-1-基2,3,4,5-四Cl-1H-吡咯-1-基2,3,4-三Cl-5-Me-1H-吡咯-1-基2,3,5-三Cl-4-Me-1H-吡咯-1-基2,4-二Cl-3,5-二Me-1H-吡咯-1-基2,5-二Cl-3,4-二Me-1H-吡咯-1-基3,4-二Cl-2,5-二Me-1H-吡咯-1-基 |
| 栏1 | 栏2 | 栏3 | |
| 202122 | 3-Cl-5-Br-1H-吡咯-1-基4-Cl-5-Br-1H-吡咯-1-基2-Cl-3-Me-1H-吡咯-1-基 | 2-CN-3,4-二Me-1H-吡咯-1-基]2-CN-3,5-二Me-1H-吡咯-1-基2-CN-4,5-二Me-1H-吡咯-1-基 | 2,3,4-三Cl-5-CN-1H-吡咯-1-基2,4-Cl-3-Me-5-CN-1H-吡咯-1-基 |
表7Z=
| 栏1 | 栏2 | 栏3 | |
| 123456789101112131415161718192021222324 | C6H52-F-C6H43-F-C6H44-F-C6H42-Cl-C6H43-Cl-C6H44-Cl-C6H42-Br-C6H43-Br-C6H44-Br-C6H42-I-C6H43-I-C6H44-I-C6H42-Me-C6H43-Me-C6H44-Me-C6H42-Et-C6H42-CN-C6H42-CF3-C6H42-n-Pr-C6H42-i-Pr-C6H42-n-Bu-C6H43-SiMe3-C6H42-CH2F-C6H4 | 2-CN-4-Me-C6H32-CN-5-Me-C6H32-CN-6-Me-C6H32-Br-4-F-C6H32-Br-5-F-C6H33-Br-6-F-C6H34-Br-2-F-C6H32-Cl-5-Me-C6H33-Cl-5-Me-C6H33-Cl-6-Me-C6H32-n-Pr-3-F-C6H32-n-Pr-4-F-C6H32-n-Pr-5-F-C6H32-n-Pr-6-F-C6H32-n-Pr-3-Cl-C6H32-n-Pr-5-Cl-C6H32-n-Pr-5-Br-C6H32-n-Pr-5-Me-C6H32-n-Pr-6-CN-C6H32-Cl-3-F-C6H32-Cl-4-F-C6H32-Cl-5-F-C6H32-Cl-6-F-C6H33-Cl-2-F-C6H3 | 5-Br-2-噻吩基3-n-Pr-2-噻吩基5-n-Pr-2-噻吩基5-i-Pr-2-噻吩基3-(CH2CN)-2-噻吩基3-(CH=CH2)-2-噻吩基3-(CH=CHMe)-2-噻吩基3-(CH2CH=CH2)-2-噻吩基3-(CH2C≡CH)-2-噻吩基3-(C≡CMe)-2-噻吩基3-(CH=CHBr)-2-噻吩基3-(CH=CHCN)-2-噻吩基3,5-二F-2-噻吩基3,5-二Cl-2-噻吩基3,5-二Br-2-噻吩基3-F-5-Cl-2-噻吩基3-Cl-5-F-2-噻吩基3-F-5-Br-2-噻吩基3-Br-4-F-2-噻吩基3-Br-5-F-2-噻吩基3-F-5-Me-2-噻吩基3-Me-5-F-2-噻吩基3-Br-5-Cl-2-噻吩基3-Cl-5-Me-2-噻吩基 |
| 栏1 | 栏2 | 栏3 | |
| 252627282930313233343536373839404142434445464748495051525354555657585960 | 3-CH2F-C6H42-CH2CN-C6H42-CH2CH2F-C6H42-CH2CH2CN-C6H42-(CH=CH2)-C6H42-(CH=CHMe)-C6H42-(CH2CH=CH2)-C6H42-(CH=CHCl)-C6H42-(CH=CHBr)-C6H42-(CH=CHCN)-C6H42-(C≡CH)-C6H42-(CH2C≡CH)-C6H42-(C=CMe)-C6H42-(t-Bu)-C6H42-(CH2C≡CMe)-C6H42-[CH(F)Me]-C6H42-[CH(Cl)Me]-C6H42-[CH(Br)Me]-C6H42-[CH(CN)Me]-C6H42-[CH(CN)CH2Me]-C6H42-[CH=C(Me)2]-C6H42-[CH(Me)CH=CH2]-C6H42-(CH2C(Me)=CH2)-C6H42-(CH2CH2C≡CH)-C6H42,3-二F-C6H32,4-二F-C6H32,5-二F-C6H32,6-二F-C6H33,4-二F-C6H33,5-二F-C6H32,3-二Cl-C6H32,5-二Cl-C6H32,5-二Br-C6H32-Br-5-Cl-C6H33-Br-2-Cl-C6H33-Br-6-Cl-C6H3 | 3-Cl-6-F-C6H34-Cl-2-F-C6H32-F-3-Me-C6H32-F-5-Me-C6H32-F-6-Me-C6H33-F-6-Me-C6H32,3,4-三F-C6H22,3,5-三F-C6H22,3,6-三F-C6H22,4,5-三F-C6H22,3,5-三Cl-C6H22,3-二F-5-Cl-C6H22,3-二F-6-Cl-C6H22,5-二F-3-Cl-C6H22,5-二F-6-Cl-C6H22,6-二F-3-Cl-C6H22,3-二Cl-5-F-C6H22,3-二Cl-6-F-C6H22,5-二Cl-3-F-C6H22,5-二Cl-6-F-C6H22,6-二Cl-3-F-C6H22,3-二F-5-Me-C6H22,5-二F-3-Me-C6H22,5-二F-6-Me-C6H22-CN-3,5-二Cl-C6H22-CN-3,6-二Cl-C6H22-CN-3,5-二F-C6H22-CN-3,6-二F-C6H22-CN-5,6-二F-C6H22-CN-3-F-5-Cl-C6H22-CN-3-Me-5-Cl-C6H22-CN-3-Me-5-F-C6H22-Cl-3-F-5-Me-C6H22-F-3-Cl-5-Me-C6H22,3,4,5-四F-C6H2,3,4,6-四F-C6H | 3-Me-5-Cl-2-噻吩基3-Br-5-Me-2-噻吩基3-Me-5-Br-2-噻吩基3-n-Pr-5-Cl-2-噻吩基3-CN-5-F-2-噻吩基3-CN-5-Cl-2-噻吩基3-CN-5-Br-2-噻吩基3-CN-5-Me-2-噻吩基3-噻吩基2-F-3-噻吩基4-F-3-噻吩基5-F-3-噻吩基2-I-3-噻吩基5-I-3-噻吩基2-Me-3-噻吩基5-Me-3-噻吩基2-Et-3-噻吩基2-Cl-3-噻吩基4-Cl-3-噻吩基5-Cl-3-噻吩基2-CN-3-噻吩基2-(C≡CH)-3-噻吩基2-Br-3-噻吩基5-Br-3-噻吩基2-n-Pr-3-噻吩基2-i-Pr-3-噻吩基2-n-Bu-3-噻吩基2-CH2F-3-噻吩基2-(CH2CN)-3-噻吩基2-t-Bu-3-噻吩基2-SiMe3-3-噻吩基2-(CH2CH2CN)-3-噻吩基2-(CH=CH2)-3-噻吩基2-(CH=CHMe)-3-噻吩基2-(CH2CH=CH2)-3-thienyl2-(CH2C≡CH)-3-噻吩基 |
| 栏1 | 栏2 | 栏3 | |
| 61626364656667686970717273747576 | 4-Br-2-Cl-C6H32-Br-4-Me-C6H32-Br-5-Me-C6H33-Br-6-Me-C6H32-CN-3-F-C6H32-CN-4-F-C6H32-CN-5-F-C6H32-CN-6-F-C6H32-CN-3-Cl-C6H32-CN-5-Cl-C6H32-CN-6-Cl-C6H32-CN-5-Br-C6H32-CN-3-I-C6H32-CN-3-CF3-C6H32-CN-6-CF3-C6H32-CN-3-Me-C6H3 | 2,3,5,6-四F-C6H2-噻吩基3-F-2-噻吩基4-F-2-噻吩基5-F-2-噻吩基5-I-2-噻吩基3-Me-2-噻吩基5-Me-2-噻吩基3-Et-2-噻吩基5-Et-2-噻吩基3-Cl-2-噻吩基4-Cl-2-噻吩基5-Cl-2-噻吩基3-CN-2-噻吩基5-(C≡CH)-2-噻吩基3-Br-2-噻吩基 | 2-(C≡CMe)-3-噻吩基2-(CH=CHCN)-3-噻吩基2,4-二F-3-噻吩基2,5-二F-3-噻吩基2,4-二Cl-3-噻吩基2,5-二Cl-3-噻吩基2,5-二Br-3-噻吩基2-Cl-5-Br-3-噻吩基2-Br-5-Cl-3-噻吩基2-Br-5-Me-3-噻吩基2-Me-5-Br-3-噻吩基2-n-Pr-5-Cl-3-噻吩基2-n-Pr-5-Br-3-噻吩基2-CN-5-Cl-3-噻吩基2-CN-5-Br-3-噻吩基2-CN-5-Me-3-噻吩基 |
表8Z=
| 栏1 | 栏2 | 栏3 | |
| 1234567891011 | C6H52-F-C6H43-F-C6H44-F-C6H42-Cl-C6H43-Cl-C6H44-Cl-C6H42-Br-C6H43-Br-C6H44-Br-C6H42-I-C6H4 | 2-CN-3-Cl-C6H32-CN-4-Cl-C6H32-CN-5-Cl-C6H32-CN-6-Cl-C6H32-CN-5-Br-C6H32-CN-3-I-C6H32-CN-3-CF3-C6H32-CN-6-CF3-C6H32-CN-3-Me-C6H32-CN-5-Me-C6H32-Br-4-F-C6H3 | 2,3,5,6-四Cl-C6H2,3,5-三Cl-6-CN-C6H2,3,4-三F-6-CN-C6H2,5-二Cl-3,6-二F-C6H2,5-二F-3-Cl-6-CN-C6H1H-吡咯-1-基2-F-1H-吡咯-1-基3-F-1H-吡咯-1-基2-I-1H-吡咯-1-基2-Cl-1H-吡咯-1-基3-Cl-1H-吡咯-1-基 |
| 栏1 | 栏2 | 栏3 | |
| 121314151617181920212223242526272829303132333435363738394041424344454647 | 3-I-C6H44-I-C6H42-Me-C6H43-Me-C6H44-Me-C6H42-Et-C6H42-CN-C6H42-CF3-C6H42-n-Pr-C6H43-n-Pr-C6H42-i-Pr-C6H43-i-Pr-C6H42-n-Bu-C6H43-SiMe3-C6H42-CH2F-C6H43-CH2F-C6H42-CH2Cl-C6H42-CH2Br-C6H42-CH2CN-C6H42-CH2CH2F-C6H42-CH2CH2Cl-C6H42-CH2CH2CN-C6H42-(CH=CH2)-C6H42-(CH=CHMe)-C6H42-(CH2CH=CH2)-C6H42-(C≡CH)-C6H42-(CH2C≡CH)-C6H42-(C≡CMe)-C6H42-(C≡CCH2Me)-C6H42-(i-Bu)-C6H42-[CH(F)Me]-C6H42-[CH(Cl)Me]-C6H42-[CH(Br)Me]-C6H42-[CH(CN)Me]-C6H42-[CH=C(Me)2]-C6H42-[CH(Me)CH=CH2]-C6H4 | 2-Br-5-F-C6H33-Br-6-F-C6H32-Cl-3-Me-C6H32-Cl-5-Me-C6H33-Cl-5-Me-C6H32-n-Pr-3-F-C6H32-n-Pr-4-F-C6H32-n-Pr-5-F-C6H32-n-Pr-6-F-C6H32-n-Pr-3-Cl-C6H32-n-Pr-5-Cl-C6H32-n-Pr-5-Br-C6H32-n-Pr-5-Me-C6H32-Cl-3-F-C6H32-Cl-4-F-C6H32-Cl-5-F-C6H32-Cl-6-F-C6H33-Cl-2-F-C6H33-Cl-6-F-C6H32-F-3-Me-C6H32-F-5-Me-C6H32-F-6-Me-C6H33-F-6-Me-C6H32,3,4-三F-C6H22,3,5-三F-C6H22,3,6-三F-C6H22,4,5-三F-C6H22,4,6-三F-C6H22,3,5-三Cl-C6H22,3,6-三Cl-C6H22,3-二F-5-Cl-C6H22,3-二F-6-Cl-C6H22,5-二F-3-Cl-C6H22,5-二F-6-Cl-C6H22,6-二F-3-Cl-C6H22,3-二Cl-5-F-C6H2 | 2-CN-1H-吡咯-1-基2-Br-1H-吡咯-1-基2-n-Pr-1H-吡咯-1-基2-n-Bu-1H-吡咯-1-基2-t-Bu-1H-吡咯-1-基2,3-二Cl-1H-吡咯-1-基2,4-二Cl-1H-吡咯-1-基2,5-二Cl-1H-吡咯-1-基2,3-二Br-1H-吡咯-1-基2,4-二Br-1H-吡咯-1-基2,5-二Br-1H-吡咯-1-基2-Cl-3-Br-1H-吡咯-1-基2-Cl-4-Br-1H-吡咯-1-基2-Cl-5-Br-1H-吡咯-1-基3-Cl-5-Br-1H-吡咯-1-基4-Cl-5-Br-1H-吡咯-1-基2-Cl-3-Me-1H-吡咯-1-基2-Cl-4-Me-1H-吡咯-1-基2-Cl-5-Me-1H-吡咯-1-基2-Br-3-Me-1H-吡咯-1-基2-Br-4-Me-1H-吡咯-1-基2-Br-5-Me-1H-吡咯-1-基3-Br-4-Me-1H-吡咯-1-基2-CN-3-Cl-1H-吡咯-1-基2-CN-4-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-3-Br-1H-吡咯-1-基2-CN-4-Br-1H-吡咯-1-基2-CN-5-Br-1H-吡咯-1-基2-CN-3-Me-1H-吡咯-1-基2-CN-4-Me-1H-吡咯-1-基2-CN-5-Me-1H-吡咯-1-基2-CN-5-n-Pr-1H-吡咯-1-基2,3,4-三Cl-1H-吡咯-1-基2,3,5-三Cl-1H-吡咯-1-基2,3-二Cl-4-Me-1H-吡咯-1-基 |
| 栏1 | 栏2 | 栏3 | |
| 484950515253545556575859606162636465666768697071 | 2-(CH2C(Me)=CH2)-C6H42-(CH2CH2C≡CH)-C6H42,3-二F-C6H32,4-二F-C6H32,5-二F-C6H32,6-二F-C6H33,4-二F-C6H33,5-二F-C6H32,3-二Cl-C6H32,4-二Cl-C6H32,5-二Cl-C6H32,6-二Cl-C6H33,4-二Cl-C6H33,5-二Cl-C6H32,5-二Br-C6H32-Br-5-Cl-C6H33-Br-2-Cl-C6H33-Br-6-Cl-C6H32-Br-5-Me-C6H33-Br-6-Me-C6H32-CN-3-F-C6H32-CN-4-F-C6H32-CN-5-F-C6H32-CN-6-F-C6H3 | 2,5-二Cl-3-F-C6H22,5-二Cl-6-F-C6H22,6-二Cl-3-F-C6H22,3-二F-5-Me-C6H22,5-二F-3-Me-C6H22,5-二F-6-Me-C6H22,5-二Cl-3-Me-C6H22,5-二Cl-6-Me-C6H22-CN-3,5-二Me-C6H22-CN-3,5-二Cl-C6H22-CN-3,5-二F-C6H22-CN-5,6-二F-C6H22-CN-3-F-5-Cl-C6H22-CN-3-Me-5-Cl-C6H22-CN-3-Me-5-F-C6H22-CN-5-F-6-Cl-C6H22-Cl-3-F-5-Me-C6H22-Cl-3-F-6-Me-C6H22-F-3-Cl-5-Me-C6H22,3,4,5-四F-C6H2,3,4,6-四F-C6H2,3,5,6-四F-C6H2,3,4,5-四Cl-C6H2,3,4,6-四Cl-C6H | 2,3-二Cl-5-Me-1H-吡咯-1-基2,4-二Cl-3-Me-1H-吡咯-1-基2,4-二Cl-5-Me-1H-吡咯-1-基2,5-二Cl-3-Me-1H-吡咯-1-基2-CN-3,5-二Me-1H-吡咯-1-基2-CN-4,5-二Me-1H-吡咯-1-基2-CN-3,5-二Cl-1H-p吡咯-1-基2-CN-4,5-二Cl-1H-吡咯-1-基2-CN-3-Cl-4-Me-1H-吡咯-1-基2-CN-3-Cl-5-Me-1H-吡咯-1-基2-CN-3-Me-4-Cl-1H-吡咯-1-基2-CN-3-Me-5-Cl-1H-吡咯-1-基2-CN-4-Me-5-Cl-1H-吡咯-1-基2-CN-4-Cl-5-Me-1H-吡咯-1-基2-CN-4-Br-5-Me-1H2,3,4,5-四Cl-1H-吡咯-1-基2,3,5-三Cl-4-Me-1H-吡咯-1-基2,5-二Cl-3,4-二Me-1H-吡咯-1-基2,3,4-三Cl-5-CN-1H-吡咯-1-基2,3,4-三Me-5-CN-1H-吡咯-1-基2,3-Cl-4-Me-5-CN-1H-吡咯-1-基2,4-Cl-3-Me-5-CN-1H-吡咯-1-基3,4-Cl-2-Me-5-CN-1H-吡咯-1-基 |
表9
制剂/用途
| R1 R2 R3 R4 R5 X | 栏1 | 栏2 |
| H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z= | C6H52-F-C6H42-Cl-C6H42-CN-C6H4 | 2,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H3 |
| R1 R2 R3 R4 R5 X | 栏1 | 栏2 |
| H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H O Z=H H Et Me H O Z=H H Et Me H O Z=H H Et Me H O Z=H H Et Me H O Z=H H Et Me H O Z=Me Me Et Me H O Z=Me Me Et Me H O Z=Me Me Et Me H O Z=Me Me Et Me H O Z=Me Me Et Me H O Z=Me Me Et Me H O Z=Me Et Et Me H O Z=Me Et Et Me H O Z=Me Et Et Me H O Z=Me Et Et Me H O Z=Me Et Et Me H O Z=Me Et Et Me H O Z=Me H Et Me H CH(Me)Z=Me H Et Me H CH(Me)Z=Me H Et Me H CH(Me)Z=Me H Et Me H CH(Me)Z=Me H Et Me H CH(Me)Z=Me H Et Me H CH(Me)Z=Me H Et Me H CH(Et)Z=Me H Et Me H CH(Et)Z=Me H Et Me H CH(Et)Z=Me H Et Me H CH(Et)Z= | 3-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H4 | 2-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H3 |
| R1 R2 R3 R4 R5 X | 栏1 | 栏2 |
| Me H Et Me H CH(Et) Z=Me H Et Me H CH(Et) Z=Me H Et Me H CH(n-Pr)Z=Me H Et Me H CH(n-Pr Z=Me H Et Me H CH(n-Pr)Z=Me H Et Me H CH(n-Pr)Z=Me H Et Me H CH(n-Pr)Z=Me H Et Me H CH(n-Pr)Z=Me H Et Me H =C(Me) Z=Me H Et Me H =C(Me) Z=Me H Et Me H =C(Me) Z=Me H Et Me H =C(Me) Z=Me H Et Me H =C(Me) Z=Me H Et Me H =C(Me) Z=Me H Et Me H =C(Et) Z=Me H Et Me H =C(Et) Z=Me H Et Me H =C(Et) Z=Me H Et Me H =C(Et) Z=Me H Et Me H =C(Et) Z=Me H Et Me H =C(Et) Z=Me H Et Me H CH2 Z=Me H Et Me H CH2 Z=Me H Et Me H CH2 Z=Me H Et Me H CH2 Z=Me H Et Me H CH2 Z=Me H Et Me H CH2 Z=Me H Et Me H =CH Z=Me H Et Me H =CH Z=Me H Et Me H =CH Z=Me H Et Me H =CH Z=Me H Et Me H =CH Z=Me H Et Me H =CH Z=Me H Et H Me O Z=Me H Et H Me O Z=Me H Et H Me O Z=Me H Et H Me O Z= | 3-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H4 | 2-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H3 |
| R1 R2 R3 R4 R5 X | 栏1 | 栏2 |
| Me H Et H Me O Z=Me H Et H Me O Z=Me H Et H Me CH2 Z=Me H Et H Me CH2 Z=Me H Et H Me CH2 Z=Me H Et H Me CH2 Z=Me H Et H Me CH2 Z=Me H Et H Me CH2 Z=Me H Et H Me =CH Z=Me H Et H Me =CH Z=Me H Et H Me =CH Z=Me H Et H Me =CH Z=Me H Et H Me =CH Z=Me H Et H Me =CH Z=Me H -(CH2)4- Me O Z=Me H -(CH2)4- Me O Z=Me H -(CH2)4- Me O Z=Me H -(CH2)4- Me O Z=Me H -(CH2)4- Me O Z=Me H -(CH2)4- Me O Z=Me H -(CH2)3- Me O Z=Me H -(CH2)3- Me O Z=Me H -(CH2)3- Me O Z=Me H -(CH2)3- Me O Z=Me H -(CH2)3- Me O Z=Me H -(CH2)3- Me O Z=Me H -(CH2)3- Me CH2 Z=Me H -(CH2)3- Me CH2 Z=Me H -(CH2)3- Me CH2 Z=Me H -(CH2)3- Me CH2 Z=Me H -(CH2)3- Me CH2 Z=Me H -(CH2)3- Me CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z= | 3-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H43-Cl-C6H43-F-C6H4C6H52-F-C6H42-Cl-C6H42-CN-C6H4 | 2-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H32-CN-5-F-C6H32-CN-5-Cl-C6H32,5-二F-C6H32,5-二Cl-C6H32-Cl-5-F-C6H32-F-5-Cl-C6H3 |
| R1 R2 R3 R4 R5 X | 栏1 | 栏2 |
| H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H CH2 Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=H H Et Me H =CH Z=Me Ph H Me H O Z=Me Ph H Me H O Z=Me Ph H Me H O Z=Me Ph H H Me O Z= | 3-Cl-C6H43-F-C6H42-噻吩基3-F-2-噻吩基3-Cl-2-噻吩基3-CN-2-噻吩基5-F-2-噻吩基5-Cl-2-噻吩基3-噻吩基2-F-3-噻吩基2-Cl-3-噻吩基2-CN-3-噻吩基5-F-3-噻吩基5-Cl-3-噻吩基1H-吡咯-1-基2-F-1H-吡咯-1-基2-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基5-F-1H-吡咯-1-基5-Cl-1H-吡咯-1-基2-噻吩基3-F-2-噻吩基3-Cl-2-噻吩基3-CN-2-噻吩基5-F-2-噻吩基5-Cl-2-噻吩基3-噻吩基2-F-3-噻吩基2-Cl-3-噻吩基2-CN-3-噻吩基5-F-3-噻吩基5-Cl-3-噻吩基2-CN-C6H42-CN-5-Cl-C6H32,5-二F-C6H32-CN-C6H4 | 2-CN-5-F-C6H32-CN-5-Cl-C6H33,5-二F-2-噻吩基3,5-二Cl-2-噻吩基3-Cl-5-F-2-噻吩基3-F-5-Cl-2-噻吩基3-CN-5-F-2-噻吩基3-CN-5-Cl-2-噻吩基2,5-二F-3-噻吩基2,5-二Cl-3-噻吩基2-Cl-5-F-3-噻吩基2-F-5-Cl-3-噻吩基2-CN-5-F-3-噻吩基2-CN-5-Cl-3-噻吩基2,5-二F-1H-吡咯-1-基2,5-二Cl-1H-吡咯-1-基2-Cl-5-F-1H-吡咯-1-基2-F-5-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-5-F-1H-吡咯-1-基3,5-二F-2-噻吩基3,5-二Cl-2-噻吩基3-Cl-5-F-2-噻吩基3-F-5-Cl-2-噻吩基3-CN-5-F-2-噻吩基3-CN-5-Cl-2-噻吩基2,5-二F-3-噻吩基2,5-二Cl-3-噻吩基2-Cl-5-F-3-噻吩基2-F-5-Cl-3-噻吩基2-CN-5-F-3-噻吩基2-CN-5-Cl-3-噻吩基2-CN-5-F-C6H32-CN-5-Me-C6H32-F-5-Cl-C6H32-CN-5-F-C6H3 |
| R1 R2 R3 R4 R5 X | 栏1 | 栏2 |
| Me Ph H H Me O Z=Me Ph H H Me O Z=H H Et Me H O Z=H H Et Me H O Z=H H Et Me H O Z=H H Et Me H O Z=H H Et Me H O Z=H H Et Me H O Z=Me H H Me Et O Z=Me H H Me Et O Z=Me H (CH2)2CN Me H O Z=Me H (CH2)2CN Me H O Z=Me H (CH2)2F Me H O Z=Me H (CH2)2F Me H O Z=Me H CH2CN Me H O Z=Me H CH2CN Me H O Z=Me H (CH2)2Cl Me H O Z=Me H (CH2)2Cl Me H O Z= | 2-CN-5-Cl-C6H32,5-二F-C6H31H-吡咯-1-基2-F-1H-吡咯-1-基2-Cl-1H-吡咯-1-基2-CN-1H-吡咯-1-基5-F-1H-吡咯-1-基5-Cl-1H-吡咯-1-基3-F-C6H42,5-二F-C6H33-F-C6H42,5-二F-C6H33-F-C6H42,5-二F-C6H33-F-C6H42,5-二F-C6H33-F-C6H42,5-二F-C6H3 | 2-CN-5-Me-C6H32-F-5-Cl-C6H32,5-二F-1H-吡咯-1-基2,5-二Cl-1H-吡咯-1-基2-Cl-5-F-1H-吡咯-1-基2-F-5-Cl-1H-吡咯-1-基2-CN-5-Cl-1H-吡咯-1-基2-CN-5-F-1H-吡咯-1-基2-CN-3-Cl-C6H32-CN-3-Cl-C6H32-CN-3-Cl-C6H32-CN-3-Cl-C6H32-CN-3-Cl-C6H3 |
本发明的化合物通常作为制剂或组合物与农用合适的载体一起使用,其中载体包括至少一种液体稀释剂、固体稀释剂或表面活性剂。制剂或组合物成份的选择应当与活性成份的物理特性、施用方式和环境因素如土壤类型、湿度和温度相一致。有用的制剂包括液体如溶液(包括乳油)、悬浮液、乳状液(包括微乳液和/或超乳液)等,这些均可任意被增稠为凝胶。有用的制剂还包括固体如粉剂、粉末、颗粒、药丸、片剂、薄膜等,这些均可被水分散(“可湿润”)或水溶。活性成份可以被包(微)胶囊和进一步制成悬浮液或固体制剂;整个活性成份的制剂也可以被包胶囊(或“涂层”)。包胶囊可以控制或延迟活性成份的释放。可喷射的制剂可以在合适的介质中扩散,使用的喷射体积为每公顷约一-几百升。高强度的组合物主要用作中间体用于进一步配制。
制剂中通常含有下面近似范围内有效量的活性成份、稀释剂和表面活性剂,其含量加起来为100%(重量)。重量百分数
活性成份 稀释剂 表面活性剂可被水分散或水溶的颗 5-90 0-94 1-15粒、片剂和粉末悬浮液、乳状液、溶液(包 5-50 40-95 0-15括乳油)粉剂 1-25 70-99 0-5颗粒和药丸 0.01-99 5-99.99 0-15高强度组合物 90-99 0-10 0-2
典型的固体稀释剂在Watkins,等人,杀虫剂粉剂的稀释剂和载体手册,第2版,Dorland Books,Caldwell,New jersey中描述。典型的液体稀释剂在Marsden,溶剂指南,第2版,Interscience,New York,1950中描述。McCutcheon′s Detergents and Emulsifiers Annual,AlluredPubl.Corp.,Ridge wood,New Jersey,以及Sisely and Wood,表面活性剂百科全书,Chemical Publ.Co.,Inc.,New York,1964中列出了表面活性剂和推荐用途。所有的制剂中可以含有微量的添加剂以降低泡沫、结块、腐蚀、微生物生长等,或含有增稠剂以增加粘度。
表面活性剂包括,例如,聚乙氧基化醇、聚乙氧基化烷基酚、聚乙氧基化脱水山梨醇脂肪酸酯、二烷基磺基琥珀酸酯、烷基硫酸脂、烷基苯磺酸酯、有机硅氧烷、N,N-二烷基牛磺酸酯、木素磺酸酯、萘磺酸酯甲醛缩合物、聚羧酸酯和聚氧化乙烯/聚氧化丙烯嵌段共聚物。固体稀释剂包括,例如,粘土如膨润土、蒙脱石、硅镁土和高龄土、淀粉、糖、二氧化硅、滑石、硅藻土、尿素、碳酸钙、碳酸钠和碳酸氢钠以及硫酸钠。液体稀释剂包括,例如,水、N,N-二甲基甲酰胺、二甲亚砜、N-烷基吡咯烷酮、乙二醇、聚丙二醇、石蜡、烷基苯、烷基萘、橄榄油、蓖麻、亚麻子、油桐、芝麻、玉米、花生、棉籽、大豆、菜子和椰子油,脂肪酸酯,酮类如环己酮、2-庚酮、异佛尔酮和4-羟基-4-甲基-2-戊酮,和醇类如甲醇、环己醇、癸醇和四氢糠醇。
溶液包括乳油可以通过将成份简单地混合来制备。粉剂和粉末可以通过掺合,通常在锤磨机或流动能量磨中研磨来制备。悬浮液通常通过湿磨法来制备;参见,例如U.S.3060084。颗粒和药丸可以通过在预备的颗粒载体上通过喷涂活性物质或通过附聚技术来制备。参见Browning,“附聚”,化学工程,December 4,1967,147-48页,Perry′s化学工程手册,第4版,McGraw-Hill,New York,1963,8-57页以及WO91/13546。药丸可以按照U.S.4172714中所描述的方法进行制备。可被水分散和水溶的颗粒可以按照U.S.4144050,U.S.3920442和DE3246493中所描述的方法进行制备。片剂可以按照U.S.5180587,U.S.5232701和U.S.5208030这所描述的方法进行制备。薄膜可以按照GB2095558和U.S.3299566所描述方法进行制备。
有关制剂领域的详细信息,参见U.S.3235361第6栏第16行-第7栏第19行和实施例10-41;U.S.3309192第5栏第43行-第7栏第62行和实施例8、12、15、39、41、52、53、58、132、138-140、162-164、166、167和169-182;U.S.2891855第3栏第66行-第5栏第17行和实施例1-4;Klingman,Weed Control as a Science,JohnWiley and Sons,Inc.,New York,1961,81-96页;和Hance等人,WeedControl handbook,第8版,Blackwell Scientific Publications,Oxford,1989。
在下面的实施例中,所有百分数均为重量百分数以及所有制剂均按传统方法制备。化合物序号是指索引表A-D中的化合物。
实施例A可湿润的粉末
化合物2 65.0%
十二烷基酚聚乙二醇醚 2.0%
木素磺酸钠 4.0%
硅铝酸钠 6.0%
蒙脱石(煅烧) 23.0%
实施例B颗粒
化合物13 10.0%
硅镁土(低挥发物质,0.71 90.0%/0.30mm;U.S.No.25-50筛)
实施例C挤压成的药丸
化合物80 25.0%
无水硫酸钠 10.0%
粗木素磺酸钙 5.0%
烷基萘磺酸钠 1.0%
钙/镁膨润土 59.0%
实施例D乳油
化合物2 20.0%
油溶磺酸酯和聚氧乙烯醚的混合物 10.0%
异佛尔酮 70.0%
本发明的化合物可用作植物病害的控制剂。因此本发明还包括一种控制由真菌植物病原体引起的植物病害的方法,该方法包括将有效量的本发明化合物或含有所述化合物的杀菌组合物施用到植物或其受保护的部分中,或者施用到植物种子或受保护的幼苗中。本发明的化合物和组合物提供了控制由担子菌、子囊菌、Oomycete和半知菌类中广谱真菌植物病原体引起的病害。它们在控制广谱植物病害方面是有效的,特别是装饰植物、蔬菜、田地、谷类和水果作物中的叶病原体。这些病原体包括葡萄生单轴霉、蔓延疫霉、Peronospora tabacing、古巴假霜霉、瓜果腐霉、甘蓝黑斑病链格孢、颖枯壳针孢、小麦壳针孢、球座尾孢、花生尾孢、Pseudocer cospo rella herpotrichoides、甜菜尾孢、灰色葡萄孢、Monilinia fructicola、Pyricu laria oryzae、苹果白粉病柄球菌、苹果黑星菌、禾白粉菌、葡萄白粉病钩丝壳霉、隐匿柄锈菌、禾柄锈菌、Hemileia vastatrix、条形柄锈菌、落花生柄锈菌、茄属丝核菌、苍耳单丝壳菌、尖孢镰孢、大丽花轮枝孢、瓜果腐霉、大雄疫霉、油菜核盘菌、整齐小核菌、蓼白粉菌、圆核腔菌、Gaeuman nomycesgraminis、Rynchosporium secalis、玫瑰色镰孢、莴苣盘梗霉和其他与这些病原体紧密相关的属和种。
本发明的化合物也可以与一种或多种其他杀虫剂、杀菌剂、杀线虫剂、杀菌剂、杀螨剂、生长调节剂、化学消毒剂、semiochemicals、驱避剂、诱引剂、信息激素、进料刺激剂或其他生物活性化合物混合形成多组分杀虫剂,提供更广范围的农业保护。可以用本发明化合物配制的这种农业保护剂的例子是:杀虫剂如阿巴美丁、高灭磷、谷硫磷、bifenthrin、bupro fezin、呋喃丹、chlorfenapyr、毒死蜱、chlorpyrifos-methyl、cyfluthrin、β-cyfluthrin、格林奈、λ-格林奈、溴氰菊酯、diafenthiuron、二嗪磷、二氟脲、乐果、esfenvalerate、fenoxycarb、分朴葡酯、杀灭菊酯、fipronil、氟氰戊菊酯、τ-氯氟胺氰戊菊酯、fonophos、imidacloprid、异丙胺磷、马拉硫磷、多聚乙醛、甲胺磷、杀扑磷、灭多虫、甲氧普林、甲氧氯、7-氯-2,5-二氢-2-[[N-(甲氧羰基)-N-[4-(三氟甲氧基)苯基]氨基]羰基]茚并[1,2-e][1,3,4]恶二嗪-4a(3H)-羧酸甲酯(DPX-JW062)、久效磷、草氨酰、对硫磷、甲基对硫磷、苄氯菊酯、甲拌磷、伏杀磷、亚胺硫磷、磷胺、抗蚜威、profe nofos、鱼藤酮、硫灭克磷、tebufenozide、tefluthrin、特丁磷、杀虫畏、硫双卡、tralomethrin、敌百虫和triflumuron;杀菌剂如azoxystrobin、苯菌灵、减瘟素、波尔多液(三硷基硫酸铜)、bromuconazole、敌菌丹、克菌丹、多菌灵、地茂散、四氯二氰苯、王铜、铜盐、cymoxanil、cyproconazole、cyprodinil(CGA219417)、diclomezine、2,6-二氯-4-硝基苯胺、difeno conazole、dimethomorph、diniconazole、diniconazole-M、多果定、稻瘟光、epoxiconazole(BAS480F)、famoxadone、fenarimol、fenbuconazole、fenpiclonil、fenpropidin、fenpropimorph、fluazinam、fluquinconazole、flusilazole、flutolanil、flutriafol、灭菌丹、fosetyl-铝、furalaxyl、hexaconazole、ipconazole、iprobenfos、异丙二酮、稻瘟灵、春日霉素、kresoxim-methyl、代森锰锌、代森锰、mepronil、甲霜灵、metconazole、7-苯并噻唑硫代羧酸S-甲酯(CGA 245704)、myclobutanil、新戊基-asozin(甲胂酸铁)、oxadixyl、penconazole、pencycuron、probenazole、proch loraz、propiconazole、pyrifenox、pyroquilon、quinoxyfen、spiroxamine(KWG4168)、硫、tebuconazole、tetraconazole、噻苯达唑、托布津、福美双、三唑酮、唑菌醇、三环唑、triticonazole、井冈霉素和烯菌酮;杀线虫剂如aldoxycarb和fenamiphos;杀菌剂如链霉素;杀螨剂如虫螨脒、chinomethionat、乙酯杀螨醇、三环锡、三氯杀螨醇、dienochlor、etoxazole、fenazaquin、杀螨锡、分朴萄酯、fenpyroximate、hexythiazox、克螨特、pyridaben和tebufenpyrad;以及生物试剂如苏云金芽孢杆菌、苏云金芽孢杆菌δ-内毒素、baculovirus和昆虫病原菌、病毒和真菌。
在特定的情况下,与其他具有类似控制范围但不同作用方式的杀菌剂的结合对于抗药性处理尤其有利。
植物病害的控制通常通过如下方法来完成,即在传染前期或传染后期将有效量的本发明化合物施用到植物中受保护的部分如根、茎、树叶、果实、种子、块茎或,或球茎中,或施用到受保护植物生长的介质(土壤或砂子)中。化合物也可施用到种子中以保护种子和秧苗。
这些化合物的施用比率会受到许多环境因素的影响,应当在实际使用条件下进行测定。当以小于1g/ha-5000g/ha活性成份的比率处理时,树叶通常会受到保护。当以0.1-10g/公斤种子的比率处理种子时,种子和秧苗通常会受到保护。
下面的试验证明了本发明的化合物在特定的病原体上的有效控制。然而,通过化合物获得的病原体的控制保护不局限于这些菌种。参见索引表A-E关于化合物的描述。下列缩写用于索引表中:t=叔,n=正,i=异,F=氟,Br=溴,Cl=氯,I=碘,Me=甲基,Et=乙基,Pr=丙基,Bu=丁基,CF3=三氟甲基和CN=氰基。缩写“Ex.”代表“实施例”,且后面含有表明制备化合物的实施例序号。缩写“Config.”代表“构型”。
No. R1 * R2 ** R6 X Z 熔点(℃)1a Me R,S H - t-Bu O C6H5 125-1331b# Me R,S H - t-Bu O C6H5 132-1381c## Me R,S H - t-Bu O C6H5 111-1141d# Me R H - t-Bu O C6H5 78-801e## Me R H - t-Bu O C6H5 78-802a Me R,S H - t-u O 2-F-C6H4 油·2b# Me R H - t-Bu O 2-F-C6H4 油·2c## Me R H - t-Bu O 2-F-C6H4 100-1023a Me R,S H - t-Bu O 3-F-C6H4 油·3b# Me R,S H - t-Bu O 3-F-C6H4 131-1333c## Me R,S H - t-Bu O 3-F-C6H4 112-1153d# Me R H - t-Bu O 3-F-C6H4 油·3e## Me R H - t-Bu O 3-F-C6H4 96-984a# Me R,S H - t-Bu O 4-F-C6H4 油·化合物 Conf.at Conf.atNo. R1 * R2 ** R6 X Z 熔点(℃)4b## Me R,S H - t-Bu O 4-F-C6H4 85-884c Me R H - t-Bu O 4-F-C6H4 油·5a Me R,S H - t-Bu O 2-Cl-C6H4 油·5b Me R H - t-Bu O 2-Cl-C6H4 104-1076a# Me R,S H - t-Bu O 3-Cl-C6H4 112-1146b Me R,S H - t-Bu O 3-Cl-C6H4 油·6c## Me R,S H - t-Bu O 3-Cl-C6H4 132-1356d## Me R H - t-Bu O 3-Cl-C6H4 油·6e## Me R H - t-Bu O 3-Cl-C6H4 油·7a# Me R,S H - t-Bu O 4-Cl-C6H4 油·7b## Me R,S H - t-Bu O 4-Cl-C6H4 107-1107c# Me R H - t-Bu O 4-Cl-C6H4 油·7d## Me R H - t-Bu O 4-Cl-C6H4 油·8a Me R,S H - t-Bu O 2-Br-C6H4 123-1258b# Me R H - t-Bu O 2-Br-C6H4 103-1058c## Me R H - t-Bu O 2-Br-C6H4 112-1149a Me R,S H - t-Bu O 3-Br-C6H4 油·9b# Me R H - t-Bu O 3-Br-C6H4 106-1089c## Me R H - t-Bu O 3-Br-C6H4 油·10a# Me R,S H - t-Bu O 4-Br-C6H4 油·10b## Me R,S H - t-Bu O 4-Br-C6H4 油·10c# Me R H - t-Bu O 4-Br-C6H4 油·10d## Me R H - t-Bu O 4-Br-C6H4 油·11a Me R,S H - t-Bu O 2-I-C6H4 140-14211b Me R H - t-Bu O 2-I-C6H4 124-12612a# Me R H - t-Bu O 3-I-C6H4 油·12b## Me R H - t-Bu O 3-I-C6H4 油·13a Me R,S H - t-Bu O 2-CN-C6H4 Oil·13b# Me R H - t-Bu O 2-CN-C6H4 油·13c## Me R H - t-Bu O 2-CN-C6H4 油·14a# Me R H - t-Bu O 2-Cl-4-Me-C6H3 油·14## Me R H - t-Bu O 2-Cl-4-Me-C6H3 油·15a# Me R H - t-Bu O 2-Cl-5-Me-C6H3 103-10615b## Me R H - t-Bu O 2-Cl-5-Me-C6H3 112-11516 Me R H - t-Bu O 2-(CH2CN)-C6H4 120-122化合物 Conf.at Conf.atNo. R1 * R2 ** R6 X Z 熔点(℃)17a Me R,S H - t-Bu O 2-CF3-C6H4 92-9417b Me R H - t-Bu O 2-CF3-C6H4 92-9418a# Me R H - t-Bu O 3-CF3-C6H4 油·18b## Me R H - t-Bu O 3-CF3-C6H4 98-10019 Me R H - t-Bu O 2-Me-C6H4 104-10720a Me R,S H - t-Bu O 2-Et-C6H4 94-97Ex.620b Me R H - t-Bu O 2-Et-C6H4 102-10421a Me R,S H - t-Bu O 2-n-Pr-C6H4 95-9721b Me R H - t-Bu O 2-n-Pr-C6H4 78-8122 Me R H - t-Bu O 2-i-Pr-C6H4 112-11423 Me R H - t-Bu O 2-i-Bu-C6H4 油·24 Me R H - t-Bu O 4-t-Bu-C6H4 97-10025a Me R,S H - t-Bu O 2-(CH2CH=CH2)-C6H4 油·25b Me R H - t-Bu O 2-(CH2CH=CH2)-C6H4 70-7226a# Me R H - t-Bu O 2,3-二F-C6H3 86-8826b## Me R H - t-Bu O 2,3-二F-C6H3 120-12227a# Me R H - t-Bu O 2,4-二F-C6H3 油·27b## Me R H - t-Bu O 2,4-二F-C6H3 油·28a# Me R H - t-Bu O 2,5-二F-C6H3 104-10628b## Me R H - t-Bu O 2,5-二F-C6H3 油·28c Me R H - t-Bu O 2,5-二F-C6H3 101-10329a Me R,S H - t-Bu O 2,6-二F-C6H3 油·29b Me R H - t-Bu O 2,6-二F-C6H3 油·30a# Me R H - t-Bu O 3,4-二F-C6H3 油·30b## Me R H - t-Bu O 3,4-二F-C6H3 油·31a# Me R H - t-Bu O 2,3-二Cl-C6H3 122-12431b## Me R H - t-Bu O 2,3-二Cl-C6H3 104-10632a# Me R H - t-Bu O 2,4-二Cl-C6H3 油·32b## Me R H - t-Bu O 2,4-二Cl-C6H3 油·33a# Me R H - t-Bu O 2,5-二Cl-C6H3 103-10533b## Me R H - t-Bu O 2,5-二Cl-C6H3 103-10533c Me R H - t-Bu O 2,5-二Cl-C6H3 110-11234 Me R H - t-Bu O 2,6-二Cl-C6H3 128-13035a# Me R H - t-Bu O 3,5-二Cl-C6H3 135-137化合物 Conf.at Conf.atNo. R1 * R2 ** R6 X Z 熔点(℃)35b## Me R H - t-Bu O 3,5-二Cl-C6H3 121-2336a# Me R H - t-Bu O 2-F-4-Cl-C6H3 油·36b## Me R H - t-Bu O 2-F-4-Cl-C6H3 油·37a# Me R H - t-Bu O 2-Cl-4-F-C6H3 88-9037b## Me R H - t-Bu O 2-Cl-4-F-C6H3 油·38 Me R,S H - t-Bu O 2-F-4-Br-C6H3 油·39 Me R,S H - t-Bu O 2-CN-3-F-C6H3 143-14940 Me R,S H - t-Bu O 2-CN-4-F-C6H3 110-11641 Me R H - t-Bu O 2-CN-5-F-C6H3 油·42 Me R,S H - t-Bu O 2-CN-3-Cl-C6H3 115-13543 Me R H - t-Bu O 2-CN-5-Cl-C6H3 油·44 Me R H - t-Bu O 2-CN-5-Br-C6H3 油·45 Me R,S H - t-Bu O 2-CN-3-I-C6H3 53-7346 Me R H - t-Bu O 2-CN-5-I-C6H3 油·47 Me R,S H - t-Bu O 2-CN-3-CF3-C6H3 60-9048 Me R,S H - t-Bu O 2-CF3-6-CN-C6H3 135-17049 Me R,S H - t-Bu O 2-Me-3-Cl-5-CN-1H-吡咯-1-基 127-12950 Me R,S H - t-Bu O 2-Me-3-Br-5-CN-1H-吡咯-1-基 油·51 Me R H - t-Bu O 2,3-二Cl-5-CN-1H-吡咯-1-基 110-11652 Me R H - t-Bu O 2,3,4-三Cl-5-CN-1H-吡咯-1-基 110-11653 Me R,S H - t-Bu CH2 3-Cl-5-CN-1H-吡咯-1-基 75-10654# H - H - t-Bu CH2 C6H5 93-9655# H - H - t-Bu CH2 2,3-二Cl-5-CN-1H-吡咯-1-基 油·56 Me R H - CH(Me)C(Me)3 O C6H5 油·57 Me R H - CH(Me)C(Me)3 O 2-F-C6H4 油·58 Me R H - CH(Me)C(Me)3 O 2-Cl-C6H4 油·59 Me R H - CH(Me)C(Me)3 O 2-Br-C6H4 油·60 Me R H - CH(Me)C(Me)3 O 2-CN-C6H4 油·61 Me R H - CH(Me)C(Me)3 O 2-(CH2CN)-C6H4 油·62 Me R H - CH(Me)C(Me)3 O 2,5-二Cl-C6H3 油·63 Me R,S H - CH(Me)C(Me)3 O 2-CN-3-F-C6H3 油·64 Me R,S H - CH(Me)C(Me)3 O 2-CN-3-Cl-C6H3 油·65 Me R,S H - CH(Me)C(Me)3 O 2-CN-3-I-C6H3 油·66 Me R,S H - CH(Me)C(Me)3 O 2-CN-3-CF3-C6H3 油·67 Me R,S H - CH(Me)C(Me)3 O 2-F-6-CN-C6H3 147-165化合物 Conf.at Conf.atNo. R1 * R2 ** R6 X Z 熔点(℃)68 Me R,S H - CH(Me)C(Me)3 O 2-CF3-6-CN-C6H3 油·69 Me R,S H - CH(Me)C(Me)3 O 2-CN-3,5-二F-C6H2 油·70 Me R,S H - CH(Me)C(Me)3 O 2-Me-3-Br-5-CN-1H-吡咯-1-基 油·71a Me R,S H - CH(Me)C(Me)3 O 2-Me-3-Cl-5-CN-1H-吡咯-1-基 油·71b Me R,S H - CH(Me)C(Me)3 O 2-Me-3-Cl-5-CN-1H-吡咯-1-基 油·72 Me R,S H - CH(Me)C(Me)3 CH22-Me-3-Cl-5-CN-1H-吡咯-1-基 111-118Ex.473 Me R,S H - CH(Me)C(Me)3 CH22-Me-3-Br-5-CN-1H-吡咯-1-基 油·74 Me R,S H - CH(Me)C(Me)3 CH23-Cl-5-CN-1H-吡咯-1-基 油·165a# Me R H - t-Bu O 2-Br-4-F-C6H3 95-98165b## Me R H - t-Bu O 2-Br-4-F-C6H3 油·166a# Me R H - t-Bu O 2-Br-5-F-C6H3 95-98166b## Me R H - t-Bu O 2-Br-5-F-C6H3 77-80168a# Me R H - t-Bu O 2,3,5-三F-C6H2 111-114168b## Me R H - t-Bu O 2,3,5-三F-C6H2 116-119169a## Me R H - t-Bu O 2-Cl-3,5-二F-C6H2 109-112169b## Me R H - t-Bu O 2-Cl-3,5-二F-C6H2 油·170a# Me R H - t-Bu O 2,3,5-三Cl-C6H2 油·170b## Me R H - t-Bu O 2,3,5-三Cl-C6H2 109-112171a# Me R H - t-Bu O 2,3,6-三Cl-C6H2 油·171b## Me R H - t-Bu O 2,3,6-三Cl-C6H2 油·172 Me R H - t-Bu O 2,4,6-三Cl-C6H2 81-83173a# Me R H - t-Bu O 4-Cl-2,5-二F-C6H2 93-95173b## Me R H - t-Bu O 4-Cl-2,5-二F-C6H2 112-115174a# Me R H - t-Bu O 2,4,5-三Cl-C6H2 油·174b## Me R H - t-Bu O 2,4,5-三Cl-C6H2 139-142175 Me R,S H - t-Bu O 2-(CH2F)-C6H4 139-142176 Me R H - t-Bu O 3-Me-C6H4 油·177 Me R H - t-Bu O 3-Et-C6H4 油·181a# Me R H - t-Bu O 3,4-二Cl-C6H3 油·181b## Me R H - t-Bu O 3,4-二Cl-C6H3 油·182a# Me R H - t-Bu O 3-F-4-Cl-C6H3 油·182b## Me R H - t-Bu O 3-F-4-Cl-C6H3 油·183a# Me R H - t-Bu O 3-Cl-4-F-C6H3 油·183b## Me R H - t-Bu O 3-Cl-4-F-C6H3 85-88化合物 Conf.at Conf.atNo R1 * R2 ** R6 X Z 熔点(℃)184a# Me R H - t-Bu O 3,5-二F-C6H3 123-126184b## Me R H - t-Bu O 3,5-二F-C6H3 85-88185 Me R H - t-Bu O 2-(CH2CH=CH2)-4-Me-C6H3 84-86186 Me R H - t-Bu O 2,3,6-三F-C6H2 油·187a# Me R H - t-Bu O 2-Br-3,4-二F-C6H2 115-118187b## Me R H - t-Bu O 2-Br-3,4-二F-C6H2 油·188a# Me R H - t-Bu O 2,4,5-三F-C6H2 油·188b## Me R H - t-Bu O 2,4,5-三F-C6H2 油·189a# Me R H - t-Bu O 2,4,6-三F-C6H2 76-79189b## Me R H - t-Bu O 2,4,6-三F-C6H2 油·190a# Me R H - t-Bu O 2,3,4-三F-C6H2 油·190b## Me R H - t-Bu O 2,3,4-三F-C6H2 油·191a# Me R H - t-Bu O 2-Cl-5-F-C6H3 油·191b## Me R H - t-Bu O 2-Cl-5-F-C6H3 油·191c Me R H - t-Bu O 2-Cl-5-F-C6H3 油·19 Me R H - C(Me)2CH=CH2 O 2-Cl-5-F-C6H3 79-81192b## Me R H - C(Me)2CH=CH2 O 2-Cl-5-F-C6H3 油·193 Me R H - C(Me)2C≡CH O 2-Cl-5-F-C6H3 99-102194 Me R H - CH(Me)C(Me)3 O 2-Cl-5-F-C6H3 99-102195 Me R H - t-Bu O 2,3,5,6-四F-C6H 81-83196 Me R H - t-Bu O 2,6-二Br-4-F-C6H2 130-133197 Me R H - t-Bu O 2,6-二Cl-4-F-C6H2 120-123198a# Me R H - t-Bu O 2-F-5-Cl-C6H3 101-104198b## Me R H - t-Bu O 2-F-5-Cl-C6H3 油·199 Me R H - CH(Me)C(Me)3 O 2-F-5-Cl-C6H3 油·200a# Me R H - C(Me)2CH=CH2 O 2-F-5-Cl-C6H3 104-107200b## Me R H - C(Me)2CH=CH2 O 2-F-5-Cl-C6H3 油·201 Me R,S H - t-Bu O 2-(OCF2CF2H)-C6H4 油·202 Me R,S H - t-Bu O 2-(SCF2CF2H)-C6H4 80-110203 Me R,S H - t-Bu O 2-F-6-CN-C6H3 油·204 Me R,S H - t-Bu O 2-(CH2CH=CH2)-6-CN-C6H3 油·205 Me R,S H - t-Bu O 2-(CH2CH2CH3)-6-CN-C6H3 油·206 Me R,S H - t-Bu O 2-CF2H-6-CN-C6H3 93-145207 Me R,S H - t-Bu O 2-CN-4,5-二F-C6H2 55-105208 Me R,S H - t-Bu O 2-CN-3,6-二F-C6H2 113-156化合物 Conf.at Conf.atNo. R1 * R2 ** R6 X Z 熔点(℃)209 Me R,S H - t-Bu O 2-CN-6-Me-C6H3 油·210 Me R,S H - t-Bu O 2-CN-6-Cl-C6H3 118-150211 Me R H - C(Me)2C≡CH O 2,5-二F-C6H3 85-87212 Me R H - C(Me)2C≡CH O 2,5-二Cl-C6H3 93-97213 Me R H - C(Me)2C≡CH O 2-Cl-5-Me-C6H3 84-86214 Me R H - C(Me)2CH=CH2 O 2,5-二F-C6H3 107-112215a# Me R H - C(Me)2CH=CH2 O 2,5-二Cl-C6H3 82-110215b## Me R H - C(Me)2CH=CH2 O 2,5-二Cl-C6H3 油·216 Me R,S H - t-Bu O 2-(C≡CH)-C6H4 128-146217 Me R H - C(Me)2CF=CH2 O 2,5-二F-C6H3 106-110Ex.7218 Me R H - C(Me)(CH2F)CH=CH2O 2,5-二F-C6H3 70-85219 Me R H - C(Me)(CH2F)CH=CH2O 2,5-二Cl-C6H3 油·220 Me R H - C(Me)(CH2F)CH=CH2O 2-Cl-5-F-C6H3 73-88221a# Me R H - C(Me)2CH=CHF O 2,5-二F-C6H3 油·221b## Me R H - C(Me)2CH=CHF O 2,5-二F-C6H3 油·222 Me R H - C(Me)2CH=CHF O 2-Cl-5-F-C6H3 油·223 Me R H - C(Me)2CF=CH2 O 2-Cl-5-F-C6H3 油·224 Me R H - C(Me)2CH=CHF O 2-F-5-Cl-C6H3 78-86225 Me R H - C(Me)(CH2F)CH=CHF O 2-(OCF2CF2H)-5-F-C6H3 油·226 Me R H - C(Me)(CH2F)CH=CHF O 2-F-5-Me-C6H3 70-81227 Me R H - C(Me)(CH2F)CH=CHF O 2-Cl-5-Me-C6H3 油·320 Me R H - C(Me)2C≡CH O 2-F-5-Cl-C6H3 98-101275 Me R,S H - CH(Me)C(Me)3 O 2-(CH2CH=CH2)-6-CN-C6H3 油·276 Me R,S H - CH(Me)C(Me)3 O 2-(CH2CH2CH3)-6-CN-C6H3 油·277 Me R,S H - CH(Me)C(Me)3 O 2-CN-5-(OCF2H)-C6H3 油·278 Me R,S H - CH(Me)C(Me)3 O 2-CN-4,5-二F-C6H2 油·279 Me R,S H - CH(Me)C(Me)3 O 2-CN-3,6-二F-C6H2 油·280 Me R,S H - CH(Me)C(Me)3 O 2-CN-6-Me-C6H3 油·281 Me R,S H - CH(Me)C(Me)3 O 2-CN-6-Cl-C6H3 油·282 Me R H - CH(Me)2CH=CH2 O 2-F-5-Me-C6H3 102-108283 Me R C6H5 S CH2CH=CH2 O 2,5-二F-C6H3 油·284 Me R C6H5 S CH2CH=CH2 O 2-CN-5-F-C6H3 油·285 Me R C6H5 S CH2CH=CH2 O 2-CN-C6H4 油·286 Me R C6H5 S CH2CH3 O 2-CN-5-F-C6H3 油·化合物 Conf.at Conf.atNo. R1 * R2 ** R6 X Z 熔点(℃)287 Me R C6H5 S CH2CH2CH3 O 2-CN-5-F-C6H3 油·288 Me R C6H5 S CH2CH2CH3 O 2-CN-C6H4 油·289 Me R C6H5 S CH(CH3)2 O 2-CN-5-F-C6H3 油·290 Me R C6H5 S CH(CH3)2 O 2-CN-C6H4 油·291 Me R C6H5 S C(CH3)3 O 2-CN-C6H4 油·292 Me R H - C(CH3)3 O 2-(OCF2H)-5-F-C6H3 油·293 Me R C6H5 R CH2CH3 O 2,5-二F-C6H3 油·294 Me R H - CH(Me)2CH=CH2 O 2-(OCF2H)-5-F-C6H3 油·295 Me R H - CH(Me)2C≡CH O 2-(OCF2H)-5-F-C6H3 油·296 Me R H - CH(Me)(Et)CH=CH2 O 2,5-二F-C6H3 96-106297 Me R H - CH(Me)(Et)CH=CH2 O 2-F-5-Cl-C6H3 油·298 Me R H - CH(Me)(Et)CH=CH2 O 2-Cl-5-F-C6H3 93-104299 Me R H - CH(Me)2CF=CH2 O 2-F-5-Cl-C6H3 115-123300 Me R H - CH(Me)2CF=CH2 O 2,5-二Cl-C6H3 94-99301 Me R H - CH(Me)(C≡CH)CH=CH2 O 2,5-二F-C6H3 84-92302 Me R H - CH(Me)(C≡CH)CH=CH2 O 2-F-5-Cl-C6H3 油·303 Me R H - CH(Me)(C≡CH)CH=CH2 O 2-Cl-5-F-C6H3 60-83304 Me R C6H5 R CH2CH3 O 2-CN-C6H4 油·305 Me R H - t-Bu O 2-CN-5-t-Bu-C6H3 油·306 Me R H - t-Bu O 2-CH(Me)(Et)-C6H4 油··参见索引表E中的’H NMR数据#单个非对映异构体A##单个非对映异构体B索引表下列化合物均为非对映异构体的混合物,除非另有说明化合物 ConfigurationNo R1 at* R6 Z 熔点(℃)75 H - CH(Me)C(Me)3 2-F-C6H4 油·76 H - CH(Me)C(Me)3 3-Br-C6H4 油·167 H - t-Bu C6H5 144-147化合物 ConfigurationNo R1 at* R6 Z 熔点(℃)178 H - t-Bu 2-F-C6H4 114-117179 H - t-Bu 2-Cl-C6H4 105-108180 H - t-Bu 3-Cl-C6H4 112-115228 Me R,S t-Bu C6H5 油·229a# Me R t-Bu 2,5-二F-C6H3 油·229b## Me R t-Bu 2,5-二F-C6H3 油·272 H - t-Bu 3-Br-C6H4 112-115273 H - t-Bu 2,4-二F-C6H3 122-125274 H - t-Bu 2,4-二Cl-C6H3 83-86307 Me R t-Bu 2-CN-C6H4 油·308 Me R t-Bu 2-F-C6H4 油·309 Me R t-Bu 2,4-二F-C6H3 油··参见索引表E中的’H NMR数据#单个非对映异构体A##单个非对映异构体B索引表下列化合物均为非对映异构体的混合物,除非另有说明化合物 Config.No R1 at* R2 R3 R4 R5 X Z 熔点(℃)77a Me R,S H Et Me H O C6H5 95-9977b Me R H Et Me H O C6H5 94-9678a Me R,S H Et Me H O 2-F-C6H4 94-9678b Me R H Et Me H O 2-F-C6H4 77-7979a Me R,S H Et Me H O 3-F-C6H4 110-11379b Me R H Et Me H O 3-F-C6H4 86-8880a Me R,S H Et Me H O 4-F-C6H4 104-10780b Me R H Et Me H O 4-F-C6H4 油·81a Me R,S H Et Me H O 2-Cl-C6H4 114-11781b Me R H Et Me H O 2-Cl-C6H4 96-98化合物 Config.No R1 at* R2 R3 R4 R5 X Z 熔点(℃)82a Me R,S H Et Me H O 3-Cl-C6H4 118-12182b Me R H Et Me H O 3-Cl-C6H4 油·83a Me R,S H Et Me H O 4-Cl-C6H4 121-12483b Me R H Et Me H O 4-Cl-C6H4 77-7984a Me R,S H Et Me H O 2-Br-C6H4 124-12684b Me R H Et Me H O 2-Br-C6H4 油·85a Me R,S H Et Me H O 3-Br-C6H4 83-8685b Me R H Et Me H O 3-Br-C6H4 油·86a Me R,S H Et Me H O 4-Br-C6H4 124-12786b Me R H Et Me H O 4-Br-C6H4 102-10487a Me R,S H Et Me H O 2-I-C6H4 108-11187b Me R H Et Me H O 2-I-C6H4 油·88 Me R H Et Me H O 3-I-C6H4 75-7789a Me R,S H Et Me H O 2-CN-C6H4 134-13689b Me R H Et Me H O 2-CN-C6H4 油·90 Me R,S H Et Me H O 2-(OCF2CF2H)-C6H4 90-9891 Me R,S H Et Me H O 2-(SCF2CF2H)-C6H4 61-7692 Me R,S H Et Me H O 2-CH2F-C6H4 105-10793 Me R,S H Et Me H O 3-CH2F-C6H4 123-12594a Me R,S H Et Me H O 2-CF3-C6H4 131-13294b Me R H Et Me H O 2-CF3-C6H4 油·95 Me R H Et Me H O 2-Me-C6H4 油·96 Me R H Et Me H O 3-Me-C6H4 80-8297a Me R,S H Et Me H O 2-Et-C6H4 102-10597b Me R H Et Me H O 2-Et-C6H4 油·98a Me R,S H Et Me H O 2-n-Pr-C6H4 90-9298b Me R H Et Me H O 2-n-Pr-C6H4 油·99 Me R H Et Me H O 2-i-Pr-C6H4 油·100 Me R H Et Me H O 2-t-Bu-C6H4 油·101a Me R,S H Et Me H O 2-(CH2CH=CH2)-C6H490-92101b Me R H Et Me H O 2-(CH2CH=CH2)-C6H4油·102 Me R,S H Et Me H O 3-CH2F-C6H4 105-107103 Me R H Et Me H O 2-(CH2CN)-C6H4 油·104 Me R H Et Me H O 2,3-二F-C6H3 95-97105a Me R,S H Et Me H O 2,6-二F-C6H3 95-97化合物 Config.No R1 at* R2 R3 R4 R5 X Z 熔点(℃)105b Me R H Et Me H O 2,6-二F-C6H3 油·106 Me R H Et Me H O 2,4-二F-C6H3 油·107 Me R H Et Me H O 2,5-二F-C6H3 67-72108 Me R H Et Me H O 3,4-二F-C6H3 油·109 Me R H Et Me H O 2,3,5-三F-C6H2 86-88110 Me R H Et Me H O 2,4,5-三F-C6H2 69-71111 Me R H Et Me H O 2,3-二Cl-C6H3 87-89112 Me R H Et Me H O 2,4-二Cl-C6H3 70-72113 Me R H Et Me H O 2,5-二Cl-C6H3 93-95114 Me R H Et Me H O 2,6-二Cl-C6H3 87-89115 Me R H Et Me H O 3,5-二Cl-C6H3 87-89116 Me R H Et Me H O 2,3,5-三Cl-C6H2 94-96117 Me R H Et Me H O 2,3,6-三Cl-C6H2 95-97118 Me R H Et Me H O 2,4,6-三Cl-C6H2 118-121119 Me R H Et Me H O 2-(CH2CH=CH2)-6-Me-C6H3 油·120 Me R H Et Me H O 2-F-4-Cl-C6H3 油·121 Me R H Et Me H O 2-Cl-4-F-C6H3 65-67122 Me R,S H Et Me H O 2-F-4-Br-C6H3 107-109123 Me R H Et Me H O 2-Cl-3,5-二F-C6H2 84-86124 Me R H Et Me H O 2-Br-4-F-C6H3 62-64125 Me R H Et Me H O 2-Br-5-F-C6H3 73-75126 Me R H Et Me H O 2-Cl-4-Me-C6H3 73-74127 Me R H Et Me H O 2-Cl-5-Me-C6H3 102-104128 Me R,S H Et Me H O 2-F-6-CN-C6H3 102-106129 Me R,S H Et Me H O 2-CN-4-F-C6H3 119-123Ex3130 Me R,S H Et Me H O 2-CN-3-F-C6H3 143-149131 Me R,S H Et Me H O 2-CN-3-Cl-C6H3 120-122132 Me R,S H Et Me H O 2-CN-3-I-C6H3 146-151133 Me R,S H Et Me H O 2-CN-3-CF3-C6H3 120-138134 Me R,S H Et Me H O 2-CN-6-CF3-C6H3 110-134135 Me R,S H Et Me H O 2-CN-3,5-二F-C6H2 164-166136 Me R,S H Et Me H O 2-CN-3,5-二Me-1H-吡咯-1-基 油·137 Me R,S H Et Me H O 3-Br-5-CN-1H-吡咯-1-基 130-146138 Me R,S H Et Me H O 3-Cl-5-CN-1H-吡咯-1-基 108-112化合物 Config.No R1 at* R2 R3 R4 R5 X Z 熔点(℃)139 Me R,S H Et Me H O 2,3-二Cl-5-CN-1H-吡咯-1-基 油·140a Me R,S H Et Me H O 2-Me-3-Cl-5-CN-1H--吡咯-1-基 107-117140b Me R H Et Me H O 2-Me-3-Cl-5-CN-1H-吡咯-1-基 油·Ex.2141 Me R,S H Et Me H O 2-Me-3-Br-5-CN-1H-吡咯-1-基 油·142 Me R,S H Et Me H CH2 2-Me-3-Cl-5-CN-1H-吡咯-1-基 109-115143 Me R,S H Et Me H CH2 2-Me-3-Br-5-CN-1H-吡咯-1-基 123-141144 Me R,S H Et Me H CH2 3-Cl-5-CN-1H-吡咯-1-基 油·145# H - H Et Me H CH2 1H-吡咯-1-基 71-78146# H - H Et Me H CH2 2-Cl-1H-吡咯-1-基 98-100147# H - H Et Me H CH2 2,5-二Cl-1H-吡咯-1-基 105-110148# H - H Et Me H CH2 2,3,5-三Cl-1H-吡咯-1-基 131-133149# H - H Et Me H CH2 2-CN-1H-吡咯-1-基 油·150# H - H Et Me H CH2 2-CN-3,5-二Me-1H-吡咯-1-基 82-84151# H - H Et Me H CH2 2,3-二Cl-5-CN-1H-吡咯-1-基 138-142152# H - H Et Me H CH2 2-Cl-5-CN-1H-吡咯-1-基 油·153# H - H Et Me H O C6H5 65-69154# H - H Et Me H CH2 C6H5 93-95155# H - H Et H Me CH2 C6H5 66-70Ex.1230 Me R H Et Me H O 3,4-二Cl-C6H3 油·231 Me R H Et Me H O 3-F-4-Cl-C6H3 Oil·232 Me R H Et Me H O 3-Cl-4-F-C6H3 77-80233 Me R H Et Me H O 2,3,6-三F-C6H2 81-84234 Me R H Et Me H O 3,5-二F-C6H3 84-87235 Me R H Et Me H O 2-Br-4,5-二F-C6H2 油·236 Me R H Et Me H O 2,4,5-三F-C6H2 油·237 Me R H Et Me H O 2,4,6-三F-C6H2 油·238 Me R H Et Me H O 2,3,4-三F-C6H2 油·239 Me R H Et Me H O 2-CN-5-Cl-C6H3 油·240 Me R H Et Me H O 3-Et-C6H4 油·241 Me R H Et Me H O 4-t-Bu-C6H4 油·242 Me R H Et Me H O 2,4,5-三Cl-C6H2 80-83243 Me R H Et Me H O 2,3,4-三Cl-C6H2 82-85244 Me R,S H Et Me H CH2 C6H5 105-108化合物 Config.No R1 at* R2 R3 R4 R5 X Z 熔点(℃)245 Me R H Et Me H O 2-CN-5-F-C6H3 油·246 Me R H Et Me H O 2-CN-5-Br-C6H3 油·247 Me R H Et Me H O 2-CN-5-I-C6H3 油·248 Me R H Et Me H O 2-CN-5-t-Bu-C6H3 油·249 Me R H Et Me H O 2,3,5,6-四F-C6H 92-95250 Me R H Et Me H O 2,6-二Br-4-F-C6H2 88-90251 Me R H Et Me H O 2,6-二Cl-4-F-C6H2 85-88252 Me R H Et Me H O 2-F-5-Cl-C6H3 110-113253 Me R H Et Me H O 2-Cl-5-F-C6H3 97-100254 Me R,S H Et Me H O 2-(CH2CH=CH2)-6-CN-C6H3 油·255 Me R,S H Et Me H O 2-(CH2CH2CH3)-6-CN-C6H3 油·256 Me R,S H Et Me H O 2-CN-5-(OCF2H)-C6H3 油·257 Me R,S H Et Me H O 3,4-二F-6-CN-C6H2 油·258 Me R,S H Et Me H O 2,5-二F-6-CN-C6H2 98-108259 Me R,S H Et Me H O 2-CN-6-Me-C6H3 97-114260 Me R,S H Et Me H O 2-Cl-6-CN-C6H3 90-92310 Me R,S H Me Me H O C6H5 70-75311 Me R,S H Me H H O C6H5 油·312 Me R,S H Me H H O 2-CF3-C6H4 油·313 Me R,S H Me H H O 2-Br-C6H4 油·314 Me R,S H Me H H O 2-(CH2CH=CH2)-C6H4 油·315 Me R,S H Me H H O 2-F-C6H4 油·316 Me R,S H Et Me H O 2-CN-6-F-C6H3 87-94317 Me R,S H Et Me H O 3-(CH2F)-C6H4 123-125318 Me R H Et Me H O 2-Cl-3,5-二F-C6H2 84-86·参见索引表E中的’H NMR数据#单个非对映异构体
索引表下列化合物均为非对映异构体的混合物,除非另有说明化合物No R1 Configuration at* R2 X Z 熔点(℃)156# H - H CH C6H5 109-111157# H - H CH 2-F-C6H4 103-105Ex.5158# H - H CH 2-Cl-C6H4 143-145159# H - H CH 3-Cl-C6H4 油·160# H - H CH 3-Br-C6H4 油·161# H - H CH 2-(CH2CN)-C6H4 油·162# H - H CH 2,4-二F-C6H3 油·163# H - H CH 2,5-二Cl-C6H4 170-172164# H - H CH 2-噻吩基 120-122261 Me R,S H CH 4-F-C6H4 90-92262# H - H C(Et) 2,5-二Cl-C6H3 油·263 Me R,S H CH C6H5 油·264# H - H CH 3-F-C6H4 油·265# H - Me CH C6H5 油·266 Me R H CH 2,4-二Cl-C6H3 油·267a# Me R H CH 2,5-二F-C6H3 油·Ex.8267b## Me R H CH 2,5-二F-C6H3 102-105Ex.8268# H - H C(Me) C6H5 油·269# H - H C(Et) C6H5 120-123270# H - Me CH 2,5-二Cl-C6H3 油·271# H - H C(Me) 2,5-二Cl-C6H3 油··参见索引表E中的’HNMR数据#单个非对映异构体A##单个非对映异构体B
索引表化合物序号 1HNMR数据(CDCI3溶液,除非另有说明)a
2a δ7.10(m,2H),6.95(m,2H),6.90(dd,1H),4.40(m,1H),4.08(m,2H),1.40(dd,3H),
1.24(d,9H)
2b δ7.08(m,2H),6.95(m,2H),6.2(d,1H),4.40(m,1H),4.05(m,2H),3.15(2s,1H),
1.40(d,3H),1.20(2s,9H)
3a δ7.22(m,1H),6.65(m,2H),6.10(m,1H), 4.40(m,1H),4.05(m,2H),3.15(2s,1H),
1.40(d,3H),1.20(2s,9H)
3d δ7.22(m,1H),6.65(m,3H),6.12(d,1H)4.44(m,1H),4.00(m,2H),3.16(s,1H),
1.40(d,3H),1.20(s,9H)
4a δ7.00(d,2H),6.82(d,2H),6.18(dd,1H),4.40(m,1H),3.95(m,2H),3.15(2s,1H),
1.37(d,3H),1.20(2s,9H)
4c δ7.00(d,2H),6.82(d,2H),6.18(dd,1H),4.40(m,1H),3.95(m,2H),3.14(d,1H),
1.40(d,3H),1.20(d,9H)
5a δ7.25(m,2H),6.82(m,2H),6.15(m,1H),4.40(m,1H),3.98(m,2H),3.15(2s,1H),
1.40(d,3H),1.20(2s,9H)
6b δ7.20(m,2H),6.96(d,2H),6.90(m,1H),6.80(dd,1H),6.18(d,1H)4.44(m,1H),
4.00(m,2H),3.15(2s,1H),1.38(d,3H),1.24(2s,9H)
6d δ7.21(t,2H),6.98(dd,2H),6.90(t,1H),6.80(m,1H),6.10(dd,1H)4.40(m,1H),
4.00(dd,1H),3.96(dd,1H),3.15(s,1H),1.38(d,3H),1.24(s,9H)
6e δ 7.21(t,2H),6.98(dd,2H),6.90(t,1H),6.80(m,1H),6.18(dd,1H)4.40(m,1H),
3.96(ddd,2H),3.13(s,1H),1.38(d,3H),1.24(s,9H)
7a δ7.22(d,2H),6.82(d,2H),6.18(d,1H),4.40(m,1H),3.93(m,2H),3.16(s,1H),1.37
(d,3H),1.20(s,9H)
7c δ7.25(d,2H),6.80(d,2H),6.15(brd,1H),4.40(m,1H),4.00(dd,1H),3.90(dd,1H),
3.15(s,1H),1.40(d,3H),1.20(s,9H)
7d δ7.25(d,2H),6.80(d,2H),6.15(br d,1H),4.40(m,1H),4.00(m,2H),3.12(s,1H),
1.40(d,3H),1.20(s,9H)
9a δ7.12(m,2H),7.05(m,1H),6.80(m,1H),6.15(d,1H),4.40(m,1H),4.00(m,2H),
3.12(2s,1H),1.36(m,3H),1.18(2s,9H)
9c δ7.18(m,2H),7.08(m,1H),6.82(m,1H),6.15(dd,1H),4.40(m,1H),4.00(dd,2H),
3.12(s,1H),1.40(d,3H),1.28(s,9H)
10a δ7.40(d,2H),6.80(d,2H),6.12(d,1H),4.40(m,1H),3.95(ddd,2H),3.15(s,1H),
1.36(d,3H),1.20(s,9H)
10b δ7.40(d,2H), 6.80(d,2H),6.20(d,1H),4.40(m,1H), 3.95(m,2H),3.12(s,1H),
1.36(d,3H),1.20(s,9H)化合物序号 1HNMR数据(CDCI3溶液,除非另有说明)a
10c δ7.40(d,2H),6.80(d,2H),6.10(brd,1H),4.40(m,1H),4.00(dd,1H),3.90(dd,1H),
3.15(s,1H),1.40(d,3H),1.20(s,9H)
10d δ7.40(d,2H),6.80(d ,2H),6.10(brd, 1H),4.40(m,1H),4.00(m,2H),3.12(s,1H),
1.40(d,3H),1.20(s,9H)
12a δ7.32(m,1H),7.25(m,1H), 7.02(t,1H), 6.82(dd,1H),6.10(d,1H),4.40(m,1H),
4.40(m,1H),4.00(dd,1H),3.90(dd,1H),3.15(s,1H),1.40(d,3H),1.20(s,9H)
12b δ7.32(m,1H),7.25(m,1H),7.02(t,1H),6.82(dd,1H),6.10(d,1H), 4.40 (m,1H),
4 40(m,1H),4.00(dd,1H),3.90(dd,1H),3.15(s,1H),1.40(d,3H), 1.20(s,9H)
13a δ7.60(m,2H),7.15(m,1H),7.02 (m,1H),6.60(d,1H),4.65(dd,1H),4.20(m,2H),
3.21(d,1H),1.30(m,3H),1.10(d,9H)
13b δ7.57(dt,2H),7.05(t,1H),7.02(m,1H),6.30(d,1H),4.41(dd,1H),4.10(m,2H),
3.18(s,1H),1.42(m,3H),1.18(d,9H)
13c δ7.57(dt,2H),7.02(m,2H),6.30(d,1H),4.41(dd,1H),4.10(m,2H),3.18(s,1H),
1.42(m,3H),1.18(d,9H)
14a δ7.20(s,1H),7.00(d,1H),6.80(d,1H),6.35(br d,1H),4.40(m,1H),4.00(m,2H),
3.14(s,1H),2.27(s,3H),1.42(d,3H),1.20(s,9H)
14b δ7.20(s,1H),7.00(d,1H),6.80(d,1H),6.40(br d,1H),4.40(m,1H),4.00(m,2H),
3.13(s,1H),2.27(s,3H),1.42(d,3H),1.17(s,9H)
18a δ7.60(d,1H),7.50(t,1H),7.08(t,1H),6.97(d,1H),6.30(2d,1H),4.40(m,1H),
4.10(m,2H),3.11(2s,1H),1.38(d,3H),1.20(2s,9H)
23 δ7.30(d,1H),7.20(t,1H),6.92(t,1H),6.84(d,1H),4.50(m,1H),4.05(m,2H),
3.13(s,1H),1.40(m,12H),1.20(2s,9H)
25a δ7.20(t,2H),6.90(t,1H),6.80(d,1H),6.20(dd,1H),6.00(m,1H),5.05(m,2H),
4.40(m,1H),4.00(m,2H),3.40(m,2H),3.12(2s,1H),1.40(d,3H),1.20(2s,9H)
27a δ6.90(m,3H),6.18(d,1H)4.40(m,1H),4.05(m,2H),3.95(dd,1H),3.15(s,1H),
1.40(d,3H),1.20(s,9H)
27b δ6.90(m,3H),6.21(d,1H)4.40 (m,1H),4.05(m,2H),3.95(dd,1H),3.14(s,1H),
1.40(d,3H),1.20(s,9H)
28b δ7.00(m,1H),6.70(m,1H),6.62(m,1H),6.20(d,1H),4.40(m,1H),4.02(m,2H),
3.13(s,1H),1.40(d,3H),1.20(s,9H)
29a δ6.95(m,3H),6.40(dd,1H),4.35(m,1H),4.10(m,2H),3.17(s,1H),1.40(d,3H),
1.20(s,9H)
29b δ6.95(m,3H),6.40(dd,1H),4.35(m,1H),4.10(m,2H),3.17(2s,1H),1.40(d,3H),
1.20(s,9H)
30a δ7.10(dd,1H), 6.72(m,1H),6.60(m,1H),6.10(d,1H),4.40(m,1H),4.00(m,2H),
3.15(s,1H),1.40(d,3H),1.20(s,9H)化合物序号 1HNMR数据(CDCI3溶液,除非另有说明)a30b δ7.10(dd,1H),6.72(m,1H),6.60(m,1H),6.15(d,1H),4.40(m,1H),4.00(m,2H),
3.13(s,1H),1.40(d,3H),1.20(s,9H)32a δ7.39(d,1H),7.20(dd,1H),6.83(dd,1H),6.22(d,1H),4.40(m,1H),4.02(m,2H),
3.15(s,1H),1.40(d,3H),1.20(s,9H)32b δ7.39(d,1H),7.20(dd,1H),6.83(dd,1H),6.30(d,1H),4.40(m,1H),4.02(m,2H),
3.13(s,1H),1.40(d,3H),1.20(s,9H)36a δ7.10(d,1H),7.05(d,1H),6.90(t,1H),6.20(d,1H),4.40(m,1H),4.05(dd,1H),
3.98(dd,1H),3.16(s,1H),1.40(d,3H),1.20(s,9H)36b δ7.10(d,1H),7.05(d,1H),6.90(t,1H),6.19(d,1H),4.40(m,1H),4.05(dd,1H),
3.98(dd,1H),3.12(s,1H),1.40(d,3H),1.20(s,9H)37b δ7.15(dd,1H),6.90(m,2H),6.25(d,1H)4.40(m,1H),4.02(m,2H),3.15(s,1H),
1.40(d,3H),1.17(s,9H)38 δ7.22(m,2H),6.90(m,1H),6.20(dd,1H),4.40(m,1H),4.02(m,2H),3.15(d,1H),
1.40(dd,3H),1.17(d,9H)41 δ7.60(t,1H),6.77(m,2H),6.20(d,1H),4.41(m,1H),4.10(m,2H),3.15(s,1H),
1.42(d,3H),1.17(s,9H)43 δ7.50(d,1H),7.08(d,1H),7.00(s,1H),6.20(dd,1H),4 41(m,1H),4.10(m,2H),
3.15(s,1H),1.42(d,3H),1.17(s,9H)44 δ7.41(d,1H),7.22(d,1H),7.17(s,1H),6.20(dd,1H),4.41(m,1H),4.10(m,2H),
3.15(s,1H),1.42(d,3H),1.17(s,9H)46 δ7.41(d,1H),7.32(d,1H),7.25(s,1H),6.18(dd,1H),4.41(m,1H),4.10(m,2H),
3.15(2s,1H),1.42(d,3H),1.17(s,9H)50 δ6.60(s,1H),6.20(d,1H),4.14(m,1H),4.25(d,2H),3.20(s,3H),1.40(d,3H),
1.20(s,9H)55 δ6.80(s,1H),6.30(br s,1H),4.15(t,2H),3.35(q,2H),3.15(s,1H),2.00(m,2H),
1.20(s,9H)56 δ7.30(m,4H),6.95(m,3H),6.60(dd,1H),4.40(m,1H),4.02(m,2H),3.60(d,1H),
2.20(m,1H),1.40(m,3H),1.00(m,12H)57 δ7.00(m,4H),6.60(m,1H),4.40(m,1H),4.02(m,2H),3.60(d,1H),2.20(m,1H),
1.40(m,3H),1.05(m,12H)58 δ7.40(m,1H),7.20(t,1H),6.95(m,2H),6.63(br s,1H),4.42(m,1H),4.04(m,2H),
3.60(d,1H),2.20(m,1H),1.40(d,3H),1.00(m,12H)59 δ7.57(m,1H),7.30(t,1H),6.90(m,2H),6.70(br s,1H),4.40(m,1H),4.05(m,2H),
3.60(d,1H),2.20(m,1H),1.40(m,3H),1.00(m,12H)60 δ7.80(m,1H),7.50(m,2H),7.00(m,1H),6.60(d,1H),4.40(m,1H),4.07(m,2H),
3.60(d,1H),2.18(m,1H),1.40(m,3H),1.20(m,3H),1.00(m,9H)化合物序号 1HNMR数据(CDCI3溶液,除非另有说明)a61 δ7.30(d,1H),6.90(m,2H),6.60(d,1H),4.40(m,1H),4.03(m,2H),3.60(d,1H),
2.20(m,1H),140(d,3H),1.00(m,12H)62 δ7.30(d,2H),7.00(t,1H),6.90(m,1H),6.63(d,1H),4.44 (m,1H),4.05(m,2H),
3.70(s,2H),3.60(d,1H),2.20(m,1H),1.40(d,3H),1.00(m,12H)63 δ7.50(m,1H),6.80(m,2H),6.75(m,1H),4.40(m,1H),4.15(m,2H),3.75(s,1H),
3.35(m,1H),3.60(d,1H),2.20(m,1H),1.45(d,3H),1.10(m,3H),1.00(s,9H)64 δ7.45(t,1H),7.1(d,1H),6.4(m,1H),6.1(s,1H),4.4(m,1H),4.1(m,2H),
3.3(m,2H),2.2(m,1H),1.41(d,3H),1.0(s,9H)65 δ7.50(d,1H),7.20(t,1H),6.95(m,1H),6.40(brs,1H),4.40(m,1H),4.10(m,2H),
3.50(m,1H),2.10(m,1H),1.40(dd,3H),1.15(m,3H),1.00(s,9H)66 δ7.50(t,1H),7.40(d,1H),7.20(d,1H),6.60(br s,1H),4.45(m,1H),4.20(m,2H),
3.80(s,1H),3.65(d,1H),3.55(m,1H),2.10(m,1H),1.45(d,3H),1.10(dd,3H),
1.00(s,9H)68 δ7.90(d,1H),7.80(d,1H),7.30(t,1H),6.60(m,1H),4.20(m,3H),3.50(m,1H),2.10
(m,2H),1.45(m,3H),1.10(m,3H),1.00(s,9H)69 δ6.60(t,2H),6.46(m,1H),4.40(m,1H),4.10(m,1H),4.00(m,1H),3.60(dd,1H),
2.20(m,1H),1.45(dd,3H),1.10(m,1H),1.00(m,12H)70 δ6.8(s,1H),6.6(m,1H),4.75(m,1H),4.4(m,1H),3.6(s,1H),2.3(s,3H),
2.7(m,1H),1.45(d,3H),1.1(dd,3H),1.0(s,9H)71a δ6.8(s,1H),6.6(m,1H),4.75(m,1H),4.4(m,1H),3.6(s,1H),2.3(s,3H),
2.7(m,1H),1.45(d,3H),1.1(dd,3H),1.0(s,9H)71b δ6.8(s,1H),6.6(m,1H),4.75(m,1H),4.4(m,1H),3.6(s,1H),2.3(s,3H),
2.7(m,1H),1.45(d,3H),1.1(dd,3H),1.0(s,9H)73 δ6.75(s,1H),6.2(m,1H),4.1(m,3H),3.4(2s,2H),2.3(s,3H),2.2(m,1H),
1.9(m,2H),1.3(m,3H),1.1(m,3H),1.0(s,9H)74 δ6.9(s,1H),6.7(s,1H),6.2(d,1H),4.0(m,3H),3.4(2s,1H),2.7(m,1H),2.0(m,
1H),1.25(m,3H),1.2(m,3H),1.0(s,9H)75 δ7.40(dt,1H),7.22(m,1H),7.10(m,2H),6.70(d,1H),6.55(br s,1H),6.27(dt,1H),
4.10(m,2H),3.63(d,1H),2.22(m,1H),1.00(m,12H)76 δ7.50(s,1H),7.40(d,1H),7.30(m,1H),7.20(t,1H),6.60(br s,1H),6.50(d,1H),
6.20(m,1H),4.10(m,2H),3.60(d,1H),2.22(m,1H),1.00(m,12H)80b δ7.00(m,2H),6.86(m,2H),5.94(d,1H),4.42(m,1H),3.96(m,1H),2.20(m,1H),
1.95(m,1H),1.60(m,1H),1.38(t,3H),1.22(d,3H),0.98(2t,3H)82b δ7.21(t,1H),6.98(dd,1H),6.90(t,1H),6.80(dd,1H),6.18(d,1H)4.42(m,2H),
4.00(m,2H),2.20(m,1H),1.95(m,1H),1.60(m,1H),1.38(t,3H),1.22(d,3H),
0.98(2t,3H)化合物序号 1HNMR数据(CDCI3溶液,除非另有说明)a84b δ7.21(d,1H),7.24(m,1H),6.83 (m,1H),6.37(2d,1H),4.40(m,2H),4.00(m,2H),
2.20(m,1H),1.95(m,1H),1.57(m,1H),1.42(t,3H),1.22(d,3H),0.98(2t,3H)85b δ7.10(m,3H),6.82(m,1H),6.00(d,1H),4.42(m,1H),4.00(m,2H),2.20(m,1H),
1.98(m,1H),1.57(m,1H),1.38(t,3H),1.22(d,3H),0.98(2t,3H)87b δ7.80(dd,1H),7.30(m,1H),6.80(m,2H),6.40(2d,1H),4.44(m,2H),4.04(m,2H),
2.20(m,1H),1.99(m,1H),1.62(m,1H),1.44(t,3H),1.22(d,3H),0.95(2t,3H)89b δ7.60(m,2H),7.00(m,2H),6.10(2d,1H),4.50(m,1H),4.10(m,2H),2.20(m,1H),
2.05(m,1H),1.62(m,1H),1.46(t,3H),1.22(d,3H),0.90(2t,3H)94b δ7.60(t,1H),7.52(m,1H),7.10(t,1H),6.97(dd,1H),6.08(d,1H),4.44(m,1H),
4.10(m,2H),2.20(m,1H),2.00(m,1H),1.52(m,1H),1.40(dt,3H),1.22(d,3H),
0.95(dt,3H)95 δ7.20(m,2H),6.92(m,1H),6.82(m,1H),6.00(t,1H),4.44(m,1H),4.00(m,2H),
2.26(s,3H),2.22(m,1H),1.95(m,1H),1.50(m,1H),1.40(t,3H),1.22(d,3H),
1.00(dt,3H)97b δ7.20(m,2H),6.95(dt,1H),6.82(m,1H),4.44(m,1H),4.00(m,2H),2.63(m,2H),
2.22(m,1H),1.95(m,1H),1.60(m,3H),1.40(t,3H),1.22(d,3H),0.95(dt,3H)98b δ7.18(m,2H),6.90(dt,1H),6.80(m,1H),6.00(m,1H),4.44(m,1H),4.00(m,2H),
2.68(m,2H),2.22(m,1H),1.95(m,1H),1.60(m,1H),1.4O(t,3H),1.22(d,3H),
1.00(dt,3H)99 δ7.25(m,1H),7.18(m,1H),6.95(m,2H),6.82(t,2H),6.00(dd,1H),4.44(m,1H),
4.00(m,2H),3.38(m,1H),2.22(m,1H),1.95(m,1H),1.55(m,3H),1.40(t,3H),
1.27(d,6H),1.22(d,3H),1.00(dt,6H)100 δ7.25(m,1H),7.19(m,1H),6.95(m,2H),6.82(t,2H),6.05(dd,1H),4.50(m,1H),
4.05(m,2H),2.22(m,1H),1.95(m,1H),1.55(m,15H),1.22(d,3H),1.00(dt,6H)101b δ7.20(m,2H),7.08(m,2H),6.78(t,1H),6.00(m,2H),5.10(m,2H),4.40(m,1H),
4.22(m,2H),4.00(m,2H),3.40(m,2H),2.22(m,1H),1.95(m,1H),1.58(m,1H),
1.30(m,3H),1.22(d,3H),0.95(dt,3H)103 δ7.30(m,2H),6.94(m,2H),6.50(dt,1H),4.55(m,1H),4.10(m,2H),3.65(ddd,2H),
2.20(q,1H),2.05(m,1H),1.50(m,1H),1.40(dt,3H),1.20(d,3H),0.94(dt,3H)105b δ6.95(m,3H),6.30(dd,1H),4.44(m,1H),4.10(m,2H),2.22(m,1H),1.95(m,1H),
1.60(m,3H),1.40(t,3H),1.22(d,3H),0.95(dt,3H)106 δ6.84(m,3H),6.05(d,1H),4.42(m,1H),4.01(m,2H),2.20(m,1H),2.00(m,1H),
1.55(m,1H),1.40(t,3H),1.24(d,3H),0.98(dt,3H)107 δ7.02(m,1H),6.70(m,1H),6.60(m,1H),6.00(d,1H),4.40(m,1H),4.00(m,2H),
2.20(m,1H),2.00(m,1H),1.55(m,1H),1.40(t,3H),1.22(d,3H),0.97(dt,3H)化合物序号 1HNMR数据(CDCI3溶液,除非另有说明)a108 δ7.03(m,1H),6.70(m,1H),6.60(m,1H), 6.20(d,1H),4.42(m,1H),3.97(m,2H),
2.20(m,1H),2.00(m,1H),1.60(m,1H),1.40(t,3H),1.22(d,3H),0.98(m,3H)119 δ7.00(m,3H),6.30(2d,1H),6.00(m,1H),5.05(m,2H),4.44(m,1H),3.80(m,2H),
3.42(m,2H),2.33(s,3H),2.20(m,1H),2.00(m,1H),1.60(m,1H),1.42(t,3H),
1.22(d,3H),0.98(dt,3H)120 δ7.10(dd,1H),7.02(m,1H),6.92(m,1H),6.05(d,1H),4.40(m,1H),4.01(m,1H),
2.20(m,1H),2.00(m,1H),1.60(m,1H),1.40(t,3H),1.22(d,3H),0.97(dt,3H)136 δ6.6(br s,1H),6.2(m,1H),5.65(m,1H),4.5(m,1H),4.2(m,1H),3.7(m,1H),
2.2(s,3H),2.15(s,3H),2.1(m,3H),1.6(m,1H),1.2(d,3H),1.0(m,3H)139 δ6.6(2s,1H),6.1(2d,1H),4.2(m,3H),2.25(m,1H),2.1(m,1H),1.6(m,1H),
1.45(t,3H),1.25(d,3H),1.0(m,3H)140b δ6.55(2s,1H),6.15 and 5.05(2d,1H),4.4-4.6(m,1H),4.2-4.4(m,2H),2.2(s,3H),
2.2-2.3(m,1H),2.0-2.2(m,1H),1.5-1.65(m,1H),1.4(2d,3H),1.2(d,3H),1.0(m,
3H)141 δ6.6(2s,1H),6.1(2d,1H),4.3(m,2H),4.1(m,1H),2.3(s,3H),2.2(m,1H),
2.1(m,1H),1.6(m,1H),1.4(t,3H),1.2(d,3H),1.0(d,3H)144 δ6.95(2s,1H),6.7(s,1H),5.91(t,1H),4.1(m,3H),2.24(m,1H),2.0(m,3H),
1.5(m,1H),1.2(m,6H),1.0(m,3H)149 δ6.95(d,1H),6.8(d,1H),6.4(d,1H),6.1(m,1H),4.15(m,2H),3.4(m,1H),
3.25(m,1H),2.1(q,1H),2.0(m,3H),1.55(m,1H),1.2(d,3H),1.0(t,3H)152 δ6.9(s,1H),6.7(s,1H),6.05(m,1H),4.1(m,2H),3.4(m,1H),3.25(m,1H),
2.0(m,3H),1.5(m,1H),1.2(d,3H),1.0(t,3H)159 δ7.32(s,1H),7.23(m,3H),6.60(d,1H),6.20(dt,1H),5.95(d,1H),4.12(m,2H),
2.22(m,1H),2.00(m,1H),1.21(d,3H),1.00(t,3H)160 δ7.50(s,1H),7.40(d,1H),7.24(d,1H),7.18(t,1H),6.50(d,1H),6.20(dt,1H),
6.00(br s,1H),4.18(m,2H),2.22(m,1H),2.00(m,1H),1.60(m,1H),1.24(m,
3H),1.00(m,3H)161 δ7.32(m,4H),6.70(d,1H),6.15(dt,1H),6.00(br s,1H),4.20(m,2H),3.74(s,2H),
2.25(m,1H),2.00(m,1H),1.60(m,1H),1.24(d,3H),1.00(t,3H)162 δ7.32(m,1H),6.80(m,2H),6.70(d,1H),6.20(t,1H),5.95(br s,1H),4.12(m,2H),
2.24(m,1H),2.00(m,1H),1.60(m,1H),1.20(d,3H),1.00(t,3H)165b δ7.31(dd,1H),7.00(dt,1H),6.80(dd,1H),6.30(br d,1H),4.40(m,1H),4.00(m,
2H),3.14(s,1H),1.40(d,3H),1.20(s,9H)169b δ6.60(dt,1H),6.50(dt,1H),6.25(d,1H),4.40(m,1H),4.05 (m,2H),3.14(d,1H),
1.40(d,3H),1.20(d,9H)化合物序号 1HNMR数据(CDCI3溶液,除非另有说明)a170a δ7.14(d,1H),6.81(d,1H),6.20(d,1H),4.40(m,1H),4.05(m,2H),3.15(d,1H),1.40
(d,3H),1.18(d,9H)171a δ7.22(dd,2H),6.50(dd,1H),4.40(m,1H),4.05(m,2H),3.18(d,1H),1.40(d,3H),
1.20(d,9H)171b δ7.22(dd,2H),6.50(dd,1H),4.40(m,1H),4.00(m,2H),3.16(d,1H),1.40(d,3H),
1.20(d,9H)174a δ7.46(s,1H),7.00(s,1H),6.20(d,1H),4.40(m,1H),4.10(dd,1H),4.00(dd,1H),
3.15(s,1H),1.40(d,3H),1.20(s,9H)176 δ7.20(t,1H),6.80(d,1H),6.70(d,2H),6.18(dd,1H),4.40(m,1H),4.00(m,2H),
3.33(s,3H),3.15(s,1H),1.40(d,3H),1.20(dd,9H)177 δ7 20(t,1H),6.80(d,1H),6.70(d,2H),6.20(dd,1H),4.40(m,1H),4.00(m,2H),
3.15(s,1H),2.60(q,2H),1.40(d,3H),1.25(m,3H),1.20(dd,9H)181a δ7.35(d,1H),7.00(d,1H),6.78(dd,1H),6.10(brd,1H),4.40(m,1H),4.00(dd,1H),
3.90(dd,1H),3.15(s,1H),1.40(d,3H),1.20(s,9H)181b δ7.35(d,1H),7.00(d,1H),6.78(dd,1H),6.20(br d,1H),4.40(m,1H),4.00(m,2H),
3.13(s,1H),1.40(d,3H),1.20(s,9H)182a δ7.25(d,1H),6.70(m,2H),6.10(brd,1H),4.40(m,1H),4.00(dd,1H),3.90(dd,1H),
3.16(s,1H),1.40(d,3H),1.20(s,9H)182b δ7.25(d,1H),6.70(m,2H),6.10(br d,1H),4.40(m,1H),3.95(m,2H),3.13(s,1H),
1.40(d,3H),1.20(s,9H)183a δ7.05(t,1H),6.95(m,1H),6.75(m,1H),6.10(br d,1H),4.40(m,1H),4.00(dd,1H),
3.90(dd,1H),3.16(s,1H),1.40(d,3H),1.20(s,9H)186 δ6.90(m,2H),6.30(br t,1H),4.40(m,1H),4.20(m,2H),3.16(s,1H),1.40(dd,3H),
1.20(s,9H)18b δ7.40(t,H),6.80(t,1H),6.30(brd,1H),4.40(m,1H),4.00(m,2H),3.14(s,1H),
1.40(d,3H),1.20(s,9H)188a δ7.00(m,1H),6.82(m,1H),6.10(br d,1H),4.40(m,1H),4.05(dd,1H),3.95(dd,
1H),3.16(s,1H),1.40(dd,3H),1.20(s,9H)188b δ7.00(m,1H),6.82(m,1H), 6.10(br d,1H),4.40(m,1H),4.00(m,2H),3.15(s,1H),
1.40(dd,3H),1.20(s,9H)189b δ6.70(m,2H),6.35(br d,1H)4.40(m,1H),4.05(m,2H),3.16(s,1H),1.40(dd,3H),
1.20(s,9H)190a δ6.90(m,1H),6.70(m,1H),6.15(d,1H),4.40(m,1H),4.10(dd,1H),3.95(dd,1H),
3.16(s,1H),1.40(dd, 3H),1.20(s,9H)190b δ6.90(m,1H),6.70(m,1H),6.15(d,1H),4.40(m,1H),4.05(m,2H),3.14(s,1H),
1.40(dd,3H),1.20(s,9H)化合物序号 1HNMR数据(CDCI3溶液,除非另有说明)a191a δ7.30(m,1H),6.64(m,1H),6.30(brd,1H),4.40(m,1H),4.05(m,2H),3.15(s,1H),
1.40(d,3H),1.20(s,9H)191b δ7.30(m,1H),6.64(m,1H),6.30(brd,1H),4.40(m,1H),4.05(m,2H),3.14(s,1H),
1.40(d,3H),1.20(s,9H)191c δ7.30(m,1H),6.64(m,2H),6.25(brdd,1H),4.42(m,1H),4.05(m,2H),3.15(s,1H),
1.40(d,3H),1.20(d,9H)192b δ7.30(m,1H),6.64(m,2H),6.20(br d,1H),5.90(dd,1H),5.10(dd,2H),),4.40(m,
1H),4.00(m,2H),3.25(s,1H),1.40(d,3H),1.25(d,6H)198b δ7.00(t,1H),6.95(m,2H),6.18(d,1H),4.40(m,1H),4.10(m,2H),3.13(s,1H),1.40
(d,3H),1.20(s,9H)199 δ7.00(m,3H),6.55(m,1H),4.40(m,1H),4.10(m,2H),3.60(m,1H),2.20(m,1H),
1.40(d,3H),1.10(m,3H),1.00(s,9H)200b δ7.00(t,1H),6.95(m,2H),6.15(br d,1H),5.95(dd,1H),5.20(m,2H),4.40(m,1H),
4.00(m,2H),3.24(s,1H),1.35(d,3H),1.25(d,6H)201 δ7.25(m,1H),7.00(m,2H),6.20(m,1H),6.00(t,1H),4.45(m,1H),4.00(m,2H),
3.10(2s,1H),1.45(2d,3H),1.15(s,9H)203 δ7.35(m,2H),7.10(m,1H),6.35(d,1H),4.30(m,3H),3.20(2s,1H),1.45(2d,3H),
1.20(s,9H)204 δ7.45(m,2H),7.15(m,1H),6.50(d,1H),5.95(m,1H),5.10(m,2H),4.40(m,1H),
4.0-4.2(m,2H),3.45(m,2H),3.2(2s,1H),1.4(2d,3H),1.2(s,9H)205 δ7.45(m,1H),7.15(m,2H),6.5(d,1H),4.4(m,1H),4.0-4.2(m,2H),3.2(2s,1H),2.6
(m,2H),1.6-1.7(m,2H),1.45(2d,3H),1.2(s,9H),0.95(t,3H)209 δ7.45(m,2H),7.10(m,1H),6.50(d,1H),4.45(m,1H),4.0-4.2(m,2H),3.20(s,1H),
2.30 and 2.35(2s,3H),1.45(2d,3H),1.20(s,9H)215b δ7.25(d,1H)6.70(m,2H),6.2-6.3(m,1H),5.8-6.0(m,1H),5.1-5.2(m,2H),4.40(m,
1H),3.9-4.1(m,2H),3.25(2s,1H),2.30(s,2H),1.40(2d,3H),1.25(m,6H)219 δ7.30(m,2H),6.90(m,2H),5.8-6.0(m,1H),5.2-5.4(m,2H),4.1-4.6(m,3H),4.00
(m,2H),3.60(s,1H),1.05-1.4(m,6H)221a δ7.00(m,1H),6.70(m,1H),6.65(m,1H),6.60(m,1H),6.10 and 6.20(2d,1H),5.5-
5.6(m,1H),4.40(m,1H),3.9-4.1(m,2H),3.20(2s,1H),1.1-1.4(m,9H)221b δ7.30(m,1H),6.65(m,2H),6.45(m,1H),6.20 and 6.25(2d,1H),5.4-5.6(m,1H),
4.40(m,1H),3.9-4.1(m,2H),3.20(2s,1H),1.40(d,3H),1.30(m,6H)222 δ7.30(m,1H),6.6-6.7(m,2H),6.10(m,1H),4.4-4.7(m,2H),4.40(m,1H),4.00(m,
2H),3.60(s,1H),1.40(m,9H)223 δ7.00(m,1H),6.6-6.7(m,2H),6.40(dt,1H),6.20(m,1H),4.80(m,1H),4.40(m,1H),
4.05(m,1H),3.95(m,1H),3.50(s,1H),1.40(m,9H)化合物序号 1HNMR数据(CDCI3溶液,除非另有说明)a225 δ7.15(m,1H),6.65(m,2H),6.50(2t,1H),6.25(m,1H),5.8-6.0(m,1H),5.2-5.4(m,
2H),4.2-4.4(m,3H),3.9-4.1(m,2H),3.60(s,1H),1.30 and 1.35(2m,6H)227 δ7.20(d,1H),6.70(m,2H),6.3-6.4(m,1H),5.8-6.0(m,1H),5.2-5.4(m,2H),4.2-4.6
(m,3H),3.95-4.10(m,2H),3.60(s,1H),2.30(s,3H),1.25-1.40(m,6H)228 δ7.35(m,5H),6.56(d,1H),6.18(dt,1H),6.00(m,1H),4.80(m,1H),3.16(d,1H),
1.40(d,3H),1.20(d,9H)229a δ7.10(m,1H),7.00(m,2H),6.64(d,1H),6.42(dd,1H),4.80(m,1H),3.17(s,1H),
1.40(d,3H),1.20(s,9H)229b δ7.10(m,1H),7.00(m,2H),6.64(d,1H),6.42(dd,1H),4.80(m,1H),3.15(s,1H),
1.40(d,3H),1.20(s,9H)230 δ7.28(dd,1H),7.05(t,1H),6.80(dt,1H),5.90(br d,1H),4.40(m,1H),4.00(m,2H),
3.10(m,1H),2.20(m,1H),2.00(m,1H),1.60(m,1H),1.40(m,3H),1.30(m,3H),
1.00(m,3H)231 δ7.30(m,1H),6.65(m,2H),5.90(d,1H),4.45(m,1H),3.95(m,2H),3.10(m,1H),
2.20(m,1H),1.90(m,1H),1.60(m,1H),1.40(m,3H),1.20(m,3H),1.00(m,3H)235 δ7.40(dt,1H),6.80(m,1H),6.15(dd,1H),4.45(m,1H),4.00(m,2H),2.20(m,1H),
2.00(m,1H),1.60(m,1H),1.40(t,3H),1.20(d,3H),1.00(dt,3H)236 δ7.00(m,1H),6.85(m,1H),6.00(d,1H),4.45(m,1H),4.00(m,2H),2.20(m,1H),
2.00(m,1H),1.60(m,1H),1.40(t,3H),1.20(d,3H),100(dt,3H)237 δ6.70(m,2H),6.20(dd,1H),4.40(m,1H),4.10(m,2H),2.20(m,1H),2.00(m,1H),
1.60(m,1H),1.40(t,3H),1.20(d,3H),1.00(dt,3H)238 δ6.90(m,1H),6.70(m,1H),6.00(d,1H),4.45(m,1H),4.05(m,2H),2.20(m,1H),
2.00(m,1H),1.60(m,1H),1.40(t,3H),1.25(d,3H),1.00(dt,3H)239 δ7.50(d,1H),7.05(m,1H),6.95(m,1H),6.10(dd,1H),4.40(m,1H),4.15(m,2H),
2.20(m,1H),2.00(m,1H),1.60(m,1H),1.40(t,3H),1.25(d,3H),1.00(dt,3H)240 δ7.20(m,1H),6.80(m,1H),6.75(m,2H),6.00(br s,1H),4.40(m,1H),4.00(m,2H),
2.60(m,2H),2.20(m,1H),2.00(m,1H),1.60(m,1H),1.40(t,3H),1.25(m,6H)
1.00(dt,3H)241 δ7.30(d,2H),6.84(d,2H),6.00(d,1H),4.40(m,1H),4.00(m,2H),2.20(m,1H),
1.95(m,1H),1.55(m,1H),1.35(t,3H),1.30(s,9H),1.20(d,3H),1.00(dt,3H)245 δ7.60(m,1H),6.70(m,2H),6.10(br t,1H),4.45(m,1H),4.00(m,2H),2.20(m,1H),
2.00(m,1H),1.60(m,1H),1.40(t,3H),1.25(d,3H),1.00(dt,3H)246 δ7.40(d,1H),7.20(m,2H),6.10(brt,1H),4.45(m,1H),4.15(m,2H),2.20(m,1H),
2.00(m,1H),1.60(m,1H),1.40(t,3H),1.25(d,3H),1.00(dt,3H)247 δ7.40(dt,1H),7.30(d,1H),7.25(d,1H),6.1O(brt,1H),4.45(m,1H),4.10(m,2H),
2.20(m,1H),2.00(m,1H),1.60(m,1H),1.40(t,3H),1.25(d,3H),1.00(dt,3H)化合物序号 1HNMR数据(CDCI3溶液,除非另有说明)a248 δ7.50(d,1H),7.10(dt,1H),6.95(d,1H),6.10(dd,1H),4.45(m,1H),4.10(m,2H),
2.20(m,1H),2.00(m,1H),1.60(m,1H),1.40(t,3H),1.30(s,9H),1.25(d,3H),
1.00(dt,3H)254 δ7.40-7.50(m,2H),7.15(m,1H), 6.25 and 6.50(2d,1H),5.85-6.00(m,1H),5.00-5.20
(m,2H),4.45(m,1H),4.00-4.20(m,2H),3.45(d,2H),2.20-2.30(m,1H),2.00-2.20
(m,1H),1.50-1.60(m,1H),1.45(2d,3H),1.20(d,3H),0.95(m,3H)255 δ7.00-7.40(m,3H),6.30 and 6.50(2d,1H),4.40-4.50(m,1H),4.00-4.20(m,2H),2.60
(t,2H),2.00-2.40(m,2H),1.40-1.70(m,9H),1.20(m,3H),0.80-1.10(m,6H)256 δ7.55(d,1H),6.70-6.90(m,2H),6.60(t,1H),6.00(m,1H),4.40-4.50(m,1H),4.05-
4.20(m,2H),2.20(m,1H),1.95-2.15(m,1H),1.60(m,1H),1.45(m,3H),1.20(d,
3H),0.90 and 1.00(2t,3H)257 δ7.55(d,1H),6.70-6.90(m,2H),6.60(t,1H),6.00(m,1H),4.40-4.50(m,1H),4.05-
4.20(m,2H),2.20(m,1H),1.95-2.15(m,1H),1.60(m,1H),1.45(m,3H),1.20(d,
3H),0.90 and 1.00(2t,3H)262 δ7.30 (m,3H),5.80(m,2H),4.15(m,2H),2.50(m,2H),2.20(m,1H),2.00(m,1H),
1.50(m,1H),1.20(m,3H),1.00(m,3H)263 δ7.20 (m,5H),6.50(t,1H),6.20(dd,1H),5.70(t,1H),4.80(m,1H),2.22(m,1H),
2.00(m,1H),1.40(dd,3H),1.20(dd,3H),1.00(dt,3H)264 δ7.30(dt,1H),7.10(d,1H),7.05(d,1H),6.95(dt,1H),6.50(dt,1H),6.00(br s,1H),
4.08(m,2H),2.20(m,1H),2.00(m,1H),1.60(m,1H),1.20(d,3H),1.00(t,3H)265 δ7.30(m,5H),6.50(s,1H),5.90(s,1H),4,10(d,2H),2.30(m,1H),2.20(m,1H),1.60
(m,1H),1.90(s,3H),1.22(m,3H),1.00(m,3H)266 δ7.40(m,1H),7.20(m,1H),6.95(m,1H),6.20(m,1H),5.75(d,1H),4.85(m,1H),
2.20(m,1H),2.00(m,1H),1.60(m,1H),1.40(m,3H),1.25(m,3H),1.00(m,3H)267a δ7.10(m,1H),6.95(m,2H),6.65(d,1H),6.30(dd,1H),5.80(br s,1H),4.05(m,1H),
2.20(q,1H),2.00(m,1H),1.60(m,1H),1.40(d,3H),1.20(d,3H),1.00(t,3H)268 δ7.35(m,5H),6.40(m,1h),5.80(m,1H),4.15(m,2H),2.20(m,1H),2.00(m,1H),
1.60(m,1H),1.20(m,3H),1.10(m,3H),1.00(m,3H)270 δ7.30(m,2H),7.20(m,2H),6.45(s,1H),5.90(m,1H),4.10(m,2H),3.45(s,3H),
2.25(m,1H),2.00(m,1H),1.60(m,1H),1.44(m,3H),1.00(m,3H)271 δ7.35(m,3H),6.80(m,1H),5.80(m,1H),4.10(m,2H),2.20(m,1H),2.00(m,1H),
1.55(m,1H),1.25(m,3H),1.15(m,3H),1.00(m,3H)275 δ7.4-7.5(m,2H),7.15(m,1H),6.70(m,1H),5.8-6.0(m,1H),5.0-5.2(m,2H),4.40
(m,1H),3.8-4.2(m,2H),3.40 and 3.50(2d,1H),3.40(m,2H),2.1-2.5(m,1H),1.4-
1.5(m,3H),1.10 and 1.20(2d,3H),1.00(s,9H)化合物序号 1H NMR数据(CDCl3溶液,除非另有说明)a276 δ7.40(m,1H),7.1-7.2(m,1H),6.70(m,1H),4.40(m,1H),3.8-4.2(m,2H),3.45-3.7
(m,1H),2.60(m,2H),2.1-2.5(m,1H),1.60(m,2H),1.45(d,2H),1.20 and 1.20
(2m,3H),1.00(s,9H),0.90-1.00(m,3H)277 δ7.55(d,1H),6.30-6.4(m,3H),4.40(m,1H),3.80-4.20(m,3H),3.40-3.65(m,1H),
2.15(m,1H),1.45(d,3H),1.00-1.25(m,3H),1.00(s,9H)278 δ7.50(m,1H),6.75-6.90(m,1H),6.20-6.50(m,1H),4.40(m,1H),3.90-4.20(m,2H),
3.60(m,1H),2.20(m,1H),1.40(d,3H),1.00-1.25(m,3H),1.00(s,9H)279 δ7.20-7.40(m,1H),6.80-6.90(m,1H),6.50(m,1H),4.00-4.50(m,3H),3.45-3.70(m,
1H),2.10-2.25(m,1H),1.40(m,3H),1.00-1.20(m,3H),1.00(s,9H)280 δ7.40(m,2H),7.00-7.15(m,1H),6.70(m,1H),4.40(m,1H),3.80-4.20(m,2H),3.45-
3.70(m,1H),2.30(s,3H),2.10-2.30(m,1H),1.50(d,3H),1.10-1.20(m,3H),1.00
(s,9H)281 δ7.65(m,1H),7.50(m,1H),7.20(m,1H),6.75(m,1H),3.90-4.50(m,3H),3.45-3.70
(m,1H),2.10-2.40(m,1H),1.60(m,3H),1.00-1.20(m,3H),1.00(s,9H)283 δ1.2(d,3H),2.6-2.7(m,2H),3.4(m,1H),4.4(m,1H),5.0-5.3(m,3H),5.6-5.85(m,
1H),6.6(m,1H),7.0(m,1H),7.3-7.5(m,5H)284 δ1.25(m,3H),2.65(m,2H),3.45(m,1H),4.4(m,1H),5.0-5.3(m,2H),5.4(s,1H),
5.6-5.85(m,1H),6.35-6.45(m,2H),6.7(m,1H),7.3-7.5(m,5H),7.5-7.6(m,1H)285 δ1.25(m,3H),2.65(m,2H),3.45(m,1H),4.4(m,1H),5.0-5.2(m,2H),5.4(s,1H),
5.6-5.8(m,1H),6.45(m,1H),6.65(d,1H),7.0(t,1H),7.3-7.4(m,6H),7.8(d,1H)286 δ1.0-1.1(m,3H),1.25(d,3H),1.9-2.05(m,1H),3.3-3.4(m,1H),4.4(m,1H),5.4(m,
1H),6.2(d,2H),6.7(m,1H),7.5(m,5H),7.5-7.6(m,1H)287 δ0.9(m,3H),1.25(d,3H),1.4(m,2H),1.8-1.95(m,2H),3.4(m,1H),4.4(m,1H),5.2
(s,1H),6.6(d,2H),6.7(m,1H),7.3-7.45(m,5H),7.7-7.8(m,1H)288 δ0.9(m,3H),1.25(d,3H),1.4(m,2H),1.8-1.95(m,2H),3.4(m,1H),4.4(m,1H),
5.45(s,1H),6.4(m,1H),6.65(d,1H),7.0(t,1H),7.3-7.4(m,6H),7.6(d,1H)289 δ0.95-1.1(m,6H),1.25(d,3H),2.4(m,1H),3.3(m,1H),4.4(m,1H),5.4(s,1H),6.4
(d,2H),6.7(t,1H),7.4(m,5H),7.55(m,1H)290 δ0.95-1.1(m,6H),1.25(d,3H),2.4(m,1H),3.3(m,1H),4.4(m,1H),5.45(s,1H),6.4
(m,1H),6.65(d,1H),7.0(t,1H),7.3-7.4(m,6H),7.6(d,1H)291 δ1.1(s,9H),1.25(m,3H),3.15(2s,1H),4.4(m,1H),5.45 and 5.5(2d,1H),6.25(d,
1H),6.65(m,1H),7.0(m,1H),7.3-7.4(m,6H),7.6(d of m,1H)292 1.15(2s,9H),1.4(d,3H),3.1(s,1H),3.95-4.1(m,2H),4.4(m,1H),6.2(m,1H),6.5(t,
1H)6.7(d,2H),7.5(m,1H)293 δ1.0 and 1.1(2t,3H),1.25(d,3H),1.7-2.1(m,2H),3.3-3.4(m,1H),4.4(m,1H),5.3
(m,1H),6.4(m,2H),6.7-6.8(m,1H),7.0(m,1H),7.3-7.4(m,5H)化合物No.1HNMR数据(CDCl3溶液,除非另有说明)a294 δ1.25(m,6H),1.35(d,3H), 3.2(s,1H),4.0(m,2H),4.4(m,1H),5.1-5.2(m,2H),5.8-
6.0(m,1H),6.15(m,1H),6.45(2t,1H),6.6-6.7(m,2H),7.15(m,1H)295 δ1.4-1.5(m,9H),2.4(2s,1H),3.15(2s,1H),4.0-4.1(m,2H),4.4-4.5(m,1H),6.45(t,
1H),6.4-6.7(m,3H),7.15(m,1H)297 δ0.8-0.9(m,3H),1.2-1.4(m,6H),1.5-1.7(m,2H),3.3(4s,1H),3.9-4.1(m,2H),4.2
and 4.4(2m,1H),5.1-5.4(m,2H),5.75-5.9(m,1H),6.0.-6.2(m,1H),6.9-7.1(m,
3H)302 δ1.3-1.4(m 3H),1.5-1.6(m,3H),2.6-2.7(3s,1H),3.4-3.4(4s,1H),3.9-4.1(m,2H),
4.2 and 4.4(2m,1H),5.2-5.9(m,3H),6.1 and 6.2(2m,1H),6.9-7.1(m,3H)304 δ1.0(m,3H),1.3(d,3H),2.0(m,2H),3.23(q,1H),4.4(m,1H),5.45(m,1H),6.5(d,
1H),6.65(d,1H),7.0(t,1H),7.3-7.5(m,6H),7.6(d,1H)305 δ7.47(d,1H),7.08(dt,1H),6.97(d,1H),6.30(br dd,1H),4.42(m,1H),4.12(m,2H),
3.17(s,1H),1.42(d,3H),1.20(s,9H)306 δ7.18(m,2H),6.97(t,1H),6.80(d,1H),6.21(m,1H),4.42(m,1H),4.00(m,2H),
3.16(s,1H),3.10(m,1H),1.60(m,2H),1.40(d,3H),1.20(m,12H),0.85(m,3H)307 δ7.65(t,1H),7.58(t,1H),7.35(t,1H),6.90(d,1H),6.40(dd,1H),6.20(br d,1H),
4.80(m,1H),3.20(s,1H),1.42(d,3H),1.20(s,9H)308 δ7.40(q,1H),7.30(m,1H),7.10(t,1H),7.05(t,1H),6.50(d,1H),5.90(m,1H)5.63
(q,1H),4.90(m,1H),3.10(s,1H),1.30(d,3H),1.20(s,9H)309 δ7.40(m,1H),6.90(m,1H),6.85(m,1H),6.50(d,1H),6.00(brs,1H),5.60(m,1H),
4.82(m,1H),3.10(s,1H),1.40(d,3H),1.20(s,9H)311 δ7.30(m,2H),6.95(m,3H),6.00(m,1H),4.40(m,1H),4.00(m,2H),2.20(m,1H),
1.60(m,4H)312 δ7.60(d,1H),7.50(m,1H),7.O5(t,1H),6.98(t,1H),6.15(m,1H),4.50(m,1H),4.00
(m,2H),2.20(m,2H),1.50(m,3H),1.20(m,3H)313 7.50(m,1H),7.25(m,1H),6.90(m,2H),6.25(m,1H),4.40(m,1H),4.05(m,2H),
2.20(m,1H),1.60(d,3H),1.40(m,4H)314 7.20(m,2H),6.95(t,1H),6.90(t,1H),6.05(m,2H),5.08(m,2H),4.42(m,1H),4.00
(m,2H),3.42(m,2H),2.20(m,1H),1.60(d,3H),1.40(m,4H)315 7.00(m,4H),6.05(m,1H),4.40(m,1H),4.05(m,2H),2.20(m,1H),1.60(m,3H),
1.40(m,4H)a1HNMR数据为四甲基硅烷的低磁场ppm。偶合表示为(s)-单重峰,(d)-双重峰,(t)-三重峰,(q)-四重峰,(m)-多重峰,(dd)-双双重峰,(dt)-双三重峰,(br s)-宽单重峰。偶合前面的数字表示具有该偶合的一组以上的峰。例如,“2d,3H”表示两个双重峰,每个含有三个质子。
本发明的生物实施例
首先将试验化合物溶解于丙酮中,其用量等于最后体积的3%,然后以200ppm的浓度悬浮在含有250ppm表面活性剂TremR014(多元醇酯)的净化水中。然后将制得的试验悬浮液用于下面试验。在试验植物的溢出点处喷射200ppm的该试验悬浮液,这相当于500g/ha的比例。
试验A
将试验悬浮液喷射到小麦幼苗的溢出点中。接下的日子用禾白粉菌f.sp.tritici(小麦白粉病的病原菌)的孢子粉剂给幼苗接种,并在20℃下在生长箱中培养7天,然后制成疾病等级。
试验B
将试验悬浮液喷射到小麦幼苗的溢出点中。接下的日子用隐匿柄锈菌(小麦叶锈病的病原菌)的孢子悬浮液给幼苗接种,并在20℃的饱和气氛中培养24小时,然后转移到生长箱中,在20℃下培养6天,然后制成疾病等级。
试验C
将试验悬浮液喷射到水稻幼苗的溢出点中。接下的日子用Pyricularia oryzae(稻瘟病的病原菌)的孢子悬浮液给幼苗接种,并在27℃的饱和气氛中培养24小时,然后转移到生长箱中,在30℃下培养5天,然后制成疾病等级。
试验D
将试验悬浮液喷射到西红柿幼苗的溢出点中。接下的日子用蔓延疫霉(土豆和西红柿晚疫病的病原菌)的孢子悬浮液给幼苗接种,并在20℃的饱和气氛中培养24小时,然后转移到生长箱中,在20℃下培养5天,然后制成疾病等级。
试验E
将试验悬浮液喷射到黄瓜幼苗的溢出点中。接下的日子用灰色葡萄孢(许多农作物灰霉病的病原菌)的孢子悬浮液给幼苗接种,并在20℃的饱和气氛中培养48小时,然后转移到生长箱中,在20℃下培养5天,然后制成疾病等级。
表A中列出了试验A-E的结果。在表中,比率100表示100%的疾病控制以及比率0表示无疾病控制(相对于对照组)。破折号(-)表示无试验结果。ND表示由于植物毒素未测定到疾病控制。
表A化合物序号 试验A 试验B 试验C 试验D 试验E
1a 60 0 53 0 0
1b 34 11 74 0 0
1c 60 85 73 16 0
1d 92 0 100 0 0
1e 92 0 100 80 47
2a 0 0 86 0 55
2b 0 0 100 0 0
2c 86 0 100 24 0
3a 85 0 94 0 55
3b 0 0 86 32 0
3c 38 0 100 4 0
3d 92 0 100 99 0
3e 86 0 100 68 0
4a 0 67 99 66 0
4b 86 0 99 89 82
4c 35 0 94 0 58
5a 0 68 0 0 0
5b 0 86 100 24 0
6a 0 0 74 0 0
6b 38 68 53 4 0
6c 0 0 97 9 0
6d 77 28 97 0 0
6e 0 0 100 96 70
7a 77 85 91 89 0
7b 77 0 74 89 47
7c 0 0 86 9 45
7d 62 68 99 0 6
8a 0 0 85 0 7
8b 37 0 100 89 47
8c 0 0 100 0 0
9a 0 0 53 0 0
9b 62 68 99 28 0
9c 62 28 100 51 0化合物序号 试验A 试验B 试验C 试验D 试验E10a 0 27 86 23 010b 62 67 86 95 010c 0 86 53 35 010d 77 0 74 35 4511a 77 0 97 0 8211b 77 85 99 23 012a 86 68 91 0 012b 77 0 94 68 013a 34 0 51 0 013b 0 0 86 4 8314a 0 0 94 45 5814b 61 0 86 23 015a 0 28 97 92 8615b 0 0 97 45 016 0 0 97 48 017a 85 67 30 16 017b 38 28 100 0 018a 0 0 91 0 018b 77 0 94 0 019 0 0 97 0 020a 63 0 97 70 020b 0 0 100 0 021a 38 68 99 4 021b 37 27 99 - 022 0 0 100 0 023 0 0 97 48 024 62 0 53 66 9425a 95 28 32 0 025b 63 0 97 24 026a 38 28 97 51 026b 38 68 100 81 027a 38 0 100 81 027b 91 0 100 0 028a 38 28 100 68 028b 86 28 100 96 029a 0 0 74 35 6化合物序号 试验A 试验B 试验C 试验D 试验E
29b 0 0 100 23 0
30a 0 0 100 0 0
30b 77 27 97 0 0
31a 62 68 74 51 0
31b 0 0 94 0 0
32a 0 27 91 0 0
32b 0 27 94 23 0
33a 0 0 97 0 0
33b 0 67 100 80 0
34 62 85 91 0 0
35a 0 0 74 80 0
35b 37 0 91 0 0
36a 0 27 99 89 0
36b 62 27 100 80 0
37a 62 68 100 68 0
37b 77 68 99 96 0
38 0 28 53 0 22
39 0 0 86 2 0
40 21 0 86 0 0
41 62 0 97 66 47
42 0 0 53 2 0
43 0 0 86 66 0
44 0 0 94 89 0
45 0 0 86 0 0
46 0 0 53 66 0
47 0 0 53 52 0
48 0 0 91 0 0
49 0 0 0 0 0
50 86 28 53 57 0
51 71 0 53 68 0
52 71 86 0 81 0
53 0 0 53 0 0
54 34 11 32 0 16
55 0 0 85 0 0
56* 74 0 85 0 0
57* 91 0 85 0 0化合物序号 试验A 试验B 试验C 试验D 试验E
58* 57 0 52 0 0
59* 0 0 52 0 0
60* 91 0 0 0 0
61* 74 0 73 0 0
62* 74 0 52 0 0
63 0 0 0 2 0
64 0 0 53 2 0
65 0 0 0 2 0
66 0 0 0 69 0
67 0 0 0 92 0
68 62 27 86 82 0
69 0 0 53 2 0
70 63 0 0 13 0
71a 0 0 53 19 0
71b** 0 0 0 19 0
72 0 0 91 0 0
73 30 28 53 0 11
74 0 86 53 23 0
75* 0 0 52 19 0
76* 0 0 0 19 0
77a 73 28 86 - 0
77b* 33 0 74 0 0
78a 0 93 90 0 74
78b 84 0 99 - 0
79a* 0 0 53 0 0
79b* 0 0 100 0 0
80a* 0 0 86 20 0
80b* 83 0 97 0 0
81a 0 0 0 0 55
81b* 85 0 74 0 0
82a* 0 0 53 43 0
82b 31 0 97 15 0
83a* 0 0 32 0 0
83b* 52 0 53 0 0
84a* 29 0 0 20 0
84b* 57 28 73 75 0化合物序号 试验A 试验B 试验C 试验D 试验E85a 55 0 53 - 085b* 0 0 53 0 086a* 0 67 0 0 086b* 52 0 0 28 087a* 0 0 74 0 087b* 52 0 0 0 088* 52 0 0 0 089a 0 0 74 20 089b 26 68 91 - 4790 84 0 32 0 091 74 0 53 0 092* 60 0 0 0 093* 57 0 85 19 094a 0 0 0 0 094b* 71 0 0 0 095* 52 86 94 0 096* 0 0 0 90 097a* 0 0 0 20 097b* 71 0 53 0 098a 0 0 53 24 098b* 52 0 74 0 099* 83 0 0 68 0100* 52 0 0 0 0101a 0 0 0 46 22101b* 0 0 0 0 0102* 60 0 0 0 0103 0 26 53 0 0104* 84 0 97 0 0105a 0 0 53 0 55105b* 21 0 74 0 0106* 84 0 97 19 0107* 71 0 100 0 0108* 57 0 94 0 0109* 52 0 53 0 0110* 90 0 97 0 0111* 90 0 0 90 0化合物序号 试验A 试验B 试验C 试验D 试验E
112* 71 0 0 0 0
113* 0 0 97 19 0
114* 83 0 0 0 0
115* 52 0 32 0 0
116* 21 0 0 0 0
117* 83 0 74 0 0
118* 83 0 0 0 0
119 31 0 32 0 0
120* 29 0 52 19 0
121* 71 0 53 0 0
122 0 0 0 0 0
123* 90 0 53 0 0
124* 83 0 0 0 0
125* 90 0 99 0 0
126* 0 0 73 0 0
127* 0 0 94 19 0
128 86 0 74 13 0
129 38 26 74 0 0
130 0 0 32 2 0
131 0 0 53 52 0
132 0 0 0 2 0
133 0 0 0 0 0
134 0 0 0 30 0
135 0 0 53 2 0
136 34 0 78 0 0
137 0 0 53 0 0
138 0 0 53 13 0
139 71 0 91 0 0
140a 29 0 90 0 0
140b 63 28 74 38 0
141 38 68 74 84 0
143 0 0 53 0 0
144 0 28 53 0 0
145 0 9 0 20 0
146 0 22 0 0 0
148 0 0 74 0 0化合物序号 试验A 试验B 试验C 试验D 试验E
149 30 27 53 0 0
150 0 0 60 0 87
151 0 0 91 - 0
152 55 68 86 - 0
153 92 64 94 92 0
154 52 0 52 0 0
155 71 0 86 23 0
156* 0 0 0 0 0
157* 0 0 97 0 0
158* 0 0 52 0 0
159 0 0 0 0 47
160* 57 86 52 85 0
161* 0 0 0 0 0
162 0 0 74 95 82
163* 0 0 52 42 0
164 0 0 72 56 7
165a 86 0 74 23 86
165b 95 0 94 23 95
166a 0 0 99 76 58
166b 0 0 99 0 0
167 0 0 74 23 0
168a 76 0 74 0 58
168b 95 0 94 45 86
169a 84 27 91 24 0
169b 0 0 97 0 0
170a 35 0 53 0 58
170b 61 68 53 23 95
171a 0 0 86 0 0
171b 91 0 53 0 58
172 0 0 86 0 95
173a 63 28 52 33 0
173b 0 0 90 91 0
174a 0 0 31 54 0
174b 0 28 52 91 0
175* 0 0 74 33 0
176 77 0 94 56 6化合物序号 试验A 试验B 试验C 试验D 试验E
177 62 0 94 35 6
178 0 0 53 0 58
179 35 0 74 23 58
180 61 0 74 76 0
181a 0 0 86 56 69
181b 37 0 74 0 90
182a 0 0 0 0 0
182b 0 68 94 0 0
183a 0 28 86 35 0
183b 86 28 94 35 69
184a 62 0 74 0 6
184b 62 0 74 9 45
185 0 28 86 9 45
186 0 0 100 0 45
187a 0 28 94 9 6
187b 77 68 94 91 6
188a 0 0 97 56 0
188b 0 0 100 35 45
189a 0 0 97 0 6
189b 0 0 100 35 0
190a 0 0 91 0 6
190b 0 0 94 0 0
191a 0 0 100 25 85
191b 0 0 100 47 55
191c 86 0 100 23 0
192a 0 0 100 0 85
192b 0 0 100 0 0
193 0 0 100 0 55
194 0 0 100 0 0
195 85 0 99 32 -
196 0 0 86 0 -
197 59 0 86 0 -
198a 75 28 100 5 -
198b 59 28 100 5 -
199 85 68 97 5 -
200a 0 0 100 5 -化合物序号 试验A 试验B 试验C 试验D 试验E200b 0 0 100 5 -201 90 0 53 46 0202 0 0 53 0 0203 0 28 91 0 0204 0 0 74 0 0205 0 68 74 0 0206 0 0 74 0 0207 0 0 0 0 0208 0 28 94 45 0209 0 0 86 0 0210 0 0 91 0 0211 63 0 100 76 0212 0 0 100 23 0213 63 0 99 62 0214 0 0 100 23 0215a 63 0 99 45 0215b 0 28 99 76 83216 0 0 99 9 45217 0 0 99 0 0218 86 68 100 17 0219 86 86 99 96 0220 0 0 100 85 0221a 0 0 100 41 0221b 62 68 100 41 0222 62 28 100 41 0223 62 28 100 41 0224 85 0 100 5 -225 91 86 100 5 -226 0 0 100 0 -227 0 0 100 0 -228 95 0 52 7 47229a 0 0 100 0 55229b 0 0 100 25 95230 0 0 53 0 45231 0 0 97 0 93232 62 0 100 35 69化合物序号 试验A 试验B 试验C 试验D 试验E233 62 0 94 9 6234 0 0 100 0 0235 0 0 91 0 ND236 77 0 97 0 0237 62 0 53 9 0238 62 0 74 0 ND239 0 0 97 88 0240 63 0 94 96 0241 38 0 74 74 0242 0 0 74 96 0243 38 0 74 74 0244 86 0 99 74 0245 72 0 100 0 0246 53 0 97 0 0247 53 0 85 0 0248 53 0 90 62 83249 0 0 94 0 0250 0 0 52 0 85251 0 0 94 0 0252 0 0 99 5 -253 59 0 100 0 -254 0 0 53 0 0255 28 0 74 0 0256 56 0 0 0 0U7 0 0 0 0 0258 74 27 94 0 0259 84 0 91 0 48260 0 0 74 24 83261 0 0 100 54 0262 98 0 53 99 0263 86 0 86 33 0264 0 0 90 54 94265 77 0 91 96 0266 63 0 91 74 0267a 78 0 97 0 55267b 92 0 100 0 55化合物序号 试验A 试验B 试验C 试验D 试验E
268 38 0 91 88 0
269 98 0 94 74 0
270 77 0 91 96 0
271 77 0 94 96 0
272 76 0 53 63 0
273 86 0 53 23 0
274 61 28 74 23 58
275 0 0 53 0 99
276 0 0 0 0 94
277 0 0 0 0 0
278 56 67 32 0 94
279 56 0 0 0 0
280 56 0 74 0 0
281 56 0 53 0 0
282 0 0 100 24 0
283 0 0 99 0 0
284 0 0 99 0 0
285 59 0 97 0 0
286 76 0 99 0 0
287 0 0 97 23 0
288 33 0 86 0 0
289 0 0 90 45 0
290 59 0 90 0 0
291 0 0 90 0 0
292 0 0 99 46 0
293 0 0 100 23 0
294 0 0 99 24 0
295 0 0 100 0 0
296 0 0 100 24 0
297 0 0 100 46 0
298 62 0 99 99 0
301 62 0 100 24 0
302 0 0 99 24 0
303 0 0 99 100 0
304 0 0 97 0 0
305 0 0 53 0 0化合物序号 试验A 试验B 试验C 试验D 试验E306 0 67 99 0 94307 36 0 94 0 0308 86 28 100 45 0309 86 0 91 23 0310 84 25 53 0 18311 84 0 0 0 0312 0 0 0 82 0313 0 0 26 32 47314 0 0 72 0 0315 60 99 51 16 0316 0 0 53 0 0317* 57 0 85 19 0318* 90 0 53 0 0320 59 68 100 0 -*在40ppm下试验**在100ppm下试验
Claims (10)
X是-O-,-CH(R11)-或=C(R11)-;
R1是H或C1-C2烷基;
R2是H;C1-C6烷基;C3-C6环烷基;或被卤素,氰基,C1-C2烷基或C1-C2烷氧基任意取代的苯基;
R3是H,被卤素或CN任意取代的C1-C3烷基;
R4是H或C1-C2烷基;或
R3和R4一起形成-CH2CH2CH2-或-CH2CH2CH2CH2-;
R5是H,被卤素或CN任意取代的C1-C2烷基;
R6是C2-C8烷基,C2-C8链烯基,C2-C8炔基,C2-C8炔烯基或C3-C8环烷基,每个基团均可被卤素任意取代;
R7是H,CN,卤素,C1-C2卤代烷氧基或C1-C2卤代烷硫基;或C1-C4烷基,C2-C4链烯基或C2-C4炔基,每个基团均可被卤素或CN任意取代;
R8,R9和R10各自分别是H,卤素,C1-C3烷基,C1-C3卤代烷基或Si(CH3)3;以及
R11是H,C1-C5烷基,C2-C5链烯基或C2-C5炔基。
2.根据权利要求1的化合物,其中:
Q是Q-1;
R1是CH3;
R2是H;
R3是CH2CH3;以及
R4是CH3。
3.根据权利要求2的化合物,其中:
Z是Z-1或Z-4;
R7是H,卤素,CN,C1-C4烷基或C2-C4链烯基;
当Z是Z-1时,R8是H或F并且在相对于X的对位;以及
当Z是Z-1时,R9在相对于R7的对位。
4.根据权利要求2的化合物,其中:
Z是Z-2或Z-3;以及
R7是H,卤素,CN,C1-C3烷基或C2-C4链烯基。
5.根据权利要求1的化合物,其中:
Q是Q-2;
R1是CH3;
R2是H或被卤素,氰基,C1-C2烷基或C1-C2烷氧基任意取代的苯基;以及
R6是均可被卤素任意取代的C2-C6烷基或C2-C6链烯基。
6.根据权利要求5的化合物,其中:
Z是Z-1或Z-4;
R7是H,卤素,CN,C1-C3烷基,C2-C4链烯基或C2-C4炔基;
当Z是Z-1时,R8是H或F并且在相对于X的对位;以及
当Z是Z-1时,R9在相对于R7的对位。
7.根据权利要求5的化合物,其中:
Z是Z-2或Z-3;以及
R7是H,卤素,CN,C1-C4烷基,C2-C4链烯基或C2-C4炔基。
8.根据权利要求1的化合物,其中:
Q是Q-1或Q-2;
R7不是H;以及
Z是Z-1。
9.一种杀菌组合物,其中包括有效杀菌量的权利要求1的化合物和至少一种表面活性剂,固体稀释剂或液体稀释剂。
10.一种控制由真菌植物病原体引起的植物病害的方法,其中包括将有效杀菌量的权利要求1的化合物施用到植物及其局部,或施用到植物的种子或幼苗中。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3720797P | 1997-02-04 | 1997-02-04 | |
| US60/037,207 | 1997-02-04 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2006101111628A Division CN1982290A (zh) | 1997-02-04 | 1998-01-27 | 杀菌的羧酰胺 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1246845A true CN1246845A (zh) | 2000-03-08 |
Family
ID=21893045
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98802296A Pending CN1246845A (zh) | 1997-02-04 | 1998-01-27 | 杀菌的羧酰胺 |
| CNA2006101111628A Pending CN1982290A (zh) | 1997-02-04 | 1998-01-27 | 杀菌的羧酰胺 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2006101111628A Pending CN1982290A (zh) | 1997-02-04 | 1998-01-27 | 杀菌的羧酰胺 |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US6251947B1 (zh) |
| JP (1) | JP2001511147A (zh) |
| KR (1) | KR100510794B1 (zh) |
| CN (2) | CN1246845A (zh) |
| AU (1) | AU5932098A (zh) |
| WO (1) | WO1998033765A1 (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100451006C (zh) * | 2005-12-08 | 2009-01-14 | 南开大学 | 一种羧酰胺类化合物及其制备方法和用途 |
| CN104774201A (zh) * | 2006-07-27 | 2015-07-15 | 杜邦公司 | 杀真菌的氮环酰胺 |
| CN108912005A (zh) * | 2013-08-09 | 2018-11-30 | 奥斯瓦道·克鲁兹基金会 | 二苯氧基烷基胺衍生物及其药物组合物 |
| CN114230551A (zh) * | 2021-12-31 | 2022-03-25 | 江西省科学院应用化学研究所 | 一种环丙基取代的噻吩类化合物的制备方法 |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1246845A (zh) * | 1997-02-04 | 2000-03-08 | 纳幕尔杜邦公司 | 杀菌的羧酰胺 |
| WO2000046179A1 (en) | 1999-02-04 | 2000-08-10 | Sagami Chemical Research Center | Process for producing aromatic primary amine by low-pressure hydrogenation of aromatic nitrile |
| AUPR034000A0 (en) * | 2000-09-25 | 2000-10-19 | Fujisawa Pharmaceutical Co., Ltd. | Aminoalcohol derivatives |
| AUPR211400A0 (en) | 2000-12-15 | 2001-01-25 | Koppers-Hickson Timber Protection Pty Limited | Material and method for treatment of timber |
| EP1496838B1 (en) | 2002-03-12 | 2010-11-03 | Merck Sharp & Dohme Corp. | Substituted amides |
| AU2003215024B2 (en) | 2002-03-26 | 2008-02-21 | Merck Sharp & Dohme Corp. | Spirocyclic amides as cannabinoid receptor modulators |
| US7105526B2 (en) | 2002-06-28 | 2006-09-12 | Banyu Pharmaceuticals Co., Ltd. | Benzimidazole derivatives |
| KR20050088194A (ko) | 2002-12-19 | 2005-09-02 | 머크 앤드 캄파니 인코포레이티드 | 치환된 아미드 |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| WO2005028438A1 (ja) | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | 新規ピペリジン誘導体 |
| EP1734963A4 (en) | 2004-04-02 | 2008-06-18 | Merck & Co Inc | METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER |
| JP4435638B2 (ja) * | 2004-07-29 | 2010-03-24 | Sriスポーツ株式会社 | ゴルフボール |
| EP1814590B2 (en) | 2004-11-01 | 2013-12-11 | Amylin Pharmaceuticals, Inc. | Treatment of obesity and related disorders |
| US8394765B2 (en) | 2004-11-01 | 2013-03-12 | Amylin Pharmaceuticals Llc | Methods of treating obesity with two different anti-obesity agents |
| WO2006100227A1 (en) * | 2005-03-21 | 2006-09-28 | Basf Aktiengesellschaft | Insecticidal mixtures |
| US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| WO2006129826A1 (ja) | 2005-05-30 | 2006-12-07 | Banyu Pharmaceutical Co., Ltd. | 新規ピペリジン誘導体 |
| EP1916239A4 (en) | 2005-08-10 | 2009-10-21 | Banyu Pharma Co Ltd | PYRIDOLVERBINDUNG |
| BRPI0614649A2 (pt) | 2005-08-11 | 2011-04-12 | Amylin Pharmaceuticals Inc | polipeptìdeos hìbridos com propriedades selecionáveis |
| EP2330124B1 (en) | 2005-08-11 | 2015-02-25 | Amylin Pharmaceuticals, LLC | Hybrid polypeptides with selectable properties |
| DE602006017712D1 (de) | 2005-08-24 | 2010-12-02 | Banyu Pharma Co Ltd | Phenylpyridonderivat |
| JPWO2007029847A1 (ja) | 2005-09-07 | 2009-03-19 | 萬有製薬株式会社 | 二環性芳香族置換ピリドン誘導体 |
| AU2006297443B2 (en) | 2005-09-29 | 2010-08-12 | Merck Sharp & Dohme Corp. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| WO2007049798A1 (ja) | 2005-10-27 | 2007-05-03 | Banyu Pharmaceutical Co., Ltd. | 新規ベンゾオキサチイン誘導体 |
| US8158791B2 (en) | 2005-11-10 | 2012-04-17 | Msd K.K. | Aza-substituted spiro derivatives |
| JP4784402B2 (ja) | 2006-06-06 | 2011-10-05 | 東ソー株式会社 | アリールアミン類製造用触媒およびそれを用いたアリールアミン類の製造方法 |
| CA2770486C (en) | 2006-09-22 | 2014-07-15 | Merck Sharp & Dohme Corp. | Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
| CA2664358A1 (en) | 2006-09-28 | 2008-04-03 | Banyu Pharmaceutical Co., Ltd. | Diarylketimine derivative |
| EP2145884B1 (en) | 2007-04-02 | 2014-08-06 | Msd K.K. | Indoledione derivative |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| AU2008261102B2 (en) | 2007-06-04 | 2013-11-28 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| MY156662A (en) * | 2007-11-01 | 2016-03-15 | Acucela Inc | Amine derivative compounds for treating ophthalmic diseases and disorders |
| US20110015181A1 (en) | 2008-03-06 | 2011-01-20 | Makoto Ando | Alkylaminopyridine derivative |
| EP2272841A1 (en) | 2008-03-28 | 2011-01-12 | Banyu Pharmaceutical Co., Ltd. | Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| JPWO2009154132A1 (ja) | 2008-06-19 | 2011-12-01 | Msd株式会社 | スピロジアミン−ジアリールケトオキシム誘導体 |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US20110124674A1 (en) | 2008-07-30 | 2011-05-26 | Hiroyuki Kishino | 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| CN102264228A (zh) | 2008-10-22 | 2011-11-30 | 默沙东公司 | 用于抗糖尿病药的新的环状苯并咪唑衍生物 |
| CA2741644C (en) | 2008-10-30 | 2013-05-07 | Merck Sharp & Dohme Corp. | Isonicotinamide orexin receptor antagonists |
| US8329914B2 (en) | 2008-10-31 | 2012-12-11 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
| EP2379562A1 (en) | 2008-12-16 | 2011-10-26 | Schering Corporation | Bicyclic pyranone derivatives as nicotinic acid receptor agonists |
| WO2010075068A1 (en) | 2008-12-16 | 2010-07-01 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
| CA2786314A1 (en) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| SG192941A1 (en) | 2011-02-25 | 2013-09-30 | Merck Sharp & Dohme | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| WO2012121248A1 (ja) * | 2011-03-10 | 2012-09-13 | 国立大学法人名古屋大学 | ヨードアレーン誘導体、それを用いた光学活性スピロラクトン化合物の製法及び光学活性な環化付加体の製法 |
| US12466897B2 (en) | 2011-10-10 | 2025-11-11 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
| US10851178B2 (en) | 2011-10-10 | 2020-12-01 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
| AR088352A1 (es) | 2011-10-19 | 2014-05-28 | Merck Sharp & Dohme | Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina |
| MX2015001500A (es) | 2012-08-02 | 2015-04-08 | Merck Sharp & Dohme | Compuestos antidiabeticos triciclicos. |
| KR20150118158A (ko) | 2013-02-22 | 2015-10-21 | 머크 샤프 앤드 돔 코포레이션 | 항당뇨병 비시클릭 화합물 |
| EP2970119B1 (en) | 2013-03-14 | 2021-11-03 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| CN105764916B (zh) | 2013-06-05 | 2021-05-18 | 博士医疗爱尔兰有限公司 | 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法 |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| CA2959208C (en) | 2014-08-29 | 2023-09-19 | Tes Pharma S.R.L. | Pyrimidine derivatives and their use as inhibitors of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase |
| EP3455203B1 (en) * | 2016-05-12 | 2021-09-22 | Research Triangle Institute | Vinylogous phenethylamines as neurotransmitter releasers |
| CN109952292A (zh) | 2016-10-14 | 2019-06-28 | Tes制药有限责任公司 | α-氨基-β-羧基己二烯二酸半醛去羧酶的抑制剂 |
| WO2018106518A1 (en) | 2016-12-06 | 2018-06-14 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
| AR117122A1 (es) | 2018-11-20 | 2021-07-14 | Tes Pharma S R L | INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA |
| US11098029B2 (en) | 2019-02-13 | 2021-08-24 | Merck Sharp & Dohme Corp. | 5-alkyl pyrrolidine orexin receptor agonists |
| US12331018B2 (en) | 2019-02-13 | 2025-06-17 | Merck Sharp & Dohme Llc | Pyrrolidine orexin receptor agonists |
| US12312332B2 (en) | 2019-08-08 | 2025-05-27 | Merck Sharp & Dohme Llc | Heteroaryl pyrrolidine and piperidine orexin receptor agonists |
| CR20230089A (es) | 2020-08-18 | 2023-04-11 | Merck Sharp & Dohme Llc | Agonistas de bicicloheptano pirrolidina de los receptores de orexina |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4182625A (en) * | 1977-07-05 | 1980-01-08 | Stauffer Chemical Company | 3-Halo-5-(lower alkoxy) phenoxy alkyl amides |
| US4710518A (en) * | 1984-07-02 | 1987-12-01 | Nihon Tokushu Noyaku Seizo K.K. | Novel N-benzyl-cyclopropanecarboxamide fungicides |
| DE3628082A1 (de) * | 1986-08-19 | 1988-03-03 | Basf Ag | Carboxamide, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen |
| DE3702964A1 (de) * | 1987-01-30 | 1988-08-11 | Shell Agrar Gmbh & Co Kg | Aryloxycarbonsaeurederivate, ihre herstellung und verwendung |
| US4946867A (en) * | 1987-09-07 | 1990-08-07 | Sumitomo Chemical Company, Limited | Cyanoacetamide derivative, and plant disease protectant comprising the same as an active ingredient |
| DE3823521A1 (de) * | 1988-07-12 | 1990-02-15 | Basf Ag | Cyclopropancarboxamide, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen |
| DE3915756A1 (de) * | 1989-05-13 | 1990-11-29 | Bayer Ag | Cyclopropanoylaminosaeureamid-derivate |
| EP0467840A3 (en) | 1990-07-18 | 1992-10-28 | Ciba-Geigy Ag | Derivatives of cyclopropyle acetic acid |
| DE4236400A1 (de) * | 1992-10-28 | 1994-05-05 | Bayer Ag | N-Phenylacetaminonitrile |
| CN1246845A (zh) * | 1997-02-04 | 2000-03-08 | 纳幕尔杜邦公司 | 杀菌的羧酰胺 |
| US5942640A (en) * | 1998-04-20 | 1999-08-24 | American Cyanamid Company | Process for the manufacture of N-(1-cyanoalkyl)-2-phenoxypropionamide derivatives |
-
1998
- 1998-01-27 CN CN98802296A patent/CN1246845A/zh active Pending
- 1998-01-27 WO PCT/US1998/001668 patent/WO1998033765A1/en not_active Ceased
- 1998-01-27 CN CNA2006101111628A patent/CN1982290A/zh active Pending
- 1998-01-27 US US09/355,785 patent/US6251947B1/en not_active Expired - Fee Related
- 1998-01-27 KR KR10-1999-7006969A patent/KR100510794B1/ko not_active Expired - Fee Related
- 1998-01-27 JP JP53304398A patent/JP2001511147A/ja not_active Ceased
- 1998-01-27 AU AU59320/98A patent/AU5932098A/en not_active Abandoned
-
2001
- 2001-03-02 US US09/798,428 patent/US7135585B2/en not_active Expired - Fee Related
- 2001-03-02 US US09/798,423 patent/US7205331B2/en not_active Expired - Fee Related
- 2001-03-02 US US09/798,421 patent/US6642392B1/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100451006C (zh) * | 2005-12-08 | 2009-01-14 | 南开大学 | 一种羧酰胺类化合物及其制备方法和用途 |
| CN104774201A (zh) * | 2006-07-27 | 2015-07-15 | 杜邦公司 | 杀真菌的氮环酰胺 |
| CN106986866A (zh) * | 2006-07-27 | 2017-07-28 | 杜邦公司 | 杀真菌的氮环酰胺 |
| CN106986866B (zh) * | 2006-07-27 | 2020-03-03 | 杜邦公司 | 杀真菌的氮环酰胺 |
| CN108912005A (zh) * | 2013-08-09 | 2018-11-30 | 奥斯瓦道·克鲁兹基金会 | 二苯氧基烷基胺衍生物及其药物组合物 |
| CN108912005B (zh) * | 2013-08-09 | 2022-01-14 | 奥斯瓦道·克鲁兹基金会 | 二苯氧基烷基胺衍生物及其药物组合物 |
| CN114230551A (zh) * | 2021-12-31 | 2022-03-25 | 江西省科学院应用化学研究所 | 一种环丙基取代的噻吩类化合物的制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| US7135585B2 (en) | 2006-11-14 |
| US20060178425A1 (en) | 2006-08-10 |
| US6251947B1 (en) | 2001-06-26 |
| KR20000070719A (ko) | 2000-11-25 |
| US6642392B1 (en) | 2003-11-04 |
| CN1982290A (zh) | 2007-06-20 |
| JP2001511147A (ja) | 2001-08-07 |
| US7205331B2 (en) | 2007-04-17 |
| AU5932098A (en) | 1998-08-25 |
| WO1998033765A1 (en) | 1998-08-06 |
| KR100510794B1 (ko) | 2005-08-31 |
| US20060025472A1 (en) | 2006-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1246845A (zh) | 杀菌的羧酰胺 | |
| CN1158267C (zh) | 氰硫基-三唑基衍生物及其作为杀微生物剂的用途 | |
| CN1229354C (zh) | 酰基硫基-三唑其衍生物及其作为杀微生物剂的用途 | |
| CN1066439C (zh) | 异噁唑除草剂的制备方法 | |
| CN1216984A (zh) | 三唑基-硫醇盐及其作为杀微生物剂的用途 | |
| CN1025470C (zh) | 含新型硅烷衍生物的农药,杀虫剂和杀螨剂组合物 | |
| CN1044814A (zh) | (亚苄基)唑基甲基环烷烃及其杀菌剂 | |
| CN86107292A (zh) | 新型硅烷衍生物,其制法,含该衍生物的制剂及其作为农药的应用 | |
| CN1213050C (zh) | 氧杂双环[2.2.1]庚烷衍生物,其制备方法和作为农药的用途 | |
| CN1492864A (zh) | 吡唑基嘧啶 | |
| CN1217903C (zh) | 取代联苯基噁唑啉 | |
| CN1046526A (zh) | 新化合物及其制备方法 | |
| CN85108650A (zh) | 哒嗪酮衍生物的制备方法,以及杀虫成分,杀螨成分,杀线虫成分,杀(真)菌成分 | |
| CN1036879A (zh) | 杀生组合物 | |
| CN1017898B (zh) | 制备取代的酰胺衍生物的方法 | |
| CN86105510A (zh) | 哒嗪酮衍生物的制备方法及其杀虫组合物 | |
| CN1025677C (zh) | 新型杂环化合物的杀虫剂组合物及其制备方法和用途 | |
| CN1602296A (zh) | 氨基乙腈衍生物 | |
| CN1648122A (zh) | 丙二腈化合物及其用途 | |
| CN1454206A (zh) | 苯基-取代的2-烯胺基-酮腈 | |
| CN1197862C (zh) | 2-(3,5-二取代-4-吡啶基)-4-芳基苯基-1,3-噁唑啉化合物 | |
| CN1113232A (zh) | 二硫代碳酰亚胺衍生物,其中间体、制备方法和用途 | |
| CN1047285A (zh) | 新的苯基嘧啶酮衍生物及其制备方法 | |
| CN1027448C (zh) | 杂环新芬烷类似物的制备方法 | |
| CN1091423A (zh) | 含有二烯酰胺衍生物的农药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: E. I. DU PONT DE NEMOURS AND CO. TO: ARKANSAS UNIVERSITY COURT |
|
| CP03 | Change of name, title or address |
Address after: American Arkansas Applicant after: Texas A. & M. Univ Sys Address before: Wilmington, Delaware, USA Applicant before: E. I. du Pont de Nemours and Co. |
|
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |